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ABSTRACT 
STEPHANIE GUZIK LENDRUM: Drosophila melanogaster myosin-18 represents a highly 
divergent molecular motor with actin tethering properties 
(Under the direction of Dr. James R. Sellers, NIH/NHLBI) 
 
Myosins are actin-based molecular motors that use energy from ATP hydrolysis to 
perform work within the cell.  On a cellular scale their influence is vast, driving intracellular 
trafficking, cell motility, contraction, and division.  On a larger scale, myosins are integral to the 
developmental process, immunological response, vision, hearing, and muscle contraction.  
Class 18 of the myosin superfamily has been implicated as a factor in clinically relevant 
roles as a support system for stromal cell differentiation (myosin-18A) and as a tumor suppressor 
(myosin-18B).  Within mammalian cells, myosin-18A has been suggested to help maintain both 
the trans-Golgi structure and actin networks in the lamellipodia.  However, biochemical analysis 
of myosin-18A suggests that it has markedly different properties than other myosins, namely that 
its ability to bind actin is insensitive to ATP. Furthermore, myosin-18 differs from other myosins 
by the presence of a PDZ protein-protein interacting domain at its N-terminus.  
In this study, we investigated the biochemistry of Drosophila melanogaster myosin-18.  
Using an Sf9/baculoviral expression system, we probed the activities of this myosin from the 
perspective of its association with actin and ATP. This study suggests that myosin-18 is highly 
divergent from other molecular motors, with ATP-insensitive actin binding, and lack of 
nucleotide binding properties. These results suggest that some myosins may function more as 
actin tethers, and in this regard, may be more precisely defined as an actin binding protein. 
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CHAPTER ONE:  
BACKGROUND AND SIGNIFICANCE 
 
1.1 The Myosin Superfamily 
 
1.1.1 Introduction to the Myosin Superfamily 
According to a recent phylogenetic analysis of the myosin superfamily, which used the 
genomes of 328 eukaryotic species to identify 2,269 myosin motors, there are 35 classes of 
myosin motors and another 149 myosin-like proteins that could not be assigned to a specific class 
(Odronitz and Kollmar, 2007). 
Myosins are molecular motors that hydrolyze ATP and convert the chemical energy 
stored in the ATP molecule to mechanical energy to generate force against actin filaments in the 
cell.  The first myosins discovered were the sarcomeric myosins from skeletal and cardiac 
muscle.  Homologous isoforms of these myosins were subsequently discovered in nonmuscle 
cells.  In 1973, Pollard and Korn purified a type of myosin from Acanthamoeba castellani, which 
differed in many respects from the “conventional” myosins that had previously been studied 
(Pollard and Korn, 1973).  They referred to this myosin as Acanthamoeba myosin I, and later 
purified a conventional myosin from the same organism which they called Acanthamoeba myosin 
II ultimately giving the conventional myosins their classification as myosin II.  Subsequent 
classes of myosin, most discovered by molecular genetics, were given class numbers starting with 
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class III. With 35 currently described classes of myosins, some researchers in the field have 
moved away from the traditional Roman numeral descriptions of classes in favor of Arabic 
numbering.  
On a cellular level, the myosin superfamily acts as an integral component of the 
cytoskeleton.    Myosins play roles in virtually all cellular processes including motility, 
polarization, mitosis, intracellular trafficking, and extension of filopodia to probe the extracellular 
environment (Cheney and Mooseker, 1992; Sellers, 1999).  The involvement of myosins in 
cellular processes makes them essential to a wide variety of physiological processes.  
Consequently, mutations within myosin genes have been implicated in inherited disorders 
including deafness (Probst et al., 1998; Wang et al., 1998; Weil et al., 1995), blindness (Weil et 
al., 1995), platelet abnormalities (Kelley et al., 2000; Seri et al., 2000), cardiomyopathies 
(Seidman and Seidman, 2001), and cancers (Ajima et al., 2008; Nakano et al., 2005).  The 
widespread physiological relevance of the myosin superfamily proteins reflects the range of 
diversity within the superfamily and the pervasiveness of these motors in essential cellular 
processes (Berg et al., 2001; Sellers, 1999).  
 
 
1.1.2 Basic Structure 
All members of the myosin superfamily share a basic consensus structure consisting of a 
heavy chain that has traditionally been viewed as being separated into three regions: a head, a 
neck, and a tail (Figure 1.1).   
The head region, or motor domain, of the myosin heavy chain is the catalytic site of the 
myosin. It serves two essential roles to the motor: it acts as (a) a site for binding to the actin 
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filament and (b) contains a nucleotide binding pocket as a site for ATP binding and hydrolysis 
that produces conformational changes in the motor domain.  In serving these two essential roles, 
the motor domain is the most highly conserved region within myosins on the basis of amino acid 
sequence and is therefore the region used for recognition and classification of the myosin 
superfamily  (Sellers, 1999).   
The neck of myosin motors is a stretch of the amino acid sequence following the motor 
domain that contains binding sites for light chain proteins, usually calmodulin or calmodulin 
family members, in the form of IQ motifs having the consensus sequence IQXXXRGXXXR 
(Cheney and Mooseker, 1992). The neck acts as a lever arm for the molecule, providing 
mechanical support for the myosin to induce a force against the actin filament by magnifying the 
movement of the conformational changes in the motor domain into a larger motion of the myosin 
against an actin filament (Howard and Spudich, 1996; Whittaker et al., 1995). The number of 
light chain binding sites differs between myosins depending on their role in the cell.  In some 
myosins the neck region is involved in regulation via phosphorylation of the light chain or by 
calcium binding to the light chain (Szent-Gyorgyi, 1996).  
The myosin tail region is the most divergent domain within the myosin superfamily, 
reflecting the diverse roles for myosins. Depending on the class of myosin motor, the tail may 
have a coiled-coil motif that allows the motors to dimerize into two-headed structures 
(McLachlan and Karn, 1983).  In some classes of myosins, the coiled-coil tails can self-associate 
to form filaments. The tail can also be the site of cargo binding for intracellular transport (Wu et 
al., 2006; Wu et al., 2002).  In some,  the tail performs a regulatory mechanism for the motor, 
folding up the molecule into an inactive form under specific conditions (Burgess et al., 2007; Liu 
et al., 2006; Thirumurugan et al., 2006).  The tail region may also contain additional domains 
(Odronitz and Kollmar, 2007) including a MyTH/Ferm domain (myosin-7 and myosin-15A) or 
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PH domain (myosin-10), or GAP domains (myosin-9) linking those myosins to binding partners, 
signal transduction pathways, and the plasma membrane.  
 
 
 
 
 
Figure 1.1: Basic Myosin Heavy Chain Structure.  
As shown here, the general structure of myosin heavy chains is shared between classes. 
Representative structures from class-2 and class-5 are shown to have a head region, a neck 
with IQ domains for light chain binding, and a tail region that is highly variable between 
classes depending on the role of the motor.  
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1.2  Myosin motor mechanics 
1.2.1  Substructure of the Motor Domain  
Proteolytic digestion of the motor domain fragments the head into three structural 
segments connected by proteolytically sensitive surface loops: the 25K N-terminal segment, 
connected by Loop 1 to the middle 50K segment, which is connected by the variable-length Loop 
2 (Lorenz and Holmes, 2010) to the 20K C-terminal segment (Geeves and Holmes, 2005).  
Structurally, these loops do little to delineate one segment from another, with all segments 
composing parts of the actin binding and nucleotide binding sites of the motor (Figure 1.2) 
(Holmes and Geeves, 2000).  
The N-terminal, or 25K segment of the motor contains a SH3-like β-barrel structure with 
unknown function (Holmes and Geeves, 2000). It is physically located close to the C-terminus on 
the crystal structure of the myosin motor domain, with a portion of this segment, the P-loop, 
forming an integral component of the nucleotide binding pocket (Geeves and Holmes, 2005).   
This SH3-like domain is missing in some myosin classes such as class 1 (Kollmar et al., 2002). 
The 50K middle segment is structurally segmented into upper and lower portions by a 
flexible connector Switch II.  The upper and lower 50K portions are separated by a large cleft 
running between them, which is comprised of a 7-strand central β-sheet made up of parts of each 
motor segment surrounded by α-helices(Holmes and Geeves, 2000). The cleft running through 
the middle 50K is the epicenter of myosin activity, constituting both the actin binding and 
nucleotide binding sites (Rayment et al., 1993a; Rayment et al., 1993b; Ruppel and Spudich, 
1996) and therefore integrally linking those two motor properties to each other. This relationship 
is described in further detail below.  
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The C-terminal 20K segment forms a long, extended α-helical structure that forms the 
neck of the myosin motor. It is the site for attachment of calmodulin-like light chain proteins that 
support the structure of the neck (Holmes and Geeves, 2000). This segment is also the site of the 
converter subdomain, which acts to translate small changes in the motor domain structure into 
large rotations of the lever arm, as discussed below.  
 
 
 
Figure 1.2: Crystal structure of Dictyostelium myosin-2 motor domain with labeled 
substructure.  
The structure of the Dictyostelium myosin-2 motor domain (PDB ID: 1MMD, manipulated by 
ProteinWorkshop (version 3.8, Molecular Biology Toolbox (Moreland et al., 2005)) is color-
coded to depict substructural elements. The N-terminal SH3-like domain has unknown 
function and is not found in all myosins. The middle 50K is the result of cleavage of Loop 1 
and Loop 2, and is a structural element composed of an upper and lower segment (here shown 
in an orientation rotated 180° along the x-axis) that are connected by Switch II in the 
nucleotide binding pocket but are separated by a large cleft composed of the central β-sheet. 
The open cleft between the two segments is the site of actin binding, while the exterior of the 
molecule at the apex of the cleft is the site of nucleotide binding. The converter domain, in the 
C-terminal 20K, amplifies small structural changes within the motor domain into large 
motions of the lever arm during the powerstroke.
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At the time of a survey in 1998, a comparison of the available crystal structures of 
myosin motor domains confirmed that all the motor domain sequences preserved this basic 
conformation.  The amino acid sequences of the myosins analyzed in that survey exhibited 
differences in length of certain regions of the motor, but structurally, those extensions were 
established as surface loop extensions around a highly conserved core structure (Furch et al., 
1998; Sellers, 1999).  
 
 
1.2.2  Actin-Binding Site 
The actin binding site of the myosin motor is located at the open end of the cleft between 
the upper and lower 50K regions of the motor domain, directly opposite from the nucleotide 
binding site which lies at the opposite end of the cleft (Figure 1.2). It is comprised of several 
structural components from all segments of the motor that interact to varying degrees with the 
actin filament.  
The majority of the actin-myosin interface is created by the lower 50K region. Loop 2 is 
also modeled to have a large role in the actomyosin interaction (Lorenz and Holmes, 2010). 
Although its flexibility makes it invisible in crystallographic analysis, mutations within the loop 
have been shown to alter the affinity of the motor for actin, reflecting its major role in actomyosin 
interaction (Furch et al., 1998; Joel et al., 2003). The cardiomyopathy loop within the upper 50K 
region is also known to play a substantial role in the interface (Holmes et al., 2004; Lorenz and 
Holmes, 2010), while Loop 4 is expected to play a lesser role in binding to the actin monomer, 
and loop 3 appears to have a weak interaction with the neighboring actin monomer in the filament 
(Holmes et al., 2004).  
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Structurally, the actin binding site at one end of the cleft is located opposite from the 
nucleotide binding pocket at the apex of the cleft, which is a distance of ~4 nm (Holmes and 
Geeves, 2000). This localization serves to link the motor’s ATP binding and actin binding 
integrally, yet negatively as described in detail below.  
 
 
1.2.3  Nucleotide Binding Site 
The nucleotide binding pocket of the myosin motor is situated on the exterior of the 
molecule where the upper and lower regions of the 50K segment connect, opposite the actin 
binding interface.  The pocket is surrounded by three highly conserved loops: the P-loop, Switch I 
and Switch II.  The sequence of these three loops is conserved beyond the myosin superfamily, 
with very similar structures and sequences shared with other ATPase molecular motors (dynein 
and kinesin) and GTPase G-proteins, reflecting the integral nature of nucleotide hydrolysis to 
these proteins and a similar evolutionary origin (Smith and Rayment, 1996). (Figures 1.2 and 
1.3).  
The phosphate binding loop (P-loop) of myosins has a consensus sequence of 
GESGAGKT.  Other purine nucleotide hydrolyzing proteins, including the microtubule motor 
kinesin and signaling cascade G-proteins, have a P-loop that is structurally similar, with a 
consensus among these different protein classes of GXXXXGKT/S (Smith and Rayment, 1996).  
Switch I, with the consensus sequence NXNSSRFG for most myosins in the superfamily 
(Sasaki and Sutoh, 1998; Sellers, 1999), contains residues known to present their side chains into 
the nucleotide binding pocket, establishing interactions with the bound nucleotide and the Mg+2 
ion within the pocket (Sasaki and Sutoh, 1998; Sweeney and Houdusse, 2004).  
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In Switch II (DIXGFE), the D residue is known to interact with the water molecule 
associated with the Mg+2 ion in the nucleotide binding pocket (Sasaki and Sutoh, 1998).  The 
Switch II loop is the site of a substantial rotation between the I and G residues during the ATP 
hydrolysis cycle. This rotation brings in residues that are essential to hydrolysis of the gamma-
phosphate (γ-Pi) and the associated conformational changes serves to open and close the cleft 
between the upper and lower segments of the 50K portions of the motor  and alter actin binding 
strength (Onishi et al., 1998; Onishi et al., 1997; Ruppel and Spudich, 1996).   
Furthermore, a salt bridge is formed between the R of Switch I and the E of Switch II, 
forming a gate at the opening of the nucleotide binding pocket (Sasaki and Sutoh, 1998; Yount et 
al., 1995) which confines the ADP-Pi intermediate in the kinetic cycle and regulates the kinetics 
of the release of Pi from the motor.   
 
Figure 1.3: The nucleotide binding pocket of Dictyostelium myosin-2.  
The nucleotide binding pocket of myosin motors, as illustrated here using Dictyostelium 
myosin-2 (PDB ID: 1MMD, manipulated by ProteinWorkshop (version 3.8, Molecular 
Biology Toolbox (Moreland et al., 2005)), is comprised of three highly conserved structural 
elements: the P-loop, Switch I, and Switch II. These components interact with the bound 
nucleotide, Mg+2, and attacking water molecule during the hydrolysis of ATP.  
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1.2.4  Integral Relationship between Actin Binding, Nucleotide Binding, and Powerstroke 
Myosin motor structural intermediates from portions of the kinetic cycle have been 
captured in crystal structures. These crystallography results have provided detailed structural 
explanations for many, but not all, steps of the myosin kinetic cycle (Geeves and Holmes, 2005; 
Holmes and Geeves, 2000; Holmes et al., 2004). Moreover, they have provided a structural 
explanation to elucidate the mechanism for which actin binding and nucleotide binding are 
integrally and negatively linked to each other during the myosin motor ATPase cycle.  
In a nucleotide-free state, the myosin motor is strongly bound to actin. This strong 
affinity state is structurally the result of a closure of the cleft between the upper and lower 50K 
regions (Geeves and Holmes, 2005). Closure of the bottom of the cleft in this manner is 
coincident with an opening of the apex of the cleft, the site of the nucleotide binding pocket 
(Holmes et al., 2004). This open pocket allows for ATP to bind to the motor domain.  
Binding of ATP induces several changes within the motor structure, initiated by the 
association of the nucleotide binding pocket components with the bound nucleotide. For ATP to 
be hydrolyzed, all three components (the P-loop, Switch I and Switch II) must be closed around 
the nucleotide (Geeves and Holmes, 2005).  
Closure of the P-loop physically closes off the opening of the nucleotide binding pocket, 
trapping the bound nucleotide while also resulting in an interaction between the conserved lysine 
in the P-loop and the Mg+2 ion and the attacking water molecule (Holmes and Geeves, 2000). 
Closure of switch I serves to physically alter the cleft of the molecule, forcing the cleft to open, 
and thereby decreasing the motor’s affinity to actin and releasing the motor from the filament 
(Geeves and Holmes, 2005).  
  
11
While the closure of switch II allows the loop to interact with the γ-Pi  of the bound ATP, 
the rotation involved in closure of switch II drives a coordinated series of events that result in 
movement of the lever arm (Holmes et al., 2004). Rotation of switch II upon ATP binding exerts 
an internal pressure within the myosin motor domain. To relieve this pressure, the α-helix that 
follows switch II (the relay helix) is forced to kink, which creates a rotation of 60° in the 
subsequent converter domain (Geeves and Holmes, 2005; Holmes et al., 2004; Sweeney and 
Houdusse, 2004). This rotation is the basis of the swing of the lever arm. Upon ATP binding, the 
lever arm rotates to a “primed” position in preparation for a powerstroke (Geeves and Holmes, 
2005).  
The hydrolysis of ATP begins upon closure of the three loops of the nucleotide binding 
pocket. Hydrolysis requires that the γ-Pi is stabilized by an H-bond with switch II and that the salt 
bridge forms between switch I and switch II (Geeves and Holmes, 2005). Throughout hydrolysis 
of the ATP to ADP-Pi, the motor is still in a state with a low affinity for actin (De La Cruz and 
Ostap, 2004). But weak interaction with the actin filament serves to induce changes in the 
nucleotide binding pocket structure that support release of the Pi by opening the “back door” salt 
bridge of the molecule (Sasaki and Sutoh, 1998; Yount et al., 1995).  
Within the actin binding region of the cleft, weak binding to actin causes a shift of the 
central β-sheet within the cleft (Holmes et al., 2004; Sweeney and Houdusse, 2004). This, once 
again, induces pressure within the motor domain structure which is resolved by unkinking the 
relay helix (Holmes et al., 2004). Not only does removal of the kink relax the structure of the 
molecule, it also serves to rotate the converter domain back 60°, which in turn moves the lever 
arm through a power stroke against the actin filament (De La Cruz and Ostap, 2004; Sweeney and 
Houdusse, 2004). Coincident with this power stroke is a shift to strong actin binding and 
additionally, a forced movement of the P-loop to an open position (Geeves and Holmes, 2005). 
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Thus, the actin binding serves to decrease the affinity of the motor for nucleotide, opening the 
pocket to release the Mg+2 ion, then the bound ADP, and opening up the nucleotide binding 
pocket for a subsequent ATP to bind and repeat the cycle (Geeves and Holmes, 2005; Sweeney 
and Houdusse, 2004).  
The time that a myosin motor spends during each step of the cycle in these structural 
intermediates depends highly on the function of that motor (De La Cruz and Ostap, 2004). Non-
processive motors spend a long time in the states favoring bound nucleotide and low actin 
affinity, rapidly proceeding through the powerstroke, ADP release, and ATP binding steps. 
Processive motors, in contrast, spend a longer time in states favoring high affinity for actin, with 
low nucleotide affinity and therefore proceed through the weak-actin-affinity steps of nucleotide 
binding and hydrolysis.  
 
 
1.3  Myosin Motor Kinetics  
 
1.3.1  Myosin motor kinetic cycle 
Several studies have elucidated the kinetic mechanisms  of the myosin ATPase cycle (De 
La Cruz and Ostap, 2004). The simplified kinetic cycle shared by the myosin superfamily is 
detailed in Figure 1.4.  
In the absence of nucleotide (AM), the myosin motor is in a rigor state, tightly bound 
(Ka∼107 M-1) to the actin filament. The lever arm is positioned at a ~45° angle with respect to the 
long axis of the actin filament. Upon binding of ATP into the vacant nucleotide binding pocket 
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(AM-T), the affinity of the myosin motor for actin falls (103-fold) so that the myosin quickly 
detaches from the actin filament (M-T). Hydrolysis of ATP (M-D.Pi) results in a weak-binding 
state of the motor that allows it to re-bind the filament at low affinity (AM-D.Pi) in a pre-
powerstroke conformation with the lever arm now at a 90° angle with respect to the actin 
filament.  Subsequent release of the Pi from the nucleotide binding pocket (AM-D) produces a 
much higher affinity binding state between the motor domain and actin.  This strongly bound 
intermediate initiates the powerstroke that translocates the actin filament through a mechanical 
swing of the myosin lever arm.  Release of the ADP from the nucleotide binding pocket (AM) is 
the final step of a single round of this kinetic cycle, with the resultant apo-state being in rigor 
complex once again with actin in a post-powerstroke configuration.   A new ATP molecule can 
now enter the vacant pocket to restart the cycle (De La Cruz and Ostap, 2004).  
Throughout the kinetic cycle, the binding intermediates of the motor with actin are 
integrally linked to the binding and hydrolysis of ATP through structural changes in the myosin 
motor mechanics.  The rates of each step of the kinetic cycle vary widely within the classes of the 
myosin superfamily, and even between isoforms within the classes, contributing to the diversity 
of motor function and physiological roles for myosins (Table 1.1) (Berg et al., 2001; De La Cruz 
and Ostap, 2004; Sellers, 1999). 
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Figure 1.4: General kinetic cycle of myosin motors. 
A representative scheme for the kinetic cycle of myosin motors, as illustrated here, shows how 
myosin motor domains cycle between conformations that bind weakly or strongly to actin in 
response to the state of the nucleotide in the binding pocket. The rates of each step of the 
kinetic cycle vary widely within the myosin superfamily to reflect the physiological role of the 
myosin in cells.  
  
15
 T
ab
le
 1
.1
: K
ey
 R
at
es
 a
nd
 E
qu
ili
br
iu
m
 C
on
st
an
ts
 fo
r 
K
in
et
ic
 C
yc
le
s o
f S
el
ec
t M
yo
si
ns
 
 a 
 (K
ov
ac
s e
t a
l.,
 2
00
3)
 
b 
 (F
ur
ch
 e
t a
l.,
 1
99
9)
 
c 
 (S
el
le
rs
, 1
99
9)
 
d 
 (K
uh
lm
an
 a
nd
 B
ag
sh
aw
, 1
99
8)
 
e 
 (D
e 
La
 C
ru
z 
et
 a
l.,
 1
99
9)
 
 
  
16
1.3.2  Duty Ratio and Processivity 
Two measures of the myosin kinetics are frequently used to describe the motor: duty ratio 
and processivity (De La Cruz and Ostap, 2004; Sellers, 1999). 
The duty ratio of the myosin is defined as the fraction of a single kinetic cycle during 
which an individual myosin motor is in a state strongly bound to actin (i.e. AM and AM-D states 
in Figure 1.4). Myosins with a high duty ratio spend most of their kinetic cycle in a state strongly 
bound to the actin filament because the rate limiting step of their ATPase cycle is the release of 
ADP from the nucleotide binding pocket during the strongly bound state.  Low duty ratio motors 
spend a small fraction of their cycle in the strong stage because the entry into the strongly bound 
state (Pi release from the AM-D.Pi state) is the rate- limiting (i.e., the slowest) step in the cross 
bridge cycle. Examples of both low and high duty ratio motors and the impact of their associated 
duty ratios will be further discussed within this introduction (1.3.3 and 1.3.4).  
Processivity is defined as the ability of a molecular motor to take successive steps along 
its track (Higuchi and Endow, 2002). In the case of myosin, this refers to its ability to take 
sequential steps along the actin track before diffusing away from the filament. Generally, the 
classification of processivity for motors describes them as either being processive (being able to 
take several sequential steps during a single encounter with the actin filament) or non-processive 
(taking only a single step during an encounter with actin) and this depends on the role that the 
myosin plays within the cell.  Myosins that are involved in muscular contraction have evolved 
to be non-processive. They undergo one powerstroke followed by a detachment for each kinetic 
cycle (hydrolyzing one ATP molecule/powerstroke).  Individually, these non-processive motors 
would be ineffective at performing their cellular task. Instead, they work as an ensemble, and 
together, the rapid interaction and subsequent rapid release of non-processive myosins allows for 
efficient contraction (~ 50% efficiency) with minimal drag induced on the other motors of the 
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ensemble. Conversely, a single processive motor takes multiple ATP-dependent steps along an 
actin filament before dissociating.  In so doing they more efficiently transport their cargo (Figure 
1.5) (De La Cruz and Ostap, 2004; Sellers, 1999).  
 
 
1.3.3   Skeletal Muscle Myosin-2: A low duty ratio, non-processive motor 
The first myosin identified and studied was the myosin found in muscle, later classified 
as myosin-2 (Spudich, 1989).  Subsequently myosin-2 motors were also found in the cytoplasm 
of all cells.  In muscle, there are three subdivisions of myosin-2 established based on their muscle 
 
Figure 1.5: Processivity of Myosins. 
Myosin motors are generally classified as being processive or non-processive. Non-processive 
motors, like skeletal muscle myosin-2, work in ensembles to collectively exert a force against 
actin filaments and induce muscle contraction, with each motor undergoing a rapid interaction 
and rapid release from the filament to minimize drag on the other motors. Processive motors 
like myosin-5a often perform cargo-carrying functions, and as such are able to take multiple 
successive steps along an actin filament track before dissociating away.   
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of origin: skeletal, smooth, and cardiac (Sellers, 1999), with different isoforms of each of these 
myosins expressed in a developmentally regulated manner. The activity of the myosin-2 proteins 
in each muscle type differ substantially from one another depending on their muscle of origin and 
the speed at which that muscle contracts (Harris and Warshaw, 1993; Marston and Taylor, 1980).   
The structure of the muscle myosin-2 heavy chain (Figure 1.1) consists of a motor 
domain (having an actin binding site, an ATP binding site, and a converter region) followed by 
two IQ motifs and a long coiled-coil tail that promotes dimerization.    
In vertebrate skeletal muscle, the long coiled-coil tail of myosin-2 self-associates at low 
ionic strength to form bipolar thick filaments that are consistently 1.6 µm long (Craig and Offer, 
1976; Sjostrom and Squire, 1977; Sosa et al., 1994), containing 294 myosin-2 heads with three-
fold rotational symmetry (Davis, 1988; Kensler and Stewart, 1983)  that work as an asynchronous 
ensemble to produce a force against actin filaments within the muscle sarcomere. The bi-
directionality of the myosin cross-bridges allows motors within a single thick filament to pull 
opposing actin filaments toward each other, shortening the sarcomere and producing muscle 
contraction (Huxley, 1961).  
To work as an efficient ensemble, each skeletal muscle myosin-2 cross-bridge in the thick 
filament has a very short lifetime of interaction with the actin filament during which time it must 
induce a strong translocating force on the filament.  This rapid, strong, interaction ensures that a 
single motor does as much work as possible against the actin while not causing a drag on the actin 
filament as the other heads in the thick filament attempt to undergo their power strokes. As such, 
myosin-2 is a low duty ratio, non-processive motor that has as its rate limiting step the release of 
Pi from the nucleotide binding pocket and spends the majority of its kinetic cycle trapped in a 
weak actin-binding conformation (De La Cruz and Ostap, 2004; Harris and Warshaw, 1993; 
Harris et al., 1994; Uyeda et al., 1991).  
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1.3.4   Mammalian Myosin-5a: A high duty ratio, processive motor 
In mammalian cells, myosin-5a acts as a cargo carrier, transporting intracellular vesicles 
through the cytoplasm.  In particular, myosin-5a is directly involved in transport of melanosome 
pigment vesicles in melanocyte cells through a tripartite complex between the motor, 
melanophilin, and Rab27a in the melanosome membrane (Wu et al., 2006).  Disruption of this 
complex by null mutations in mice (myosin-5a null dilute mice; Rab27a null ashen mice; 
melanophilin null leaden mice) results in a pale coat color as a result of failure to transport 
melanosomes to the dendritic tips of melanocytes,  and other neurological defects.  
The coiled-coil motif in the myosin-5a tail region results in the dimerization of two heavy 
chains, such that a single myosin-5a motor is a two-headed complex.  Between the head and 
coiled-coil region is a neck (or lever arm) region that contains 6 IQ motifs, each of which binds a 
myosin light chain or calmodulin (Figure 1.1).   
Kinetically, the myosin-5a motor’s rate limiting step is release of the ADP from the 
nucleotide binding pocket (13 s-1)  as well as a very high affinity for ADP (Kd<0.5 µM (De La 
Cruz et al., 1999)). The remaining kinetic intermediates within the cycle are short-lived and 
therefore, each motor domain of the myosin-5a dimer spends the majority of its ATPase cycle in 
a strong actin binding intermediate.  The resulting duty ratio for this motor is calculated to be 
between 0.7 and 0.9, suggesting that each motor domain spends the majority of its kinetic cycle 
tightly bound to actin (De La Cruz et al., 1999; Forgacs et al., 2009).   
The high duty ratio for myosin-5a motors enable the myosin-5a dimer to move 
processively toward the barbed-end of actin filaments.  Several models for myosin-5a’s 
processive transport have been suggested and are still under debate, but the most widely 
supported view is a hand-over-hand stepping mechanism. In this model, the two motor domains 
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of the myosin-5a dimer alternate positions on the actin filament, stepping one in front of the other 
with one motor bound tightly to the actin filament at all times such that the dimer can take several 
progressive steps along the actin filament before dissociating (Kodera et al., ; Komori et al., 
2007; Sellers and Veigel, 2006; Snyder et al., 2004; Warshaw et al., 2005; Yildiz et al., 2003).  
The 6 IQ motifs of the myosin-5a neck allow the two heads of the molecule to bind 36 
nm apart when walking along actin.  This length is equal to the helical pseudo-repeat of the actin 
filament, suggesting that the myosin-5a steps in a path along one plane of the actin filament to 
transport its cargo through the cell with an efficiency approaching 100%. Ensembles of myosin-
5a motors bound to glass move actin filaments at a rate of approximately 400 nm s-1 in the classic 
in vitro motility assay (Reck-Peterson et al., 2000). Using another version of the assay, in which 
actin filaments are bound to the glass, single myosin-5a molecules move processively with an 
average run-length of ~1.8 µm depending on experimental conditions (Sakamoto et al., 2003). 
This processive motility of the myosin-5a dimer is inherently regulated. In vitro, under 
low ionic conditions, the myosin-5a dimer folds up on itself such that the globular tail domains 
interact with the motor domains, resulting in an inherent regulation mechanism within the protein 
(Sellers and Knight, 2007). Conversely, the myosin-5a dimer opens up to an extended active 
conformation in high ionic strength conditions or in the presence of its cargo, such as 
melanophilin. Such an inherent regulatory mechanism is essential within the complex 
environment of the cytoplasm, with only the necessary numbers of myosin-5a motors active at 
any given time. 
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1.4  Experimental Approaches to Characterize Myosin Motor Mechanics 
 
1.4.1   Steady State MgATPase Assay 
In vivo, the hydrolysis of MgATP by myosin motors provides the energy for the 
mechanical work done to contract muscles or in subcellular cargo movement.  In vitro analyses 
have been developed to test the rates of each step of the ATPase cycle.   
Myosin motors have an inherent capacity to hydrolyze MgATP, albeit at very slow rates 
(~0.05 s-1).  This basal rate of hydrolysis can be artificially increased using nonphysiological 
conditions (Pollard and Korn, 1973), while physiologically, the presence of actin accelerates the 
myosin MgATPase rate by 50-100 fold (Sellers, 1999).  
The increase of basal hydrolysis under nonphysiological conditions has been examined 
frequently through two assays. In the presence of high concentrations (0.5 M) KCl and the 
presence of either EDTA (2 mM) or Ca+2 (10 mM), the hydrolysis of ATP can be studied at easily 
measured rates (~10-20 s-1) (Pollard and Korn, 1973).  Versions of these assays, the K+-EDTA 
and Ca+2 ATPase assays, have been used to detect phosphate release from the ATP, which can be 
visualized through either radiometric or colorimetric analysis methods.  While these are very non-
physiological conditions, it has been shown by many groups over the years that these two assays 
provide diagnostic analysis of the myosin preparation, as the ATPase activity changes 
dramatically when the myosin motor is chemically modified.  
The steady state rates of MgATP hydrolysis of a population of motors in the presence of 
actin has been studied using an NADH-coupled ATP regenerating system (Hackney and Clark, 
1984). In this system (Figure 1.6), the hydrolysis of ATP to ADP by the motor is linked to the 
conversion of phosphoenolpyruvate (PEP) to pyruvate by pyruvate kinase (PK).  The resulting 
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pyruvate is converted to lactate by lactate dehydrogenase (LDH), which in turn oxidizes the 
NADH to NAD+. The resulting decrease in the amount of NADH in the system is read as a 
decrease in absorbance at 340 nm and is proportional to the amount of ATP hydrolyzed by the 
motor.   
 
 
 
 
 
 
 
 
Figure 1.6: NADH-Coupled ATP Regenerating System for Steady State MgATPase 
Assay. 
To analyze the steady state MgATPase of myosins, this NADH-coupled ATP regenerating 
system is used, through which a decrease in A340 equates to the amount of ATP hydrolyzed by 
the motor (Hackney and Clark, 1984).  
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1.4.2   Motility Assay 
The in vitro motility assay is a method to examine the interaction of myosin motors with 
actin filaments. It was developed originally by Kron and Spudich (Kron and Spudich, 1986) in 
response to previous cellular-based assays (Sheetz et al., 1986) as a method to analyze the ability 
of surface-bound myosin to translocate actin filaments using purified components (Kron and 
Spudich, 1986; Sellers et al., 1993). 
In the assay, myosin motors are non-specifically attached, or are attached via antibody 
interactions (Post et al., 2002) or biotin-streptavidin interactions (Lin et al., 2005), to a glass 
cover slip. Single actin filaments, typically stabilized and visualized by a stoichiometric binding  
of rhodamine-phalloidin (Yanagida et al., 1984), are flowed over the field of randomly-oriented 
motors. Addition of MgATP to the assay initiates active cycling of myosins to produce power 
strokes that pull the actin filaments across the field of view.  The direction of the filament’s 
movement is dependent on the polarity of the actin filament itself and the preferred directionality 
of the myosin motor (Kron and Spudich, 1986; Uyeda et al., 1991; Wells et al., 1999).  The 
translocation rate is dependent on the isoform of myosin used and can vary greatly (Sellers, 
1999).  Generally, the sliding actin filaments experience no load and so their speed is independent 
of the actin filament length, provided that sufficient myosin is bound to the surface.  For skeletal 
muscle myosins the assay measures a rate that is reflective of the unloaded shortening velocity in 
striated muscle fibers (Sellers et al., 1993).   
Various alterations to the actin gliding assay have been employed to probe the effect of 
frictional drag on myosin motility. Experiments mixing actively cycling myosins with either very 
slow or kinetically ‘inactive’ myosins have tested the mechanics of the powerstrokes of actively 
cycling molecules having to overcome the induced drag (Warshaw et al., 1990). Further 
variations on this loading assay have been performed with actin binding proteins forming the 
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frictional barrier (Greenberg and Moore, 2010; Janson et al., 1992) and by slower cycling 
myosins competing with faster cycling myosins within the system (Cuda et al., 1997; Harris et 
al., 1994).  
 
1.4.3   Cosedimentation Assay 
The actin cosedimentation assay is a method used to directly test the ability of myosin to 
bind to actin, and to characterize the affinity of that binding.  It is based on the fact that actin 
filaments (and anything strongly bound to them) rapidly (<10 min) sediment in the ultracentrifuge 
whereas free myosin does not.  In the case of the actomyosin cosedimentation assay, the 
biochemistry of the motor domain and its manipulation by the presence of nucleotide is exploited 
(Greene and Eisenberg, 1980; Greene and Eisenberg, 1982).  
Following ultracentrifugation, the pelleted actin and bound motors are separated from the 
unbound motors that remained in the supernatant during the spin. The proportion of free and 
bound myosin can be determined through densitometry of samples run on an SDS-PAGE gel or 
any other methods that permit quantification of the amount of unbound protein remaining in the 
supernatant. Performed over a range of actin concentrations, this assay provides a binding curve 
of the fraction of myosin bound to actin for estimation of the binding affinity of myosin for actin.   
 
1.4.4   Fluorescent Nucleotide Assays 
The kinetics of nucleotide binding to myosin motors has traditionally been probed with a 
variety of transient kinetic and radiometric analyses, but the advent of fluorescent nucleotide 
  
25
analogs has provided a different technique in which to visualize the binding of nucleotide to the 
motor domain.  
Two such fluorescent analogs, mant-ATP (2’- (or 3’)-O-(N-methylanthraniloyl) 
adenosine 5’-triphosphate) and deac-aminoATP (3’-(7-diethylaminocoumarin-3-carbonylamino)-
3’-deoxy-adenosine-triphosphate), have been used to analyze the detailed kinetics of myosin 
motors (Cremo et al., 1990; Forgacs et al., 2006; Franks-Skiba and Cooke, 1995; Webb et al., 
2004; Woodward et al., 1991).  These analogs structurally resemble the nucleotide with minimal 
addition to the bulk of the ribose ring of the molecule (Figure 1.7).  As myosins are generally 
promiscuous in binding and hydrolyzing nucleoside triphosphates (Weber, 1969; White et al., 
1993), the addition of fluorescent moieties to the bulk of the nucleotide still allows unhindered 
binding within the nucleotide binding pocket.  
The mant moiety has a high level of inherent fluorescence in solution when excited at 
356 nm, and its quantum yield read at 448 nm increases upon binding within the pocket (Cremo 
et al., 1990). However, that increase is only ∼2-fold.  To characterize the binding of mant 
fluorophores to the binding pocket of myosin, a more robust approach involves exciting a 
tryptophan residue near the binding pocket.  Exciting this residue with a wavelength of 280 nm 
induces a FRET response in the fluorophore to the mant-ATP bound at the active site, inducing 
an increase in quantum yield 10-30 fold over the baseline fluorescence when the mant-nucleotide 
is bound within the pocket.  
The deac moiety, unlike mant, has a very low signal in solution.  This low background 
fluorescence is accompanied by a large increase in quantum yield upon binding to the nucleotide 
binding pocket of some myosin (Webb et al., 2004). This combination of characteristics makes 
deac-amino nucleotides particularly useful in establishing the various kinetic steps of the ATPase 
cycle.  
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Figure 1.7: Molecular structure of fluorescent analogs of ATP.  
Fluorescent analogs of ATP, mant-ATP and deac-aminoATP, are useful probes to analyzing 
the transient kinetics of myosin motors. The structural adaptations required for the addition of 
the fluorescent moieties to the ATP molecule add minimal bulk allowing for unhindered 
binding of the analogs into the nucleotide binding pocket. (Structures drawn with ChemDraw 
Ultra 12.0, CambridgeSoft Corporation, Cambridge, MA, USA) 
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1.4.5   Optical Trapping Three Bead Assay 
The physical basis for optical trapping relies on the property of light, when focused to a 
diffraction-limited point through a high numerical aperture objective, to hold objects with a 
different dielectric constant than the surrounding environment.  Thus, optical traps are often 
called laser tweezers.  There are several variations in the geometry of laser tweezers.  The three-
bead assay (Figure 1.8) holds two polystyrene beads in each of two optical traps. These beads are 
prepared in a manner that will allow a rhodamine-phalloidin labeled actin filament to be 
connected between them, often using neutravidin coating on the beads and biotinylated-actin 
filaments as a method of connection. The resulting dumbbell-like structure can be visualized with 
bright-field fluorescence and moved through the reaction chamber by manipulating the trapped 
beads. The trapped filament is then moved to a third, larger bead called a “pedestal” that is coated 
sparsely (using myosin concentrations on the order of tens of pM), such that 1 out of every 5-10 
pedestals has a bound myosin.  Bringing the tethered actin filament down to the surface of the 
pedestal allows the motors to interact with the filament.   
Movement of the beads within the trap is visualized by quadrant photodiode detectors 
with high temporal (<0.1 ms) resolution.  When a myosin motor contacts the filament, the 
interaction decreases the Brownian noise of the trap system, which appears on the trace of the 
bead movements as a dampening of the noise on the detector trace.  An improvement to the 
detection system, as described by Baboolal and colleagues involves inducing an axial  sinusoidal 
motion of the actin filament by oscillating one of the trapped beads (Baboolal et al., 2009).  The 
noise in the detection system produced by this induced wave is dampened significantly upon 
myosin binding, making identification  and analysis of actomyosin interactions easier to 
distinguish from background noise (Batters et al., 2004; Sakamoto et al., 2003).  If the myosin 
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undergoes a power stroke while attached to the actin, a displacement from the averaged baseline 
position is observed. 
From single molecule analysis of myosin motors in optical trapping experiments, a 
variety of kinetic and mechanical data can be derived. The lifetime of individual interactions 
between the motor and actin filament detected in the three-bead assay can be used to calculate the 
rates of attachment and detachment for the motor.  The powerstroke of a mechanically active 
motor against the filament works to pull the bead away from the center of the trap and the 
resulting displacements can be plotted to a histogram, with the shift of the peak of the Gaussian 
fit from 0 nm equivalent to the length of the working powerstroke of the motor (Baboolal et al., 
2009; Molloy et al., 1995; Sakamoto et al., 2003).  Changing the trap stiffness, which requires the 
motor to pull against a larger force to displace the bead from the center of the trap, has been used 
for many myosins to determine the stall force, or the amount of force that is required to stop a 
mechanically active motor from exerting a powerstroke.   
 
Figure 1.8: Optical Trapping Three-Bead Assay.  
In the three-bead assay, as illustrated here, two polystyrene beads are held in optical traps and 
are manipulated to connect a rhodamine-phalloidin labeled actin filament between them. 
Bringing them down on top of a pedestal with a sparse coating of myosin allows for single-
molecule analysis of motor kinetics and mechanics against the actin filament.   
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1.5   Myosin-18 
1.5.1   Identification of Class 18 
Myosin-18 was originally identified as a gene essential for murine stromal cell support of 
hematopoietic differentiation (Furusawa et al., 2000). The gene sequence was reported to contain 
elements similar to a myosin motor domain.  However, the predicted protein had a unique N-
terminus unlike any other myosin described at that time that contained a large amount of lysine 
and glutamic acid residues (KE-rich segment) and a PDZ domain. The presence of this PDZ 
domain, which is a module for protein-protein interactions commonly found in scaffolding 
proteins and signaling complexes(Doyle et al., 1996; Good et al., 2011; Hung and Sheng, 2002; 
Sheng and Sala, 2001), led to the protein being initially named MysPDZ (Furusawa et al., 2000).   
Sequence analysis of the motor domain of MysPDZ revealed that it could not be 
classified with any already described myosin class and, thus, it was assigned a novel class 
number, myosin-18 and is now known as myosin-18A, following the identification of another 
myosin-18 gene found in mammalian genomes  (Berg et al., 2001; Yamashita et al., 2000).  
Sequence analysis of genomes suggested that myosin-18 was encoded in humans, mice, and 
Drosophila, but not in lower eukaryotes including C. elegans, Dictyostelium or S. cerevisiae 
(Mori et al., 2003). 
Myosin-18A isoforms are expressed ubiquitously by  all murine tissues, including 
stromal cells, skeletal and cardiac tissues (myosin-18Aα) (Furusawa et al., 2000), with a second 
shorter alternatively spliced variant isoform that lacked the N-terminal PDZ domain and appeared 
to be present specifically in hematopoietic tissues (myosin-18Aβ) (Mori et al., 2003).   
A second member of the myosin-18 class of proteins, myosin-18B, was originally 
identified as a tumor suppressor gene (Nishioka et al., 2002). Mutations, deletions and 
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modifications of this gene in vivo were determined to be involved in the establishment and 
progression of lung, colorectal, and ovarian cancers (Nakano et al., 2005; Nishioka et al., 2002; 
Yanaihara et al., 2004). Myosin-18B is derived as a product of a separate gene from the one that 
encodes the myosin-18A isoforms. According to genome scans of vertebrates and invertebrates, 
myosin-18B is found in vertebrates only and unlike myosin-18A, a homologue could not be 
found for myosin-18B in Drosophila (Salamon et al., 2003). Also unlike myosin-18A, the gene 
product of myosin-18B (2,566 residues in length) lacks an N-terminal KE-rich segment and PDZ 
domain, and instead features long extensions at the N- (564 residues) and C-termini (482 
residues) with undetermined physiological function (Salamon et al., 2003).  
A survey of the Drosophila genome identified a novel myosin gene with high sequence 
similarity to the mammalian myosin-18A gene. It was given the gene name Myosin Heavy Chain-
Like (Mhcl) (Berg et al., 2001; Tzolovsky et al., 2002; Yamashita et al., 2000). To date, class-18 
of the myosin superfamily is the only class of myosin motors featuring isoforms with an N-
terminal PDZ domain (Odronitz and Kollmar, 2006; Odronitz and Kollmar, 2007).  
 
1.5.2   Mammalian Myosin-18A isoform analysis  
As illustrated in Figure 1.9, alternative splicing of myosin-18A results in two isoforms, α 
and β, that differ in their N-terminus. Myosin-18Aα contains an N-terminal KE-rich region, 
followed by a short segment termed the “middle” region, and a PDZ-domain (Furusawa et al., 
2000). Myosin-18Aβ lacks these domains and, instead, begins with two amino acids prior to the 
beginning of the motor domain sequence (Mori et al., 2003).  
Despite the alternative splicing of these two isoforms, the remainder of their domain 
structure is shared. Both the α and β isoforms of myosin-18A contain a putative myosin motor 
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sequence, a single IQ motif in the neck region, and are predicted to have a long coiled-coil tail 
and a segment of globular tail domain at the C-terminus (Furusawa et al., 2000; Mori et al., 
2003). This domain structure has been a platform for suggested structural similarities to myosin-2 
(Foth et al., 2006).  
 
 
 
1.5.3   Myosin-18A cellular localization and protein interactions 
Many studies have found that mammalian myosin-18A isoforms have differential 
subcellular localizations (Figure 1.10).  The PDZ-containing myosin-18Aα is localized 
throughout the cytoplasm, with a portion of the motor population associated with the actin 
cytoskeleton and the plasma membrane (Isogawa et al., 2005; Mori et al., 2003; Mori et al., 
2005).  Localization of myosin-18Aα has also been reported in some studies to include 
perinuclear puncta that are associated with ER-Golgi structures (Furusawa et al., 2000; Mori et 
Figure 1.9: Myosin-18 mammalian isoform analysis. 
Class-18 of the myosin superfamily in mammalian cells consists of two genes, as illustrated 
here for Mus musculus encoding myosin-18A and myosin-18B that differ substantially in both 
their N- and C-termini. The gene product of myosin-18A has two alternatively spliced 
isoforms, α and β that differ within their N-terminus, with myosin-18Aα encoding an N-
terminal KE-rich region and PDZ domain, both of which are lacking in myosin-18Aβ.  Amino 
acid sequence comparison of the motor domains from the Mus musculus myosin-18A isoforms 
(NCBI reference sequence NM_011586.2) with myosin-18B (NCBI reference sequence 
NM_028901.2) analyzed with an NCBI BLAST protein alignment suggest 46% identitical 
sequence and 65% sequence similarity between these motors. 
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al., 2003; Mori et al., 2005). By contrast,  myosin-18Aβ and constructs of myosin-18Aα with 
their N-terminus truncated to mimic the β isoform, have been visualized in several reports as 
being cytoplasmically diffuse, with no specific cellular localization (Isogawa et al., 2005; Mori et 
al., 2003; Mori et al., 2005).  
Further inquiry into the localization of myosin-18Aα found that it associates with protein 
complexes within the cell, often via binding proteins by its PDZ domain. Its association with 
actin filaments in lamellipodia of cultured HeLa and U20S cells stemmed from its involvement in 
a tripartite complex with the cell protrusion regulating modulating protein, myotonic dystrophy 
kinase-related Cdc42-binding kinase (MRCK), via a linker protein, LRAP35a, which associates 
with myosin-18Aα via its PDZ domain (Tan et al., 2008). Involvement in this complex links 
myosin-18Aα to the regulation and organization of the actin cytoskeleton within lamellipodia. 
This study also established an association of endogenous myosin-18Aα to myosin regulatory light 
chain (RLC), which binds to the myosin presumably by its single IQ motif.  
An investigation of how the PAK/βPIX/GIT complex influences cell motility and actin 
cytoskeletal dynamics identified Myosin-18A through a proteomic search. The globular tail 
domain at the C-terminus of the myosin-18A tail interacts directly with βPIX, forming a protein 
complex which interacts with the actin cytoskeleton through its association with myosin-18A.  
The PAK/βPIX/GIT-myosin-18 complex was involved in the dynamics of focal adhesions, 
membrane ruffling at the lamellipodia, actin stress fiber formation, and epithelial cell migration 
(Hsu et al., 2010).  
The localization of myosin-18Aα to ER-Golgi structures was associated with binding to 
the  Golgi-associated protein GOLPH3 (also called GPP34, GMx33, MIDAS, and yeast Vps74p) 
(Dippold et al., 2009). This study established that GOLPH3 bound to phosphatidylinositol-4-
phosphate (PtdIns(4)P) in the lipid membranes of the trans-Golgi structure, and furthermore, 
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bound to myosin-18A, which provided a link to the actin cytoskeleton. Through truncation 
mutants, the N-terminus and the middle of the myosin (noted as the motor and IQ motif) were 
both able to bind GOLPH3 in immunoprecipitation assays, but that only a fraction of the pool of 
myosin-18A bound. The authors proposed that the interaction of myosin-18 with the Golgi 
membrane via GOLPH3 could produce a tensile force that establishes the flattened shape of the 
trans-Golgi network. 
 
Figure 1.10: Proposed roles for myosin-18 in mammalian cells. 
Myosin-18 has been proposed to have several roles within cells based on its interactions with 
various protein complexes. In Golgi, it has been proposed to maintain tension in the trans-
golgi structure through an interaction with GOLPH3 (Dippold et al., 2009). In the 
lamellipodia, it has been found in complexes with two separate groups of protein: with 
LRAP35a and MRCK in cell protrusions (Tan et al., 2008), and with GIT1/βPIX/PAK2 
complex in membrane ruffles, focal adhesions, and actin stress fibers (Hsu et al., 2010). 
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1.5.4   Mammalian Myosin-18A Motor Properties 
 Two studies have investigated the actin binding to myosin-18A.  Both concluded that 
myosin-18Aα requires its N-terminus for actin binding, although they differ slightly in the region 
that mediates this interaction.   
According to Mori and coworkers, the KE-rich region of the N-terminus is required for 
actin binding and that removal of this region abolishes binding to actin. Their results suggest that 
the motor domain itself is incapable of binding actin at all and that, through FRAP analysis of 
fluorescently labeled myosin-18A motor in NIH3T3 cells, recovery of photobleaching occurs in a 
random and rapid fashion with one-third of the fluorescence recovering. The authors concluded 
that their results suggest that the myosin-18A motor acts as an unusual unconventional motor that 
does not act as a transporter in cells (Mori et al., 2005).  
A similar study used protein truncations of the myosin-18A motor expressed in either 
HeLa cells or bacteria in actin cosedimentation assays. They divided the N-terminus of myosin-
18A into three regions: the KE-rich region, the PDZ domain, and the “middle” segment of amino 
acids that lies in between these two discrete domains. According to their truncation mutants, the 
“middle” region is responsible for actin binding.  Their results suggest that the myosin-18A motor 
domain is unable to bind actin on its own, and that instead, the binding of the “middle” region to 
actin is an ATP-insensitive actin binding site for the myosin (Isogawa et al., 2005).  
These two studies agree that the N-terminus is essential for actin binding, but their result 
that the motor domain does not bind actin is puzzling. Both studies refer to the amino acid 
sequence of the motor domain lacking a consensus sequence for actin binding. However, there is 
no specific consensus sequence at the amino acid sequence level for actin binding, with the actin 
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binding properties of myosin motors resultant from a multifaceted structural interaction between 
the motor and the actin filament.  
  
 
CHAPTER TWO: 
DROSOPHILA MELANOGASTER MYOSIN-18 REPRESENTS A HIGHLY DIVERGENT 
MOTOR WITH ACTIN TETHERING PROPERTIES 
 
2.1 Abstract 
The gene encoding Drosophila myosin-18 is complex and can yield six alternatively-
spliced mRNAs.  One of the major features of this myosin is an amino-terminal PDZ domain that 
is included in some of the alternatively-spliced products.  To explore the biochemical properties 
of this protein we have engineered two minimal motor domain (MMD)-like constructs, one that 
contains the amino-terminal PDZ (myosin-18 M-PDZ) domain and one that does not (myosin-18 
M-∆PDZ).  These two constructs were expressed in the baculovirus/Sf9 system. The results 
suggest that Drosophila myosin-18 is highly divergent from most other myosins in the 
superfamily. Neither of the MMD constructs have an actin-activated MgATPase activity, nor do 
they even bind ATP.  Both myosin-18 M-PDZ and M-∆PDZ proteins bind to actin with Kd values 
of 2.61 and 1.04 µM, respectively, but only about 50-75% of the protein binds to actin even at 
high actin concentrations. Unbound proteins from these actin-binding assays reiterate the 60% 
saturation maximum, suggesting an equilibrium between actin-binding and non-actin-binding 
conformations of Drosophila myosin-18 in vitro. Neither the binding affinity nor the 
substoichiometric binding is significantly affected by ATP. Optical trapping of single molecules 
in three-bead assays show short lived interactions of the myosin-18 motors with actin filaments. 
Combined, these data suggest that this highly divergent motor may function as an actin tethering 
protein. 
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2.2  Introduction  
The myosin superfamily is composed of 35 classes of myosin motors based on amino 
acid sequence similarities and another 149 myosin-like proteins that could not be assigned to a 
specific class (Odronitz and Kollmar, 2007).  In general, myosins are characterized by a catalytic 
motor domain responsible for binding actin and hydrolyzing ATP.  Despite high amino acid 
sequence similarity in the motor domains, there is considerable variation in the enzymatic and 
mechanical properties of myosins that allow for the performance of widely different tasks within 
cells.  
The founding member of class 18 of the myosin superfamily, originally called MysPDZ 
and later myosin-18A, was distinguished from other myosin classes by the presence of a PDZ 
domain located upstream of the motor domain (Furusawa et al., 2000). PDZ domains are protein 
interacting modules that are common components of proteins that establish and maintain 
molecular complexes within the cell, such as scaffolding proteins involved in cellular signaling 
cascades (Doyle et al., 1996).  Amino-terminal PDZ domains within the myosin superfamily are 
specific to class 18 (Odronitz and Kollmar, 2007).  There is also a lysine and glutamic acid (KE)-
rich sequence in mammalian myosin-18A that lies at the extreme amino-terminus, followed by a 
short amino acid sequence between this domain and the PDZ domain.  Both the PDZ domain and 
the KE-rich domain are missing in some alternatively spliced isoforms of mammalian myosin-
18A.  
Mammals express another myosin-18, termed myosin-18B, which is encoded by a unique 
gene (Ajima et al., 2007; Nishioka et al., 2002).  This myosin is missing the PDZ domain.  A 
gene in Drosophila melanogaster encoding myosin-18 was identified through genome sequence 
analyses searching for myosin motor domains (Berg et al., 2001; Yamashita et al., 2000). Since 
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its initial identification as a possible myosin, no analyses have been published on Drosophila 
myosin-18.  
The amino acid sequences of myosin-18 isoforms reveal the presence of a consensus IQ 
motif that might be expected to bind calmodulin or a calmodulin family member such as the 
regulatory or essential light chains.  It also has a long tail region that is predicted to form an 
extended, but interrupted, coiled-coil domain which should serve to dimerize the molecule.  In 
this regard, the myosin-18 has some similarities to class-2 myosins (Foth et al., 2006).  Whether 
myosin-18 molecules can self associate to form filaments via this tail is an open question. 
Class 18 myosins in mice and humans have been implicated in physiological events 
including stromal cell differentiation (18A) (Furusawa et al., 2000) and tumor suppression (18B) 
(Nakano et al., 2005; Nishioka et al., 2002; Yanaihara et al., 2004). In mice, attempts to generate 
knockout animals from the myosin-18A gene have been embryonic lethal (personal 
communication, Inna Belyantseva, NIDCD, NIH).  In mammalian cell culture, myosin-18A has 
been suggested to play a role in maintenance of trans-Golgi structure and maintenance of actin 
networks in the lamellipodia (Figure 1.10)  (Dippold et al., 2009; Tan et al., 2008). However, a 
biochemical analysis of murine myosin-18A suggested that its actin-binding properties are 
markedly different from previously described myosins.  There is an ATP-insensitive actin binding 
site located in the KE region or the region in between the KE region and the PDZ domain (Mori 
et al., 2005).  Furthermore the isoform lacking the KE region does not appear to bind actin even 
in the absence of ATP (Isogawa et al., 2005; Mori et al., 2005).  
In this study, the Drosophila myosin-18 gene, Mhcl, was investigated on a cellular, 
embryonic, and biochemical level. We expressed Drosophila myosin-18 motor domain-
containing fragments in an Sf9/baculoviral system for biochemical analysis.  We show that this 
myosin motor is found ubiquitously in embryonic tissues, localizes to actin-based structures in 
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cells, but does not bind ATP.  Unlike the mammalian myosin-18A, the core motor domain of 
Drosophila myosin-18 does bind actin. This suggests a role for Drosophila myosin-18 as a 
dynamic actin tether. 
 
 
2.3 Experimental Procedures 
Genomic, Exon and Domain Analysis – A FlyBase (http://flybase.org) search for the Drosophila 
melanogaster gene Mhcl aligned the gene in reverse orientation on chromosome 3R (NCBI 
Reference Sequence: NT_033777.2) between bases 11890021-11929981. FlyBase also served as 
a resource for information regarding potential P-elements within the Mhcl gene. The reverse 
complement of the portion of the genome containing Mhcl was determined using the GCG-
Emboss-Lite DNA analysis Reverse algorithm (http://helixweb.nih.gov/emboss_lite).   The 
sequences of the six isoforms of the Drosophila melanogaster Mhcl gene, CG31045, were 
aligned with the reverse complement of the genomic sequence using ClustalW sequence 
alignment algorithm (EMBL, www.ebi.ac.uk/Tools/msa/clustalw2). The exons determined 
through this analysis were compiled into a table listing shared exons and the accompanying exon 
splicing diagram of all six myosin-18 isoforms. The amino acid sequences of all six isoforms 
were processed with the SMART (Simple Modular Architecture Research Tool) domain analysis 
algorithm (Schultz et al., 1998). The last exon of each isoform was compared by amino acid 
sequence. Subsequently, the unique sequences within each of the last exons were used for design 
of PCR primers that were used to isolate all six isoforms from cDNA pools.  
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5’ RACE -  Full length sequences of Mhcl-A and –F were isolated through 5’RACE using mRNA 
isolated from whole fly using a trizol extraction protocol (Rio et al., 2010).  A cDNA pool was 
generated by reverse transcription PCR using oligo(dT) primers and SuperScript II Reverse 
Transcriptase (Invitrogen, Corp., Carlsbad, CA, USA). Sequences were amplified from cDNA 
with Platinum HiFi Supermix (Invitrogen) and standard PCR techniques (PTC-200 
Thermocycler, MJ Research). 5’ RACE primary amplification was performed with primer pair: 
downstream Gene Specific Primer 1 (GSP1) (Isoform A, NCBI reference sequence 
NM_169700.3, base 1856) 5’ CGGAACATGGAGACAACCTT 3’, upstream Universal Anchor 
Primer (Invitrogen)  
5’ CUACUACUACUAGGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG 3’ followed by 
nested amplification with primer pair: downstream GSP2 (Isoform A, NCBI reference sequence 
NM_169700.3, base 1665; Isoform F, NCBI reference sequence NM_001043251.2, base 954) 
 5’ CTGCTTCTCGACATCGTCCT 3’,  upstream Abridged Universal Anchor Primer 
(Invitrogen) 5’ CUACUACUACUAGGCCACGCGTCGACTAGTAC 3’.  Location of GSPs 
within sequence are illustrated on Figure 2.2. 
 
Coiled-coil Analysis – Following SMART domain analysis of Drosophila myosin-18 isoforms 
from published amino acid sequences, the predicted coiled-coil domain was further analyzed. The 
Paircoil2 algorithm (McDonnell et al., 2006) was run on the shared sequence of coiled-coil, 
beginning with L1303 (isoform A), with each amino acid residue scored for its propensity to form 
a coiled-coil. Scores from the algorithm were plotted, with residues scoring below a 0.025 
threshold on the Paircoil2 algorithm expected to form coiled-coil structures.  
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Cloning of Full Length and HMM Myosin-18 Constructs - Cloning of full length myosin-18 
constructs began with isolation of whole fly total RNA extracts through Trizol extraction (Rio et 
al., 2010).  mRNA was specifically isolated through their poly-A sequences using Qiagen 
Oligotex mRNA isolation kit (Qiagen, Valencia, CA, USA).  Reverse transcription to synthesize 
cDNA utilized gene-specific primers and SuperScript II Reverse Transcriptase (Invitrogen, Corp., 
Carlsbad, CA, USA).  From this method, three pools of cDNA were synthesized (see Figure 2.1): 
Pool 1 isolated isoforms A and D through the shared sequence in exon 17 with first strand 
synthesis using reverse primer 5’ CCCGTTACTTGGCGTTATTTCT 3’; Pool 2 isolated isoform 
B alone with its unique exon 17b with reverse primer 5’ CCAGATGGACATGCCCCGTACAAT 
3’; Pool 3 isolated isoforms C, F and G together with their shared exon 17c with reverse primer 
5’ CTAGTCTATAATGCTTGTGCTGCTT 3’. Each full length isoform was amplified from the 
appropriate cDNA pool with Platinum HiFi Supermix (Invitrogen) and standard PCR techniques 
(PTC-200 Thermocycler, MJ Research) using primer pairs designed to amplify 5’ and 3’ 
segments of the sequence (Table 2.2).  PCR products from both segments of each isoform were 
ligated into pCR4-TOPO vectors (Invitrogen) for sequencing and further cloning.  To combine 
the segments, the 3’ segments were transferred via a double restriction digestion with EcoRI and 
SpeI from pCR4-TOPO into pFastBac1 vector (Invitrogen) containing a FLAG-tag 
(DYKDDDDK) between the NotI and XbaI sites.  After confirmation that the 3’ segment was in 
place and sequenced correctly, the 5’ segments were transferred to the pFastBac1 vector using a 
double digest of RsrII and EcoRI. Full length clones were fully sequenced with sequence-specific 
primers and primers within the pFastBac1 vector. Subsequent cloning of HMM constructs 
isolated a fragment of the full length sequences consisting of the N-terminal extensions, motor 
domain, two IQ motifs and 439 amino acids within the tail ending at isoform A, P1817 (NCBI 
reference sequence NM_169700.3) or isoform F, P1580 (NCBI reference sequence 
NM_001043251.2). To generate these HMM truncations, the full length clones were digested 
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with EcoRI (which cuts once within the pFB vector and once within the coiled-coil region of 
myosin-18) and transferred to pBlueScript II SK (+) vector (Stratagene, Agilent Technologies, 
Santa Clara, CA, USA). They were then transferred back to pFastBac1 via SalI and NotI to put 
them in frame with the FLAG-tag, and were fully sequenced with sequence-specific primers and 
vector primers prior to use.  
 
Expression of Full Length and HMM Myosin-18 Constructs - Full length and HMM constructs 
were expressed in the baculoviral/Sf9 system along with viruses for Drosophila calmodulin and 
LC17. Infected cells were harvested by sedimentation after 48 hours of growth. Cell pellets were 
quick-frozen in liquid nitrogen and were either processed immediately or stored at -80 ºC for 
processing later. Purification of myosin-18 proteins using the C-terminal FLAG tag was 
performed according to Wang and colleagues(Wang et al., 2000), except that 2 mL of FLAG 
resin (Invitrogen) was rotated with the cell lysate for 2 hours at 4ºC, fractions were analyzed on 
4-20 % Tris-Glycine SDS PAGE gels, and fractions containing protein were pooled and dialyzed 
three times overnight against 1 L buffer containing 0.5 M KCl, 10 mM MOPS (pH 7.2), 0.1 mM 
EGTA, 3 mM NaN3, 1 mM DTT, and 0.1 mM PMSF.  
 
Antibody Production and Validation - A polyclonal Genomic antibody (Strategic Diagnostics 
Inc., Newark, DE, USA) was generated in rabbit and affinity purified with ELISA against 
Drosophila myosin-18 amino acids V1913-I2012 (Isoform A, NCBI reference sequence 
NM_169700.3; V1676-I1775 in Isoform F, NCBI reference sequence NM_001043251.2) in the 
coiled-coil region of the protein. A BLAST search for the corresponding amino acid sequence in 
Drosophila suggested no significant matches for Drosophila proteins and a similarity of 30% to 
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Mus musculus skeletal muscle myosin heavy chain 8. The resulting purified anti-coiled-coil 
antibody was provided at a titer of 0.81 ng/mL (yield 4.3 mL at 2.5 mg/mL antibody). To validate 
the specificity of the antibody, western blots were run of Sf9 cell lysates expressing baculoviral 
clones of full-length myosin-18-PDZ and the heavy meromyosin (HMM) truncation of myosin-
18-PDZ run on 4-20% Tris-Glycine SDS-PAGE gels. Staining using the primary antibody was 
done at a 1:10,000 dilution in blocking buffer for 1 hour, followed by several changes of PBTX 
wash buffer, secondary antibody staining using goat-anti-rabbit-Alkaline Phosphatase conjugate 
antibody (Sigma Aldrich, St. Louis, MO, USA) at 1:10,000 dilution in blocking buffer, several 
changes of PBTX wash buffer and colorimetric detection using SigmaFast BCIP/NBT substrate 
(Sigma Aldrich, St. Louis, MO, USA).  
 
Antibody Staining of Embryos – Drosophila embryos were collected, fixed, and stained using 
protocols by Harlow and Lane (Harlow and Lane, 2006a; Harlow and Lane, 2006b), with the 
exceptions that 4% Paraformaldehyde solution in PBS was used in place of PIPES buffered 
formaldehyde solution for fixation and all wash steps during the staining procedure were done 
over a period of 30 minutes using PBS containing 1% Triton X-100. Embryos were stained with 
the polyclonal primary antibody generated against the coiled-coil of Drosophila myosin-18 at a 
1:1,000 dilution in blocking buffer and with secondary Alexa Fluor 488 goat-anti-rabbit antibody 
(Invitrogen, Molecular Probes) at 1:5,000 in blocking buffer. Stained embryos were stored in 
Vectashield anti-fade mounting medium (Vector Laboratories, Inc, Burlingame, CA, USA). 
Confocal microscopy was performed using a Zeiss LSM 510 confocal system with a 20x, 0.75 
NA oil immersion objective and 488 nm laser excitation using a depth of 1.2 µm per section. For 
illustrating the ubiquitous nature of the staining, 17 confocal sections were projected into a single 
image.  
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In situ hybridization of embryos – Drosophila embryos were collected from fly cages and 
processed according to the published protocol from Jowett (Jowett, 1999). DIG-labeling of RNA 
probes and controls were conducted using the DIG RNA labeling kit (Roche Diagnostics, 
Indianapolis, IN, USA) according to the product protocol. Three probes and corresponding 
controls were produced for hybridizations. Initially, one segment corresponding to the shared 
coiled-coil segment of the myosin-18 isoforms (Isoform A bases 5096-6007) was cloned between 
the EcoRI and BamHI sites of the pBlueScript II SK (+) vector (Stratagene, Agilent 
Technologies, Santa Clara, CA, USA), with probe and control produced by T7 and T3 RNA 
polymerases, respectively. Two shorter probe/control pairs, one to localize the PDZ-containing 
myosin-18 isoforms (isoforms A, B, and G bases 761-1080) and a one to localize the last exon of 
isoforms C, F and G (Isoform G bases 6156-6430), were cloned separately by transferring PCR 
products (PDZ isoforms ABG Forward Primer, 5’ CCAACGCCCGCTATGGAGCTTTA 3’, 
Reverse Primer, 5’ CAAACAGATGGCCTTGCGCAGG 3’;  CFG isoforms Forward Primer, 5’ 
GGAGGGAGCGGCGCTTAAAAAC 3’, Reverse Primer, 5’ 
CGGGCTGTTGTCGTCCTTTTCG 3’) via a TOPO TA reaction into the ZeroBlunt vector 
(Invitrogen), with the probe and control for those regions being produced by T7 and SP6 RNA 
polymerases, respectively. Detection of DIG-labeled probe and control RNA was done through 
antibody labeling of the DIG following in situ hybridization. Hybridized embryos were blocked 
for 4 hours at room temperature with blocking buffer (5% normal goat serum in PBTX buffer), 
followed by an overnight incubation at 4ºC with 1:250 dilution of mouse-anti-digoxigenin 
(Roche) in blocking buffer. Embryos were washed with four changes of blocking buffer over 1 
hour at room temperature, followed by secondary antibody staining for 2 hours at room 
temperature with AlexaFluor 488 goat-anti-mouse antibody (Invitrogen) at a 1:1,000 dilution in 
blocking buffer. Following four washes over 1 hour with blocking buffer, stained embryos were 
stored in Vectashield anti-fade mounting medium (Vector Laboratories, Inc, Burlingame, CA, 
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USA) and were imaged by confocal microscopy using a Zeiss LSM 510 confocal system with a 
20x, 0.75 NA oil immersion objective and 488 nm laser excitation using a depth of 1.2 µm per 
section. 
 
Cloning of eGFP-myosin-18 constructs –Myosin-18 HMM constructs were transferred to 
pAC5.1/VHisB vector (Invitrogen, Corp., Carlsbad, CA, USA) with an N-terminal eGFP cloned 
in between the KpnI and EcoRI sites of the vector.  Myosin-18-HMM constructs were produced 
by PCR amplification with the following primers:  
PDZ forward primer (5’ ATTTTCGGTCCGATGTTCAACTTTATGAA 3’), 
 ∆PDZ forward primer (5’ ATTATCGGTCCGATGTTCCTCAAGCCGAA 3’), 
 and shared reverse primer (5’ GAATTCCTAAAGATCCAGACGGGTGT 3’) which introduces 
a stop codon into the myosin-18 sequence, truncating the resulting protein products at L1626 
(myosin-18-PDZ; L1389 myosin-18-∆PDZ) and an artificial EcoRI site into the sequence for 
cloning by EcoRI insertion in frame after the eGFP sequence. Resulting clones with insertion of 
the HMM construct in the correct orientation to the eGFP were fully sequenced and used for 
expression in S2 R+ cells (Drosophila Genomics Research Center, Bloomington, IN, USA).   
 
S2-R+ cell expression of eGFP-myosin-18 – Expression vectors containing the eGFP-myosin-18-
HMM-PDZ and –∆PDZ constructs were transferred to S2 R+ cells (Drosophila Genomics 
Research Center, Bloomington, IN, USA) by nucleofection in the Amaxa Nucleofector system 
(Lonza Cologne AG, Cologne, Germany). Cells were first grown in Schneider’s Drosophila 
Medium [+] L-Glutamine supplemented with 10%-FBS (Gibco, Grand Island, NY, USA). For the 
nucleofection reaction, Kit V (Lonza) was used following the guildelines from the associated 
protocol, with each reaction transferring 2 µg pAC5.1/VHisB-eGFP-myosin-18 DNA into 2 x 106 
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cells. Cells were allowed to grow for 48 hr in plastic culture dishes to recover from nucleofection. 
Cells were resuspended and were plated on glass coverslips coated with 0.5 mg/mL concanavalin 
A (MP Biomedicals, Solon, OH, USA) (Rogers and Rogers, 2008). For fixed cell imaging, cells 
were allowed to spread on ConA for 30 minutes prior to fixation with 4% paraformaldehyde 
solution in PBS for 15 min at 25 ºC.  Fixed cells were washed with several changes of PBS 
containing 0.1% Triton X-100 (PBST) and were then blocked with blocking buffer containing 5% 
normal goat serum (NGS) in PBS for 15 min, followed by staining with rhodamine-phalloidin at a 
1: 1,000 dilution in blocking buffer for 1 hr. Stained cells were imaged in Vectashield anti-fade 
mounting medium (Vector Laboratories, Inc, Burlingame, CA, USA). For live cell imaging, cells 
were imaged within 60 min of plating using TIRF and confocal microscopy. To visualize actin, 
cells were simultaneously nucleofected with 2 µg of mCherry-β-actin construct in the pMT vector 
(courtesy of Steve Rogers, University of North Carolina Chapel Hill), with induction of 
expression initiated 24 hr after nucleofection with 0.5 mM CuSO4.  
 
qPCR of Myosin-18 isoforms – qPCR analysis of all six myosin-18 isoforms was attempted using 
the primer pairs shown in Figure 2.9. qPCR analysis was done on the ABI 7500 system using 
optical 96-well plates with optical caps and 2x SYBR Green mix (Applied Biosystems, Foster 
City, CA, USA), with 20 µL reactions being denatured initially for 5 minutes at 95 ºC followed 
by a run of 40 cycles of amplification with 30 s denaturation at 95 ºC, 30 s annealing at 55 ºC, 
and 35 s elongation at 72 ºC. SYBR dye was dissociated and quantified following a 5 minute final 
elongation step at 72 ºC. Serial dilutions of control plasmid DNA from expression constructs 
ranged from 10-8 to 10-14 g for sample copy number calculation. Both larval and adult fly cDNA 
libraries were used for experimental analysis of physiological mRNA copy number, generated by 
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first strand synthesis as previously described using Reverse Transcription PCR using random 
hexamers and SuperScript II Reverse Transcriptase (Invitrogen, Corp., Carlsbad, CA, USA).  
 
GST-PDZ Cloning and Expression – The myosin-18 PDZ domain and flanking amino acids (P325 
– G456, isoform B, NCBI reference sequence NM_169701.3) were amplified from plasmid DNA 
for the pFB-myosin-18B-full length construct using the following primers:  
PDZ forward primer, 5’ ATTATGGATCCCCGCCAGTGCAGCTAGTA 3’;  
PDZ reverse primer, 5’ TATTTGTCGACTGCCGTTGGTAATGGAATG 3’.  
The PCR product was transferred to the pCR4-TOPO vector (Invitrogen) and was subsequently 
transferred to the pGEX-6p-1 vector (Amersham Biosciences, GE) via SalI and BamHI for 
expression of an N-terminally GST-tagged PDZ structure. Expression of GST-PDZ constructs 
was done in chemically competent BL21(DE3)pLysS cells ODA600 ~0.7 (Invitrogen) induced with 
0.1mM IPTG for 3 hr at 220 rpm and 30 ºC.  Cell pellets were lysed by intermittent sonication on 
ice for 7 min in 1x PBS containing 1 mM DTT, 0.1 mM PMSF, and 3 mg/mL Lysozyme 
followed by a 10 min 12,200 χ g spin at 4 ºC. The GST-PDZ protein was bound to a 1 mL bed 
volume of Glutathione Sepharose 4B beads, rocking the slurry in bacterial lysate for 1 hr at room 
temperature. The beads were transferred to a column, washed with 20 mL 1x PBS containing 1 
mM DTT and 0.1 mM PMSF, and the purified GST-PDZ protein eluted with 10 mM reduced 
glutathione in 50 mM Tris-HCl buffer, pH 7.5.  Purified protein was dialyzed at 4 ºC overnight 
against 1L buffer containing 0.5 M KCl, 10 mM MOPS (pH 7.2), 0.1 mM EGTA, 3 mM NaN3, 1 
mM DTT, and 0.1 mM PMSF.  
 
GST-PDZ Pulldowns – Purified GST-PDZ and GST control proteins were bound to separate 100 
µL bed volume aliquots of Affigel-10 (Bio-Rad Laboratories, Hercules, CA, USA) with an 
  
48
overnight incubation at 4 ºC. Affigel-10- protein complexes were washed with 5 changes of 1 mL 
buffer containing 0.5 M KCl, 10 mM MOPS (pH 7.2), 0.1 mM EGTA, 3 mM NaN3, 1 mM DTT, 
and 0.1 mM PMSF.  Adult flies were homogenized with a glass tissue grinder on ice in buffer 
containing 1 mM EDTA (pH 7.6), 10 mM KCl, 40 mM NaCl, 1 mM DTT, and 0.1 mM PMSF.  
Fly lysates were spun 10 min at 14,000 χ g at 4 ºC. Supernatant was incubated with either 
Affigel-10-GST or Affigel-10-GST-PDZ, rotating for 4 hr at 4 ºC. Beads were washed with 5 
changes of 1 mL buffer containing 50 mM KCl, 10 mM MOPS (pH 7.2), 0.1 mM EGTA, 3 mM 
NaN3, 1 mM DTT, and 0.1 mM PMSF. Resulting bead-protein complexes were boiled in SDS 
sample buffer and run on 4-20 % Tris-Glycine SDS PAGE gels, followed by silver staining for 
visualization of protein bands using the Silver Stain Plus kit and associated protocol (Bio-Rad 
Laboratories).  
 
Immunoprecipitation – IP reactions for myosin-18 proteins and associated proteins from fly and 
larval lysates were run using the anti-coiled-coil antibody produced in rabbit against the myosin-
18 sequence bound to Dynabeads Protein A Immunoprecipitation Kit (Invitrogen) according to 
the associated protocol, using 5 µg antibody per reaction. Lysates were collected as described for 
GST-PDZ pulldown assays, with lysates being rocked with antibody-bound Dynabeads for 15 
minutes at room temperature. Following IP, bound proteins were analyzed by denaturing elution 
through boiling of Dynabead complexes in 1x SDS buffer containing 1 mM DTT and running on 
a 4-20 % Tris-Glycine SDS PAGE gel followed by Coomassie staining. To increase specificity of 
pulldowns, antibody was covalently linked to Dynabeads M-280 Tosylactivated (Invitrogen) 
using the associated protocol. IP reactions were performed and processed using fly lysates as 
described for Protein A IP assays.  
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Cloning of Drosophila myosin-18 Minimal Motor Domain Constructs -   Subsequent cloning of 
MMD fragments from full-length sequences utilized the QuikChangeII Site Directed Mutagenesis 
kit (Stratagene, Agilent Technologies, Santa Clara, CA, USA) with sense and corresponding 
antisense primers designed to introduce an SpeI restriction site into the myosin-18 sequence that 
corresponds to residue R761 of Dictyostelium myosin-2 (NCBI reference sequence XM_632648.1) 
to generate a construct equivalent to a characterized minimal motor domain (Kuhlman and 
Bagshaw, 1998), M-PDZ (isoform A, 3957) sense primer 
ACTAGTAGTACGTCGCGCTTGGCTT; M-∆PDZ (isoform F, 3248) sense primer 
ACTAGTAGCAGTACGTCGCGTTTAGCT. Double digestion of correctly sequenced positive 
mutant clones using EcoRI and SpeI was used for ligation into pFastBac1-NX.  
 
Baculoviral Expression of MMD-   Both MMD constructs were expressed in the baculoviral/Sf9 
system. Infected cells were harvested by sedimentation after 48 hours of growth. Cell pellets were 
quick-frozen in liquid nitrogen and were either processed immediately or stored at -80 ºC for 
processing later. Purification of myosin-18 proteins using the C-terminal FLAG tag was 
performed according to Wang and colleagues (Wang et al., 2000), except that 2 mL of FLAG 
resin (Invitrogen) was rotated with the cell lysate for 2 hours at 4ºC, fractions were analyzed on 
4-20 % Tris-Glycine SDS PAGE gels, and fractions containing protein were pooled and dialyzed 
three times overnight against 1 L buffer containing 0.5 M KCl, 10 mM MOPS (pH 7.2), 0.1 mM 
EGTA, 3 mM NaN3, 1 mM DTT, and 0.1 mM PMSF.  
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Cloning Drosophila RLC for virus production – The DNA sequence for Drosophila RLC was 
provided by D. Kiehart (Duke University) in the pCR8/GW/TOPO cloning vector (Invitrogen). 
The sequence was transferred to the pFastBac1 vector at the StuI restriction site by an In-Fusion 
Dry-Down PCR cloning reaction (Clontech Laboratories, Mountain View, CA, USA) using the 
following primers: Forward RLC primer, 5’ CGCGGAATTCAAAGGCTTATGTCATCCCGT 
3’, Reverse RLC primer, 5’ GCTCGTCGACGTAGGTTACTGCTCATCCTT 3’. Baculoviral 
virus amplification of dRLC was done in Sf9 cells to a P5 virus stock. 
 
Characterization of Nucleotide Interaction -     The actin-activated MgATPase activity of the 
myosin-18-MMD proteins were assayed with an NADH-coupled assay at 25ºC  in the presence of 
0.5 µM motor and concentrations of actin ranging to 50 µM F-actin (Trentham et al., 1972). The 
solutions used for these measurements included the following reagents: 50 mM KCl , 10 mM 
MOPS (pH 7.2), 2 mM MgCl2, 0.15 mM EGTA, 2 mM ATP, and 40 units/mL lactate 
dehydrogenase, 200 units/mL pyruvate kinase, 1 mM phosphoenolpyruvate, and 200 µM NADH. 
Changes in A340 were monitored using a Beckman DU640 spectrophotometer. The radiometric 
K+-EDTA ATPase assay as described by Pollard and colleagues (Pollard and Korn, 1973), with 
the reaction performed in buffer containing 0.5 M KCl, 20 mM MOPS (pH 7.0), 2 mM EDTA, 
and 0.5 mM 32P-γ-ATP (Perkin-Elmer, Waltham, MA, USA).   
The emission and excitation spectra of nucleotide analog 3’-(7-diethylaminocoumarin-3-
carbonylamino)-3’-deoxy-ATP (deac-amino-ATP) and –ADP in the presence and absence of 
myosin-18-MMD constructs (1 µM) were taken with a FluoroMax3 photon-counting 
spectrofluorimeter (Horiba Jobin Yvon) with thermostated cell housing.  The protein was 
clarified by sedimentation for 10 min spin at 100,000 χ g in a Beckman TLA-100 rotor at 4 ºC 
just prior to the analysis. Excitation spectra were taken using an emission wavelength of 430 nm, 
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and emission spectra were taken using an excitation wavelength of 470 nm.  The buffer 
conditions were 0.5 M KCl (25 mM KCl for myosin-5a-S1-6IQ), 10 mM MOPS (pH 7.2), 3 mM 
MgCl2, 1 mM EGTA, and 1 mM DTT at 20ºC.            
Binding of N-Methylantranoyl derivatives of 2′-deoxy-ATP (mant-ATP) and 2’-deoxy-
ADP (mant-ADP) to myosin-18-MMD constructs were analyzed using a stopped-flow apparatus 
(Sf2001, KinTek Corp., Austin, TX) by excitation at 365 nm excitation using a 400 nm long pass 
filter for emissions.  The conditions were 50 mM KCl, 20 mM MOPS (pH 7.0), 5 mM MgCl2, 
and 0.05 mM EGTA, 25 oC using 0.4 µM myosin-18-MMD and 5 µM mant-nucleotide analogs.   
Steady-state fluorescence anisotropy measurements of mant-ATP at 0.5 µM were taken 
using a FluoroMax3 photon-counting spectrofluorimeter (Horiba Jobin Yvon) with thermostated 
cell housing. Protein samples were clarified by sedimentation immediately prior to the 
measurements by spinning for 10 min at 100,000 χ g in a Beckman TLA-100 rotor at 4 ºC.  
Resulting protein concentrations used for anisotropy experiments were 1.96 µM myosin-18 M-
PDZ, 2.63 µM myosin-18 M-∆PDZ, and 6.1 µM nonmuscle myosin-2B-S1 (NM2B-S1) as a 
control. Further control anisotropy measurements to control for viscosity effects were taken in the 
presence of 2 mM unlabeled ATP.  Experiments with myosin-18 motors were performed in buffer 
containing 0. 5 M KCl, 10 mM MOPS (pH 7.2), 0.1 mM EGTA, 3 mM NaN3, and 1 mM DTT.  
Calculation of steady-state anisotropy was done with the equation: 
r = IVV-IVH/IVV + 2IVH,  
where IVV and IVH are the corrected parallel and perpendicular polarized intensities, respectively. 
Filter binding assays utilized nitrocellulose membrane pre-equilibrated with buffer 
containing 0.25 M KCl, 10 mM MOPS (pH 7.2), 4 mM MgCl2, 0.1 mM EGTA, 1 mM DTT. The 
membrane was placed under vacuum and was blotted in duplicate with 1 µM myosin-18-MMD or 
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skeletal muscle myosin-2-heavy meromyosin (SkHMM) pre-incubated with 20 µM 32P-α-ATP 
(1.3 X 1015 CPM/mol) in the buffer mentioned above, for 60 s. For quantification, dried 
membranes were exposed to Fujifilm BAS-MS Phosphor Imager screens and scanned on a Fuji 
FLA-5000 series Image Analyzer (Fuji Medical Systems, Stamford, CT, USA). Quantitation was 
done using Image Gauge software (version 3.0, Fuji Medical Systems). 
 
Protein Unfolding Analysis -   Circular dichroism (CD) spectra were recorded on a JASCO J720 
spectropolarimeter equipped with a temperature controller using a 2 mm cuvette and wavelength 
range between 205 and 240 nm. All measurements were performed in buffer containing 0.5 M 
KCl, 10 mM KH2PO4 (pH 7.2), 0.1 mM EGTA, 3 mM NaN3, and 1 mM DTT. For thermal 
denaturation experiments, the CD spectra were recorded after the protein samples were incubated 
for 5 min at different temperature points. Curves were analyzed with SigmaPlot 11.0. 
 
Characterization of Actin Binding -   Binding of myosin-18-MMD to F-actin was assayed by 
cosedimentation using 1 µM motor mixed with different concentrations of phalloidin-stabilized 
F-actin prepared from rabbit skeletal muscle (Kempler et al., 2007) in the absence of ATP. 
Incubations were for 10 min at room temperature in buffer containing 0.1 M KCl, 20 mM MOPS 
(pH 7.0), 5 mM MgCl2, 0.05 mM EGTA, 1 mM NaN3, and 1 mM DTT. Variations on the 
cosedimentation assay included using 20 µM F-actin not stabilized by phalloidin, adding 1 mM 
ATP, and increasing incubation times of myosin-18 motor with F-actin up to 60 min. Following 
incubation, centrifugation at 100,000 χ g in a Beckman TLA-100 rotor at 4 ºC was performed.  
The supernatant was removed and the pellet was resuspended in 1x SDS sample buffer to an 
equivalent volume.  Supernatants and pellets were fractionated on a 4-20 % Tris-Glycine SDS 
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PAGE gel.  Gels were stained with Coomassie Blue and analyzed by densitometry (Licor 
Biosciences, Odyssey version 3.0, Lincoln, NE, USA). Corresponding data points were fitted to a 
quadratic equation, correcting for the amount of motor that pellets itself in the absence of actin, 
typically on the range of 10 % (SigmaPlot 11.0, Systat Software, Inc., San Jose, CA, USA).  For 
repeat pelleting assays, the supernatant from the first sedimentation at 20 µM actin was brought 
to the same actin concentration again, incubated as before and then re-sedimented under the same 
assay conditions. 
 
Actin Gliding Assays -  Motility assays were performed in buffer containing 50 mM KCl, 20 mM 
MOPS (pH 7.4), 5 mM MgCl2, 0.1 mM EGTA, 1 mM ATP, 25 µg/mL glucose oxidase, 45 
µg/mL catalase, 2.5 mg/mL glucose and 50 mM DTT. All experiments were performed at 30oC 
with 0.2 mg/mL total concentration of myosin. Noise within the motility setup was determined to 
be 0.066 ± 0.035 µm/s (N = 26) using 0.2 mg/mL SkHMM in the absence of ATP. Visualization 
of filaments and quantification of motility were performed in accordance with the parameters 
published by Homsher and colleagues (Homsher et al., 1992).  
 
Optical Trapping -   Three bead assays (Finer et al., 1994; Molloy et al., 1995) were performed 
using a similar dual–beam optical trapping apparatus as reported (Vanzi et al., 2005); (Takagi et 
al., 2006).  
To perform the three-bead assay, an in vitro force assay chamber (volume  ~40 µl), was 
constructed using two coverslips, of which one that was decorated sparsely with 2.1 µm diameter 
glass microspheres (Bangs Laboratories, Fishers, IN, USA) suspended in nitrocellulose, 
assembled using double-sided adhesive tape. Myosin-18 motor constructs were diluted to a 
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concentration of  ~10 – 50 pM in  25 mM KCl, 25 mM imidazole, 4 mM MgCl2, 1 mM EGTA 
(pH 7.4) at 22 °C (AB- buffer) (Kron and Spudich, 1986) and allowed to bind nonspecifically 
inside the chamber. Approximately 4 chamber volumes of AB- buffer with 1 mg/mL bovine 
serum albumin was flushed through the chamber to reduce non-specific binding of beads and 
actin filaments. AB- buffer supplemented by the following reagents (2 mM creatine phosphate, 50 
mM DTT, 10 µM ATP, 0.1 mg/mL creatine phosphokinase, 3 mg/mL glucose, 0.1 mg/mL 
glucose oxidase and 0.02 mg/mL catalase (Kishino and Yanagida, 1988) was used in the final 
mixture, together with, 0.2 nM rhodamine-phalloidin (Invitrogen) labeled, 10% biotinylated 
filamentous actin and NeutrAvidin (Thermo Fisher Scientific, Rockfold, IL, USA) coated 1 µm 
biotin-labeled polystyrene beads conjugated with tetramethyl-rhodamine B-isothiocyanate 
(TRITC-BSA) (Rock et al., 2000). Thus, under fluorescence imaging, a single actin filament was 
attached to two 1 µm beads, via manipulation of the optical traps. These beads/actin dumbbells 
(length ~ 5 – 7 µm) were made taut and positioned above the glass microspheres attached to the 
surface of the chamber, functioning as a pedestal, to record transient unitary acto-myosin-18 
interactions. Only 1 out of 15 -20 pedestals exhibited unitary acto-myosin interactions providing 
statistical support for the concept that only a single myosin-18 motor was capable of interacting 
with the actin filament at any instance. 
Experiments were performed using optical trap stiffness of ~0.015 – 0.02 pN/nm. 
Similarly, as reported in Baboolal and colleagues (Baboolal et al., 2009), data was sampled at 20 
kHz while sine waves (Frequency = 200 Hz) of amplitudes (~300 nm, peak-to-peak) were applied 
to one of the optical traps (Batters et al., 2004; Sakamoto et al., 2003). Decrease in the standard 
deviation of the noise level of this sine wave was used to distinguish regions of the collected data, 
either as periods with or without myosin-18 motor attachments. Analysis was performed using 
custom software written in LabVIEW 6.0 (National Instruments, Corp., Austin, TX, USA) and 
histograms were plotted using SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA, USA). 
  
55
Histograms, for both myosin-18 isoforms, are compiled from data collected from five pedestals 
for M-PDZ (Nmyosin = 5) and seven pedestals for M-∆PDZ (Nmyosin = 7).    
 
Structural Comparison -  Alignment of sequences of Dictyostelium myosin 2 (NCBI reference 
sequence XM_632648) with Drosophila myosin-18 (NCBI reference sequence NM_169700.3) 
were performed with ClustalW (EMBL). Crystal structure of Dd myosin 2 (PDB: 1MMD) was 
manipulated with ProteinWorkshop (version 3.8, MBT (Moreland et al., 2005)) to reflect residue 
insertions in myosin-18.  
 
 
 
2.4 Results 
2.4.1 Drosophila Myosin-18 Gene Encodes Six Isoforms with a High Level of Redundancy.   
Analysis of the exon splicing of the myosin-18 gene Mhcl (Flybase gene annotation 
CG31045) against the reverse genomic sequence between 11894263 and 11923250 on 
chromosome 3R (GenBank ID AE014297.2, Revision: 26-April-2007) revealed the possibility of 
six alternatively spliced isoforms, as predicted by GSTs uploaded to GenBank.  Exon analysis of 
each alternatively spliced isoform determined that the longest isoforms, those encoding an N-
terminal PDZ domain, consist of 17 exons.  The genomic location of each exon was mapped and 
analyzed, as shown in Figure 2.1 with corresponding location data listed in Table 2.1.   
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Figure 2.1: Genomic, Exon and Domain Analysis of Myosin-18 (Mhcl).  
Analysis of the Drosophila melanogaster myosin-18 gene (Mhcl, FlyBase annotation 
CG31045) against the reverse complement of chromosome 3R, from 11894263 and 11923250, 
revealed six alternatively spliced isoforms. Three P-elements were investigated from FlyBase, 
as discussed in Results 2.4.1. SMART domain analysis determined that the longest isoforms 
contain an N-terminal PDZ domain, followed by a myosin motor domain, two IQ motifs, and 
a segmented coiled-coil tail.  Shorter isoforms exhibit N-terminal truncations with alternative 
first exons. For cloning of full length myosin-18 constructs, unique sequences within the last 
exons were used to generate three pools of cDNA: Pool 1 (pink) containing isoforms A and D, 
Pool 2 (green) containing isoform B, Pool 3 (yellow) containing isoforms C, F, and G. 
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Table 2.1: Location of myosin-18 exons on D. melanogaster chromosome 3R.   
Values for genomic start and end were deteremined as described in Experimental Procedures 
and Results 2.4.1, aligning myosin-18 isoform sequences to the reverse complement of 
chromosome 3R (GenBank ID AE014297.2, Revision: 26-April-2007). 
Exon Genomic Start Genomic End Length
1 11923250 11922798 452
1c 11908718 11908536 182
1d 11901303 11900080 1223
1f 11919211 11918508 703
2 11922735 11921915 820
3 11921608 11921470 138
4 11916755 11916328 427
5 11916264 11916078 186
6 11915480 11915314 166
7 11915255 11914346 909
8 11914285 11913683 602
9 11913621 11913427 194
10 11903199 11903064 135
11 11903002 11902776 226
12 11899068 11898697 371
13 11898629 11898352 277
14 11897165 11896206 959
15 11896143 11895760 383
16 11895698 11895525 173
17 11894276 11894263 13
17b 11895008 11894859 149
17c 11895698 11895475 223
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This segment of chromosome 3R was also analyzed in FlyBase for transposable elements 
that could be convenient mechanisms to generate myosin-18 phenotypic mutant flies (Figure 2.1).  
Three P-element stocks were found in the 5’ end of the gene. The P{GawB}Mhcl[NP1604] line 
contains an enhancer trap located between 11920468 and 11919748 of the chromosome, which 
lies within an intron in the myosin-18 gene and shows no notable phenotype. Analysis of 
localization suggests embryonic expression in muscle and adult expression internally, potentially 
within muscles. However, as an enhancer trap, the transposable elements flanking the insertable 
segment have been removed and would take extensive manipulation to replace them for use as a 
jumping element that may disrupt or mutate the Mhcl gene. A second line, the P{GawB}NP6650 
line is also an enhancer trap insertion located between 11923391 and 11923136, which results in 
an insertion close to the beginning of the myosin-18 first exon. There is no noted phenotype 
associated with these flies, with embryonic expression in a small number of cells and internal 
adult expression according to the detailed information provided for the fly stock (reference 
number 105311) at the Drosophila Genetic Resource Center (Kyoto Institute of Technology, 
Kyoto, Japan). The third line, P{EPgy2}EY00454, is a mobile activating element containing 
UAS that acts as a reporter construct which lies at 11923391 close to the beginning of the first 
exon. Both P{GawB}NP6650 and P{EPgy2}EY00454, however, also lie close to the beginning 
of the Akt1 gene that starts at 11924938 on chromosome 3R. Akt1, a key component of the PI3K 
signaling pathway (Scheid and Woodgett, 2001), is well characterized in fly mutants, with 
reported potential lethality or complications including sterility, neural defects and defective body 
size. The proximity of these two P-elements to Akt1 makes them inconvenient for use in 
generating mutant myosin-18 flies.  The three available P-element lines within the vicinity of 
Mhcl are decidedly beyond the scope of the current project.  
The amino acid sequence of each isoform was further analyzed by the SMART algorithm 
to determine domain structure. As shown in Figure 2.1, the domain analysis of the Mhcl gene 
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suggests the presence of an N-terminal PDZ domain, followed by a putative myosin motor 
domain sequence, two IQ motifs, and a segmented coiled-coil structure tail region. There is no 
sequence homologous to the KE-rich region found in some mammalian myosin-18A isoforms.  
As illustrated, the isoforms differ in their N-terminal start-site that can truncate off as far as the 
coiled-coil (Figure 2.2 A).  
The presence of two encoded IQ motifs differs from the singe IQ encoded by the 
mammalian myosin-18A and proteins. Initially, we suspected that the two encoded IQ motifs 
were located in too close proximity to each other to both be functional in binding light chains. 
However, personal communication with Peter Knight (University of Leeds, UK) suggested 
otherwise. Aligning the IQ region with that of scallop myosin-2 shows the same spacing between 
the two IQ motifs, suggesting that myosin-18 should be able to bind two light chains to this 
region. Furthermore, both have a WPWW motif that is expected to form a structure capable of 
binding an additional light chain.  
 
Figure 2.2:  Domain analysis of Drosophila myosin-18.  
A, Domain analysis of the six Drosophila myosin-18 isoforms using Simple Modular 
Architecture Research Tool (SMART) at EMBL was aligned with exons to illustrate six 
alternatively spliced isoforms varying at the N-terminus. GSP primers used for 5’ RACE are 
illustrated to show location on isoforms.  B, 5’ RACE analysis of whole fly mRNA using 
nested PCR to amplify PDZ and ∆PDZ isoforms yielded two bands, one at 1.7 kb 
corresponding to PDZ-containing isoforms and one at 0.9 kb corresponding to ∆PDZ isoform.  
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The PDZ-containing isoforms A, B, and G differ only in their last exon, with the 
remainder of their sequence fully shared, leading to the question of whether all three isoforms 
exist in protein form and if so, what is the difference in function or localization between them. 
Probing this question may prove difficult, however, as there is little difference between these 
three PDZ isoforms to allow for specific selection of one isoform from the others.  
The PDZ-lacking isoforms, C, D, and F, differ in their first exons and are truncated from 
the N-terminus of the gene product, with isoform F appearing to be a naturally-occurring ∆PDZ 
motor product, while isoforms C and D appear to possibly be headless myosin products (Sousa et 
al., 2006; Yamada et al., 2000).  For the purpose of analyzing the motor activity of myosin-18, 
the conducted kinetic and biochemical analyses disregarded the potential headless isoforms. 
To date, mammalian myosin-18A isoforms have been classified as containing or lacking 
N-terminal PDZ domains.   Thus, Drosophila myosin-18 PDZ and ∆PDZ isoforms that encode 
motor domains were specifically targeted for analysis by 5’ RACE using a priming region within 
the motor domain (Figure 2.2 B). cDNA sequence corresponding to both PDZ and ∆PDZ 
isoforms is present in whole fly mRNA extract.  
All six isoforms share a conserved sequence within the tail region, with the exception of 
their last exon, which distinguishes the longest isoforms from each other. The last exons of the six 
isoforms are partially shared, as is shown in Figure 2.1 and is further detailed by the amino acid 
sequence associated with the last exon as shown in Figure 2.3.  These last exons were exploited in 
later procedures, generating cDNA pools, localizing proteins by in situ hybridization, and in 
qPCR analysis. 
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As predicted in the SMART algorithm analysis of the amino acid sequence (Figure 
2.2A), the myosin-18 isoforms are expected to have a long stretch of coiled-coil structure within 
their tail region. Further analysis of this region using the Paircoils2 algorithm reveals a coiled-coil 
structure with similarities to the structure of the coiled-coil sequence in the tail of myosin-2 
(Figure 1.1).   
The coiled-coil of myosin-18 is segmented, with two major segments. The first segment 
ranges from L1378 to D1394 (isoform A), which is followed by a span of approximately 200 amino 
acids of unknown structure, followed by the second coiled-coil segment from E1555 to E2081. 
According to molecular weight estimation, the first segment is expected to be 13.4 kDa and the 
second 62.2 kDa, which combined make up approximately 30% of the total molecular weight of 
the protein. 
Figure 2.3: Sequence analysis of last exons of six isoforms of myosin-18.  
Alignment of the amino acid sequence of the last exons of all six myosin-18 isoforms shows 
that sequence is shared among all isoforms to the last segment, and that the last exons are 
shared between certain isoforms as illustrated here by color. The shared last exons were 
exploited in later procedures.  
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In the second coiled-coil segment of the myosin-18 tail, the heptad repeat is interrupted 
three times in a manner similar to myosin-2. The first interruption occurs with the presence of a 
skip residue (Craig and Offer, 1976), G1736 (isoform A, NCBI reference sequence NM_169700.3). 
The two other interruptions occur due to the presence of prolines producing a kink within the 
backbone structure at P1817 and P1950. These three disruptions of the sequence, as is illustrated in 
Figure 2.4, would be expected to form kinks in the coiled-coil structure. In the case of myosin-2, 
these kinks have been shown to correspond to flexible regions of the tail that are important to the 
structural organization of the myosin when polymerized into thick filaments. Additionally, the 
kinks respresent sites of bending that allow the tail to loop back onto the motor domain when the 
myosin has adopted its folded, off state (Burgess et al., 2007).  
 
Figure 2.4: Coiled-coil analysis of myosin-18.  
The Paircoils2 algorithm residue-by-residue analysis of the amino acid sequence within the 
shared coiled-coil segment of myosin-18 isoforms, beginning with L1303 (isoform A, NCBI 
reference sequence NM_169700.3) suggests a structure reminiscent of myosin-2. For this 
algorithm, scores below a threshold score 0.025 are considered highly expected to form a 
coiled-coil structure. Two main segments of coiled-coil are exhibited in the myosin-18 tail, 
one from L1378 to D1394 and the second from E1555 to E2081. The second segment is interrupted 
three times, once by a skip residue and the other two by the presence of proline residues 
within the sequence.  
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A section of the second segment of the coiled-coil, from V1913 to I2012, was used for the 
production of a polyclonal antibody to recognize all six isoforms of the protein in situ and in 
vitro. However, the possible regulatory mechanism of the tail region suggested by the similarity 
to myosin-2 suggested a need to truncate the expressed protein for kinetic and biochemical 
analysis of the myosin-18 motor. 
 
 
2.4.2 Full-length and HMM Constructs of Myosin-18 are Unsuitable for Biochemical Analysis.  
 Initial attempts at expressing myosin-18 proteins focused on full-length, cloned using the 
primers in Table 2.2, and HMM-like constructs. Baculoviral expression of full-length proteins in 
Sf9 cells along with coexpression of potential light chain proteins calmodulin and LC17 were 
heavily degraded (Figure 2.5, lane 2). While some of these bands may be the result of proteolysis 
in surface loops of the motor domain that would only dissociate under denaturing conditions, the 
apparent heterogeneity of the sample purified by FLAG-affinity purification suggests that the 
full-length molecule may not be suitable for such expression or subsequent biochemical analysis 
in this system.  
              Expressions of HMM-like truncation constructs were more successful (Figure 2.5, lanes 
4 and 5). FLAG-affinity purification products resulted in a major band corresponding to the 
estimated molecular weights of the constructs with minor degradation products visible on a Tris-
Glycine gel. However, despite coexpression of light chain proteins with the HMM-like 
constructs, the light chains did not appear to copurify (expected molecular weight ~16-24 kDa), 
suggesting that they may not be the appropriate light chain binding partners for the myosin-18 
proteins.  
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Using the HMM-like proteins in steady-state actin activated MgATPase assays, there was 
no apparent hydrolysis of ATP by the motor domain. This lack of inherent activity was suspected 
to be a possible result of a regulatory mechanism in the remaining segment of the tail region of 
the protein, or due to the lack of bound light chains. As a result, further truncation of the myosin-
18 sequence was pursued, with minimal motor domain constructs being cloned and expressed in 
the Sf9/baculoviral expression system for kinetic and biochemical analysis of motor activity. 
 
 
 
Table 2.2: Primer pairs used for cloning full length myosin-18 isoforms via 5’ and 3’ 
segments. 
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The full length and HMM-like constructs were used in validating the antibody generated 
against the coiled-coil. Truncation of the HMM-like proteins prior to the epitope recognized by 
the antibody made this protein construct a convenient negative control, while the full length 
 
Figure 2.5: Expression of FL and HMM truncation constructs of myosin-18.  
Baculoviral expression and FLAG-affinity purification was performed for full length and 
HMM-like truncations of myosin-18. FL myosin-18-PDZ (lane 2) was expected to have an 
estimated molecular weight of 240 kDa but was heavily degraded when run on a 4-20% Tris-
Glycine gel, and showed no sign of bound light chains. Baculoviral expression of HMM-like 
truncations of myosin-18-PDZ and –∆PDZ were more successful, with both constructs 
yielding a single product at the correct estimated molecular weight (lane 4, HMM-PDZ 180 
kDa; lane 5, HMM-∆PDZ 150 kDa), but still showed no bound light chains despite 
coexpression with calmodulin and LC17 viruses. (Lanes 1, 3 and 6 SeeBlue Plus2Pre-stained 
Standard) 
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protein expressed by Sf9 cells provided a positive control for the antibody. Both western blotting 
of Sf9 cell lysates (Figure 2.6) and immunoprecipitation of these proteins from Sf9 lysates 
confirmed that the anti-coiled-coil antibody was able to recognize only the full length myosin-18 
with no recognition of the protein lacking the epitope.  
 
 
2.4.3 Myosin-18 is Ubiquitously Expressed and is Localized to Actin-Based Structures in Cells.   
Antibody staining of Drosophila embryos was performed using the anti-coiled-coil 
polyclonal antibody to recognize all six potential isoforms of myosin-18 through their shared 
 
Figure 2.6: Testing of polyclonal antibody using FL and HMM-PDZ. 
The polyclonal antibody designed to recognize an epitope within the second segment of the 
coiled-coil domain was tested using cell lysates of Sf9 cells expressing the full length (lane 2) 
or HMM truncations (lane 3, expected 180 kDa) of myosin-18-PDZ. By Western blotting, the 
antibody can recognize its epitope on the full length molecule but not on the HMM-PDZ 
protein, which is truncated prior to that region of the coiled-coil. (Lane 1, SeeBlue Plus2 Pre-
stained Standard) 
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coiled-coil sequence.  The staining pattern seen in the embryos appears ubiquitous throughout all 
embryonic tissues (Figure 2.7, Antibody Staining) and was seen at all embryonic developmental 
stages.  Confocal microscopy was done in collaboration with Dr. Benjamin Lelouvier of the 
Laboratory of Cell Biology. 
The ubiquitous staining of the embryos required further substantiation through a series of 
fluorescent in situ hybridizations in collaboration with Dr. Amy Saw-Tin Hong of our lab. An 
initial probe to localize the mRNA of all six myosin-18 isoforms resulted in what also appeared to 
be ubiquitous localization throughout the embryos. However, the segment of the coiled-coil used 
to generate the probe was ~900 bases long, and potentially too long for adequate specificity. Two 
shorter probes were produced to increase the specificity of localization, one to localize the PDZ-
containing isoforms and another to isolate the final exon shared by isoforms C, F and G. These 
two probes, each ~300 bases long, resulted in hybridizations showing ubiquitous staining 
throughout all tissues of all embryos analyzed. Representative embryos are shown in Figure 2.7, 
PDZ Probe and CFG probe).   
The FlyBase In Situ Hybridization Library provided further evidence supporting the 
ubiquitous presence of myosin-18 in embryonic development. A search for data on hybridizations 
within the Mhcl gene suggested extensive staining within multiple tissues throughout 
development. However, the results in that library were not entirely definitive and were questioned 
as an experimental comment in the Mhcl gene expression report from the reporting researcher at 
the Berkeley Drosophila Genome Project (BDGP) as possibly being the result of non-specific 
oligos.  
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To determine the activity of the motor domain-containing isoforms of myosin-18 in 
living cells, expression constructs of myosin-18 proteins were cloned with N-terminal eGFP tags 
and were transferred to cultures of highly adherent Drosophila hemocyte derivative S2 R+ cells. 
HMM-like truncations were chosen for this application to ensure that expressed proteins were 
able to oligomerize with each other and with endogenous protein through a short segment of 
 
Figure 2.7: Localization of myosin-18 in Drosophila embryos is ubiquitous. 
Representative Drosophila embryos stained with a polyclonal antibody raised in rabbit against 
an uninterrupted segment of the coiled-coil region of myosin-18 that is shared between all six 
potential isoforms of the protein. Visualization of localization pattern used Alexa Fluor 488 
goat-anti-rabbit secondary antibody at 1:5,000 dilution in blocking buffer. Using confocal 
microscopy with a 20x, 0.75 NA oil immersion objective and a section depth of 1.2 µm, the 
localization of myosin-18 was ubiquitous throughout all embryonic tissues, as seen in this 
projection of 17 confocal sections. Alternatively, localization was determined through 
fluorescent in situ hybridization using two DIG-labeled RNA probes, one targeting the PDZ 
domain and another targeting the last exon shared by isoforms C, F and G. All three 
procedures showed ubiquitous staining of embryonic tissues, as shown here, and throughout 
all observed embryonic developmental stages.  Images were taken in collaboration with 
Benjamin Lelouvier of the Laboratory of Cell Biology. Scale bar, 50 µm.  
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coiled-coil while also removing any inherently encoded regulatory mechanism in the C-terminal 
portion of the tail region.  
As illustrated with representative images in Figure 2.8, taken with the assistance of 
Daniela Malide and Chris Combs of the NHLBI Light Microscopy Core Facility, all cells had an 
abundant cytoplasmic pool of eGFP-myosin-18 throughout the cell body. In the majority of cells, 
myosin-18-HMM-PDZ and –∆PDZ localized either to actin ruffling structures or to actin 
microspikes around the circumference of the lamellipodia that dynamically translocate around the 
periphery of the cell in a manner characteristic of these actin-based structures (Rogers and 
Rogers, 2008; Rogers et al., 2003). A small subset of cells was seen with the myosin-18 also 
localized with motile vesicles, although these vesicles tended to only be visualized out of the 
TIRF field. The wide variety of localization of the myosin-18 in these cell studies reflects the 
many roles proposed for class 18 myosins in published research, including ATP-independent 
actin association, lamellipodial architecture maintenance and Golgi vesicle trafficking.  
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Figure 2.8: Myosin-18 localization with eGFP-HMM constructs.  
Expression of eGFP-tagged HMM constructs of myosin-18-PDZ and –∆PDZ show a wide 
variety of localization. Plasmid DNA for each construct was transferred to S2 cells through the 
Amaxa Nucleofector system and were allowed 48 hours to grow and express protein prior to 
plating on ConA-coated cover slips for imaging. All cells showed an abundant cytoplasmic pool 
of myosin and association with actin structures in the lamellipodia (microspikes and ruffles). A 
subset of cells showed association with dynamic vesicles, indicated by white arrow heads. Light 
microscopy was done in collaboration with Dr. Xufeng Wu of the Laboratory of Cell Biology, 
Daniela Malide and Chris Combs of the NHLBI Light Microscopy Core Facility. Scale bar, 10 
µm.  
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2.4.4 qPCR Analysis to Detect mRNA Levels of Myosin-18 Isoforms.  
The myosin-18 gene encodes six potential alternatively spliced isoforms, with some of 
the constituent isoforms differing only by a single exon (see Figure 2.1). This high level of 
similarity between isoforms would presumably result in a high level of redundancy if all isoforms 
are expressed throughout all stages of development. Therefore, we anticipate that specific 
isoforms may be expressed at certain points during development.  
To determine the physiological level of expression of each isoform during fly 
development, a qPCR analysis was attempted from adult fly and larval cDNA pools. Primer pairs 
(Figure 2.9) were designed with the assistance of Drs. Kee-Kwang Kim and Mary Anne Conti 
(NHLBI, Laboratory of Molecular Cardiology) to amplify short segments of DNA from the 
myosin-18 gene. However, due to shared exon sequences, only certain isoforms that had unique 
exons were able to be amplified individually.  
For the remaining isoforms, an algebraic approach was designed to amplify clusters of 
isoforms with shared exons. The theory for this approach capitalized on the ability to amplify 
specific isoforms individually, and use the calculated copy number of mRNA for those isoforms 
to derive the copy number of other isoforms amplified in clusters.  
For example, amplifying the cluster of isoforms C, F, and G through primers in their 
shared last exon would determine the copy number for the pool of those three isoforms. 
Subsequently amplifying isoform C and isoform F through primers amplifying their individual 
unique first exons would directly determine copy numbers for those two isoforms.  Using these 
directly determined copy numbers for isoforms C and F would allow for derivation of the copy 
number for isoform G from the pool copy number by subtracting the values.  
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Ultimately,  
CNCFG ≈ CNC + CNF + (CNG) 
where CNn is the copy number calculated for isoform n.  
Many rounds of qPCR were performed based on this algebraic theory, but the resulting 
copy numbers calculated for the clustered isoforms failed to agree with each other. In the 
previous example, using adult fly cDNA pools, CNCFG ≈ 1.1 x 1011, CNC ≈ 3.0 x 109, and CNF ≈ 
5.5 x 109. Thus, the derived copy number for isoform G was calculated as CNG ≈ 1.0 x 1011. 
However, isoform G is also amplified within the cluster of the isoforms amplified by the PDZ 
domain (isoforms A, B, and G), and the copy number derived from that pool CNPDZ ≈ 2 x 1010. 
According to these results, the copy number of isoform G alone far outnumbers the amount of 
mRNA for all three PDZ-containing isoforms. As such, the numbers conflict drastically and 
similar problems were encountered for each algebraic approach for the six Drosophila myosin-18 
isoforms. Consequently, the qPCR analysis was deemed an unreliable method for determining the 
physiological levels of each isoform of myosin-18.  
Further investigation into the reason for the complications, through personal 
communication with Tom Friedman and Robert Morrell at NIH, revealed that the algebraic 
approach, while potentially informative, would require a high level of accuracy and efficiency at 
all levels of the experimental design and execution. Complications could arise from differences in 
efficiency of designed primer pairs to amplify their targets, the efficiency of the reverse 
transcriptase in generating the cDNA pool, and the efficiency of the polymerase used in the PCR 
reaction.  
While alternative qPCR approaches can produce more specific results, like using 
fluorescently labeled primers or TaqMan probes (Invitrogen) in the PCR reaction rather than 
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SYBR dye, the sequence of the isoforms of myosin-18 are so similar that they could not be 
expected to be teased out effectively and reliably from each other even with special primer pairs.  
 
 
 
 
Figure 2.9: Scheme for qPCR analysis of myosin-18 isoforms. 
Due to the high level of sequence similarity and presumably redundancy of the isoforms 
encoded by the myosin-18 gene, qPCR was attempted as a mechanism to determine the 
physiological expression level of each isoform during development. Primer pairs were 
designed as illustrated to amplify specific regions of the gene, some of which would amplify 
pools of isoforms, others that exploited unique exons within certain isoforms. The planned 
approach would utilize the copy numbers of unique sequences quantified by qPCR and 
subtract those from their corresponding pools of isoforms. This algebraic approach was 
unsuccessful and consequently, qPCR was deemed unreliable for this gene.  
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2.4.5 Attempted Isolation of Myosin-18- Interacting Proteins.  
The presence of the PDZ domain at the N-terminus of some isoforms of Drosophila 
myosin-18 is unique to class-18 of the myosin superfamily and suggests that the protein may play 
a role in scaffolding or transportation of cargo within the cell.  
In an attempt to identify proteins that bind to the PDZ domain of myosin-18, a GST-
fusion construct of the PDZ domain and flanking amino acids was expressed and purified. The 
purified fusion protein was then used as bait in a pulldown assay by covalently linking the fusion 
protein to an Affigel-10 matrix and passing over whole fly lysate.  
Coomassie staining of polyacrylimide gels showed the fusion protein, and the contrasting 
GST control protein, but failed to show any bands from interacting proteins. Upon using a silver 
staining approach, however, the gels showed several bands of interacting partners on the GST-
PDZ pulldowns that did not interact with GST alone (Figure 2.10).  
In speaking with Rong Fong Shen, director of the NHLBI Proteomics Core Facility, it 
was determined that the yield of interacting proteins from this assay was too low for reliable 
detection by mass spectrometry available in this facility and consequently, higher concentrations 
of protein isolates would be required for identification. Alterations of the protocol to increase the 
amount of bait used, as well as increasing the number of flies used for generation of the lysate 
pool, was unable to substantially increase the yield of isolated interacting partners to a level 
detectable by Coomassie staining and thus by mass spectrometry. Alternatively, this question was 
probed by immunoprecipitation of endogenous myosin-18 and its interacting partners from whole 
flies.  
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Figure 2.10: Expression of GST-PDZ fusion protein for isolation of binding partners. 
For identification of proteins that interact with the PDZ domain at the N-terminus of myosin-18, the 
PDZ domain and flanking amino acid residues were expressed with an N-terminal GST tag. Expression 
of both GST alone (lane 2) and GST-PDZ (lane 3) were successful, but the purified GST-PDZ fusion 
appeared to have many extra protein bands than the 40 kDa estimated molecular weight. Pulldowns 
that used Affigel-10 as a matrix for binding GST or GST-PDZ were unable to be visualized by 
Coomassie staining. Silver staining of pulldowns with GST alone (lane 4) and GST-PDZ (lane 5) from 
fly lysate showed numerous bands, with a handful of potential binding partners for the GST-PDZ 
fusion protein that were not found in the GST alone pulldowns or in the expressed GST-PDZ itself. 
(lane 1, SeeBlue Plus2 Pre-stained Standard) 
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To identify proteins that bind with endogenous myosin-18, a series of 
immunoprecipitation reactions were performed using the antibody generated against the myosin-
18 coiled-coil (Figure 2.11). Initially, the approach utilized magnetic Dynabeads coated with 
Protein A as a matrix for antibody binding. In control IPs with rabbit serum, the background level 
of binding showed numerous bands, while IPs using the myosin-18 antibody included several 
additional bands of interest for identification.  
In an attempt to increase specificity of IP reactions, the approach was altered to use 
tosylactivated Dynabeads, which covalently link antibody to the bead surface to prevent co-
elution during the elution step and allows for blocking of the bead surface to limit non-specific 
binding during the IP reaction. Despite the use of a covalent linkage approach, numerous proteins 
appear to interact with myosin-18 according to this assay. Due to the apparent low level of 
specificity – perhaps at the level of the antibody, the lysates used, or the immunoprecipitation 
reaction – these attempts at identifying binding partners for myosin-18 were halted.   
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Figure 2.11: Immunoprecipitations of endogenous myosin-18 and binding partners. 
The polyclonal antibody generated against the coiled-coil of myosin-18 was used as bait in a 
series of immunoprecipitation reactions to pull endogenous myosin-18 from fly lysates. 
Attempts using Dynabeads Protein A (lane 2) pulled numerous proteins from the lysates, as 
did control rabbit serum (lane 3). Due to the high level of background, the approach was 
shifted to use Dynabeads M280 Tosylactivated, which alone showed very little background 
interactions with lysates (lane 5) in comparison to immunoprecipitations with the antibody 
(lane 6). The high background using covalent linkage in the tosylactivated bead experiment 
suggested low specificity somewhere in the system. (lanes 1 and 4, SeeBlue Plus 2 Pre-
Stained Standard, Invitrogen) 
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2.4.6 Drosophila Myosin-18 Has No ATPase Activity.   
To analyze the PDZ and ∆PDZ isoforms kinetically, each isoform was expressed in an 
Sf9 baculoviral system as a minimal motor domain construct, containing the respective N-
terminal sequence and terminating with L1319 in M-PDZ  (Isoform A, NCBI reference sequence 
NM_169700.3) and L1082 in M-∆PDZ (Isoform F, NCBI reference sequence NM_001043251.2), 
the residues corresponding to R761 of Dictyostelium myosin-2  (NCBI reference sequence 
XM_632648) that constitutes a minimal catalytic domain for the myosin motor (Kuhlman and 
Bagshaw, 1998; Woodward et al., 1991), along with a C-terminal FLAG affinity tag for 
purification (Figure 2.12 A).   Successfully purified motor constructs were confirmed with gel 
electrophoresis and western blotting against the FLAG epitope, with the PDZ isoform running at 
140 kDa and the ∆PDZ isoform at 116 kDa, as expected based on sequence analysis (Figure 2.12 
B).  
Figure 2.12: Minimal motor domain constructs of Drosophila myosin-18.  
A, Expression constructs of minimal motors of Drosophila myosin-18 for baculoviral 
expression in Sf9 cells truncate the sequence at L1319 for M-PDZ and L1082 for M-∆PDZ, the 
residues corresponding to Dictyostelium myosin-2 R761 , followed by a C-terminal FLAG tag 
for purification.  B, M-PDZ and M-∆PDZ expressed proteins purified using FLAG affinity tag 
run in 4 – 20 % Tris Glycine SDS-PAGE gel.  Lane 1, SeeBlue Plus2 Pre-stained Standard; 
lane 2, M-PDZ at 140 kDa; lane 3, M-∆PDZ at 116 kDa: lane 4, SeeBlue Plus2 Pre-stained 
Standard. 
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The two myosin-18 motor fragments were analyzed for the ability to hydrolyze ATP in 
an ATP-regenerating NADH-coupled actin-activated ATPase assay (Figure 2.13). There was no 
detectable MgATP hydrolysis activity for either MMD construct in the absence of actin.  Neither 
construct exhibited an activation of the MgATPase activity in the presence of actin compared to 
that of the actin alone. The actin concentration in these experiments ranged up to 50 µM actin 
with 2 mM ATP.  
 
 
 
Figure 2.13: Drosophila myosin-18 lacks actin-activated MgATPase activity.  
M-PDZ and M-∆PDZ were assayed for actin-activated MgATPase activity in an NADH-
coupled assay.  Representative traces of data from M-PDZ (○) and M-∆PDZ (∆) motors in the 
absence of actin show no detectable hydrolysis of ATP.  In the presence of 45 µM F-actin and 
2 mM ATP, M-PDZ (●) and M-∆PDZ (▲)show no detectable difference in rate of change of 
A340 from the ATP hydrolysis rate of actin alone (■) at the same concentration.  Experiments 
were conducted at 25ºC in a buffer containing 50 mM KCl , 10 mM MOPS (pH 7.2), 2 mM 
MgCl2, 0.15 mM EGTA, 2 mM ATP, and 40 units/mL lactate dehydrogenase, 200 units/mL 
pyruvate kinase, 1 mM phosphoenolpyruvate, and 200 µM NADH.    The concentrations of 
myosin-18 fragments in each assay were 0.5 µM. 
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Further experiments determined there is no detectable release of the Pi in a radiometric 
basal K+-EDTA ATPase assay (Pollard and Korn, 1973) in comparison with basal Pi release in 
the absence of protein (Figure 2.14 A). In the same assay, SkHMM exhibits Pi release of 380 
nmol mg-1 min-1 (Figure 2.14 B).  
 
 
 
 
 
 
Figure 2.14: Myosin-18 shows negligible Pi release in a K+-EDTA ATPase assay.   
A, Using a radiometric assay with 32P-γ-ATP in a K+-EDTA ATPase assay, M-PDZ at 2.5 µM 
(0.35 mg/mL) (red) and M-∆PDZ at 3.8 µM (0.44 mg/mL) (green) show negligible release of 
the radiolabeled Pi in comparison with the inherent rate of Pi release from the experiment in 
the absence of myosin (blue). B, When the values from (A) are plotted against 1.0 mg/mL 
SkHMM in the same conditions, they appear as a flat line in contrast to the rate of Pi release 
from SkHMM at 380 nmol mg-1 min-1.  
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2.4.7 Drosophila myosin-18 is unable to bind nucleotide  
Three approaches were used to examine whether the MMD constructs were able to bind 
ATP.  First, the fluorescent ATP analog, deac-amino-ATP, was used.  The fluorescent intensity of 
this analog is typically enhanced upon binding to myosins (Forgacs et al., 2006; Heeley et al., 
2006).  The fluorescent intensity of deac-amino ADP (Figure 2.15 A and B) and ATP (Figure 
2.15 E and F) showed no increase in the presence of the myosin-18 constructs.   In contrast, the 
fluorescent intensities of the same nucleotides increased 20-fold in the presence of myosin-5a-S1-
6IQ (Figure 2.15 (C and D) for deac-amino-ADP; (G and H) for deac-amino-ATP) as has been 
previously shown (Forgacs et al., 2006). Similar results were seen using a stopped-flow analysis 
of nucleotide binding with mant-ATP and mant-ADP, which showed no increase in quantum 
yield in the presence of either isoforms of Drosophila myosin-18 (Woodward et al., 1991) 
(Figure 2.16).  
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Figure 2.15:  Excitation and emission spectra of deac-amino nucleotides in the presence 
and absence of myosin-18.   
(A, C, E, and G), Excitation and (B, D,F, and H) emission spectra of deac-amino-ADP (A and 
B) and –ATP (E and F) in binding assays using expressed M-PDZ (red) and M-∆PDZ (green) 
in comparison to baseline fluorescence of the deac-amino moiety (blue). Fluorometric analysis 
of fluorescence signals from deac moiety exhibited peak excitation at 430 nm and emission at 
470 nm at 20 ºC. Assays used 1 µM M-PDZ or M-∆PDZ and 0.5 µM deac-amino-ATP in 0.5 
M KCl, 10 mM MOPS (pH 7.2), 3 mM MgCl2, 1 mM EGTA, and 1 mM DTT.  The proteins 
were spun for 10 min at 100,000 χ g in a Beckman TLA-100 rotor at 4 ºC just prior to the 
assay to remove aggregates. (C and D) Excitation and emission spectra of deac-amino-ADP 
and (G and H) deac-amino-ATP assays repeated and contrasted with 1 µM mouse myosin-5a-
S1-6IQ (black).  Myosin-5a-S1-6IQ was analyzed in a similar buffer as above, but containing 
25 mM KCl.  Note the difference in the scale values for the fluorescence intensities in the two 
experiments.  These experiments were done in collaboration with Dr. Attila Nagy. 
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A second, more sensitive way to monitor nucleotide binding is to use fluorescence 
anisotropy.  Here we compared the anisotropy values of mant-ATP alone to that of mant-ATP in 
the presence of Drosophila myosin-18 M–PDZ and –∆PDZ proteins (Figure 2.17).  As controls 
we used nonmuscle myosin-2B-S1 (NM2B-S1) and also a control in which the proteins were first 
mixed with 2 mM ATP and then with mant-ATP to correct for any viscosity effects.  The 
anisotropy value of the free mant-ATP was 0.018 which only increased minimally when 
Drosophila myosin-18 M–PDZ and –∆PDZ proteins were added.  In contrast the anisotropy value 
of mant-ATP in the presence of NM2B-S1 was nearly 10 fold higher indicating binding of the 
nucleotide to myosin.  In the presence of excess unlabeled ATP, the anisotropy value of mant-
 
Figure 2.16: Binding analysis of mant-ATP to myosin-18.  
The fluorescent ATP analog mant-ATP was used in a stopped flow apparatus to analyze 
nucleotide binding to myosin-18. Control protein SkHMM at 0.4 µM (black) shows a 
characteristic binding curve in the presence of 5 µM mant-ATP, increasing in fluorescence 
intensity upon nucleotide binding when excited by 365 nm light and observed with a 400 nm 
long pass filter for emission analysis. M-PDZ (red) and M-∆PDZ (green) at 0.4 µM both lack 
the increased quantum yield expected during mant-moiety binding.  
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ATP in the presence of NM2B-S1 or the myosin-18 proteins were in the same range as found for 
the Drosophila myosin-18 M–PDZ and –∆PDZ proteins in the presence of mant-ATP alone.  The 
deac-aminoATP and mant-ATP fluorescence anisotropy experiments were done in collaboration 
with Dr. Attila Nagy from our lab.  
 
 
 
 
 
Figure 2.17: Nucleotide Binding Analysis by Fluorescence Anisotropy.  
Steady-state fluorescence anisotropy values comparing mant-ATP at 0.5 µM (black) alone in 
solution to that of mant-ATP in the presence of Drosophila myosin-18 M–PDZ and –∆PDZ 
proteins at 1.96 µM and 2.63 µM, respectively. Experiments were performed in buffer 
containing 0. 5 M KCl, 10 mM MOPS (pH 7.2), 0.1 mM EGTA, 3 mM NaN3, and 1 mM 
DTT.  Controls using 6.1 µM nonmuscle myosin-2B-S1 (NM2B-S1) and further controls for 
viscosity effects by adding 2 mM unlabeled ATP (grey) are also shown. These data were 
collected in collaboration with Dr. Attila Nagy. 
  
85
Third, to more directly examine any potential binding of ATP to the myosin-18 
nucleotide binding pocket, 32P-α-ATP was used in a filter binding assay, done with the technical 
assistance of Kathryn Callahan (NIDDK) (Figure 2.18). Subsequent phosphoimaging of the 
nitrocellulose membranes definitively shows that while a SkHMM control is able to bind 
radiolabelled ATP, the Drosophila myosin-18 M–PDZ and –∆PDZ proteins on the membrane 
showed only baseline levels of ATP.  Furthermore, to determine if this myosin binds other 
nucleotide triphosphates, the filter binding assay was repeated using 32P-α-GTP. Collectively, 
these experiments suggest that Drosophila myosin-18 is unable to bind nucleotide.  
 
  
Figure 2.18: Binding of 32P-α-ATP and 32P-α-GTP to myosin via a filter binding assay.  
 Rabbit SkHMM, M-PDZ and M-∆PDZ at 1 µM were incubated with 20 µM 32P-α-ATP or 
32P-α-GTP (1.3 X 1015 CPM/mol) for 60 s and blotted onto a nitrocellulose membrane pre-
equilibrated with buffer containing 0.25 M KCl, 10 mM MOPS (pH 7.2), 0.1 mM EGTA, 3 
mM NaN3, and 1 mM DTT under vacuum.  Blots of 20 µM 32P-α-ATP and 32P-α-GTP (1.3 X 
1015 CPM/mol) were used as controls. Following a rinse with excess equilibration buffer, the 
membrane was dried and exposed to Fujifilm BAS-MS Phosphor Imager screens for 1 hour.  
The fraction of 32P-α-ATP or 32P-α-GTP bound to M-PDZ and M-∆PDZ was calculated in 
relation to SkHMM after correcting for the amount of nucleic acid that binds nitrocellulose in 
the absence of protein. Filter binding assays were performed with the technical assistance of 
Kathryn Callahan (NIDDK). 
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2.4.8 CD Measurements and Tm calculations confirm protein folding.   
The results described above raised the question of whether the expressed myosin-18 
protein is folded properly.  To confirm the folding of the protein, the temperature-dependent 
unfolding of the proteins were analyzed using a CD spectrum of each construct.   
Both Drosophila myosin-18 motor constructs unfolded in a single step between 40 – 50 
ºC (Figure 2.19).  The Tm measured for each construct with this method is in line with previously 
reported values from proteins in the myosin superfamily, which can range from 40 – 60 ºC 
(Zolkiewski et al., 1996). Further confirmation of the folding of the Drosophila myosin-18 
expressed proteins was provided by the change in tryptophan fluorescence over the same 
temperature range used in the CD measurements, which confirmed Tm values for the Drosophila 
myosin-18 proteins to be between 40 – 50 ºC (Figure 2.20).   
The results of these experiments—namely that unfolding occurrs in a single step over a 
short range of temperature and with Tm values consistent with a single, large domain such as a 
myosin motor—suggest that the M-PDZ and M-∆PDZ proteins are folded.  This reflects back on 
the nucleotide binding assays providing further substantiating evidence that the Drosophila 
myosin-18 motor does not bind nucleotide.  Determination of Tm by CD spectroscopy and 
tryptophan quenching were done in collaboration with Dr. Attila Nagy. 
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Figure 2.20: Tryptophan fluorescence during temperature-dependent unfolding of 
Drosophila myosin-18 proteins. Data were collected at 340 nm over a range of temperatures. 
Proteins were prepared in the same manner as for CD spectroscopy. From this assay, Tm = 
43.3 ± 0.6 °C for M-PDZ (●) and Tm=41.4 ± 0.6 °C M–∆PDZ (○).  Data were collected in 
collaboration with Dr. Attila Nagy. 
 
Figure 2.19: CD spectrum of temperature-dependent unfolding of Drosophila myosin-18 
proteins.  
Data were collected at 222 nm over a range of temperatures determined Tm = 45.4 ± 0.1 ºC for 
M-PDZ (●) and Tm=46.3 ± 0.3 ºC M–∆PDZ (○).  Both proteins were dialyzed into buffer 
containing 0.5 M KCl, 10 mM KH2PO4 (pH 7.2), 0.1 mM EGTA, 3 mM NaN3, and 1 mM 
DTT prior to the assay. The final concentration of M-PDZ used in the assay was 1.78 µM and 
that of M- ∆PDZ was 2.85 µM. Data were collected in collaboration with Dr. Attila Nagy. 
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2.4.9 Myosin-18 Motor Binds to Actin in an ATP-insensitive Manner.   
Both Drosophila myosin-18 motor constructs bound to F-actin in cosedimentation assays 
and the binding of each saturated below 100% even at high actin concentrations (Figure 2.21 A).  
Data was processed to account for the amount of myosin-18 that pellets itself in the absence of 
actin using the following equation, suggested through personal communication from Mihaly 
Kovacs (Eötvös University, Budapest, Hungary):  
Pcorr = (Puncorr - Palone) / (100 - Palone) 
where Pcorr is the corrected percentage of myosin pelleted, Puncorr is the uncorrected percentage of 
myosin pelleting in the presence of actin, and Palone is the percentage of myosin pelleting in the 
absence of actin.  
Dissociation constants (Kd) determined by fitting the binding curves to a quadratic 
equation were determined to be 1.0 ± 0.2 µM with saturation at 83.2 ± 5.4 % for M–∆PDZ and 
2.6 ± 0.2 µM with saturation at 58.2 ± 11.0 % for M–PDZ.  To further explore the nature of the 
lack of complete binding of myosin-18 motor to actin, variations on the cosedimentation protocol 
were carried out at 20 µM actin (Figure 2.21 B).  Saturation consistent with the data presented for 
each motor in phalloidin-stabilized actin filaments in Figure 2.21 A was seen with untreated actin 
filaments. Varying the incubation period of myosin-18 motors with actin to 60 min (at room 
temperature) and 24 hr (on ice) before sedimentation did not change the extent of motor bound.  
There are at least two possibilities to explain this saturable fractional binding of myosin-18-MMD 
to actin.  It is possible that there is a fraction of the protein (40-50% for M-PDZ, 15-25% for M-
∆PDZ) that is denatured or improperly folded that cannot bind actin.  Alternatively, there may be 
an equilibrium between a conformation that was competent to bind actin and a conformation that 
was incompetent to do so that is established within the time course of the experiment.  
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Figure 2.21: Binding of myosin-18 isoforms to actin.  A, Drosophila myosin-18 motor 
constructs at final concentration of 1 µM in buffer containing 0.1 mM KCl, 20 mM MOPS 
(pH 7.0), 5 mM MgCl2, 0.05 mM EGTA, 1 mM NaN3, and 1 mM DTT were incubated for 10 
min at room temperature with increasing concentrations of phalloidin-stabilized F-actin in the 
absence of ATP. Reactions were sedimented at 100,000 χ g for 15 min. Pellets and 
supernatants were separated by SDS-PAGE and gels were stained and imaged with Coomassie 
blue. Fractions of motor pelleted for each reaction was calculated by densitometry, correcting 
for the amount of motor that pellets itself in the absence of actin, typically in the range of 10 
%, for each preparation of protein. Fraction of myosin-18 motor bound was plotted against 
concentration of actin introduced in each reaction.  Data collected from M-PDZ (●) defined a 
Kd = 2.6 ± 0.2 µM and saturation at 58.2 ± 11.0 %. Data from M-∆PDZ (○) resulted in Kd = 
1.0 ± 0.2 µM and saturation at 83.2 ± 5.4 %.  The data represent multiple rounds of binding 
experiments using at least 6 different preparations of purified motor constructs. B, Comparison 
of variations on the cosedimentation assay using M-PDZ and M- ∆PDZ. Cosedimentations at 
20 µM actin in (A) ( ) were compared with variations of the parameters within the 
cosedimentation assay including absence of phalloidin ( ), presence of 1 mM ATP ( ), and 
60 min incubation ( ). All variations were done at 20 µM actin, with results showing no 
significant effect of any parameter on myosin saturation curve.  C, The effect of ATP on actin 
binding was further investigated with a range of actin titrations, as in (A), in the presence of 1 
mM ATP. Data collected from M-PDZ (●) in the presence of ATP gave a Kd = 1.5 ± 0.1 µM 
and saturation at 48.2 ± 14.5 %. Data from M–∆PDZ(○) resulted in Kd =1.0 ± 0.1 µM and 
saturation at 81.3 ± 8.9 %.  Error bars are standard deviation from means. 
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To distinguish between these possibilities, the supernatant from the first sedimentation at 
20 µM actin was brought to the same actin concentration again, incubated as before and then re-
sedimented.  Of the protein remaining in the supernatant after the first sedimentation using M-
PDZ, 50.3 % rebound to actin in the second sedimentation suggesting that there is an equilibrium 
between a binding competent and a binding incompetent conformation (Figure 2.22).  A similar 
equilibrium has been observed for the myosin-18 M-∆PDZ as well as with Limulus myosin-3 
(Kempler et al., 2007) and with myosin-9 (Nalavadi et al., 2005).  
 
 
 
 
 
Figure 2.22: Evidence for two conformational states of myosin-18 motor.  
Myosin-18-MMD proteins were sedimented with 20 µM actin as in Figure 2.21.  The left two 
lanes show the supernatant and pellet fractions from a representative experiment using M-
PDZ.  The supernatant from this experiment was mixed with 20 µM actin and a second 
sedimentation performed.  The supernatant and pellet from this experiment are shown in the 
right two lanes. The fraction of actin bound in the first sedimentation was 54.9% and the 
fraction bound in the second sedimentation was 50.3%.  Ionic conditions were as described in 
Figure 2.21.   
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Additionally, binding curves for both constructs were established in the presence of 1 
mM ATP (Figure 2.21 C). Fitting those data to a quadratic equation revealed similar dissociation 
constants as determined in the absence of ATP (1.0 ± 0.1 µM and saturation at 81.3 ± 8.9 % for 
M–∆PDZ and 1.5 ± 0.1 µM and saturation at 48.2 ± 14.5 % for M-PDZ). These results further 
support our data suggesting that there is an ATP-insensitive F-actin binding property for myosin-
18.   
To explore the nature of the interaction of myosin-18 motor to actin, two approaches 
were used.  The ability of myosin-18 to impede the translocation of actin filaments by an actively 
cycling myosin, SkHMM, was measured in an in vitro motility assay.  Previous studies showed 
that either actin binding proteins or unphosphorylated smooth muscle myosin which cannot move 
actin filaments can retard and even stop the movement of actin filaments by SkHMM when 
mixed with this myosin on the coverslip surface (Harris et al., 1994; Sellers, 1985).  Mixing 
increasing molar ratios of Drosophila myosin-18 motor constructs with SkHMM resulted in a 
slowing of the rate of movement of the actin filaments to the point where the movement 
eventually ceased (Figure 2.23). M-PDZ halted SkHMM motility when the total myosin in the 
assay contained 75 % myosin-18 whereas M- ∆PDZ was able to halt SkHMM motility with as 
little as 50 % of the total myosin composition, consistent with the differences in binding affinities 
of the two motor constructs.  When present on the coverslip surface alone, either of the 
Drosophila myosin-18 motor constructs tether actin filaments to the surface but do not translocate 
them (Figure 2.24 B and C). 
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Figure 2.23: Attenuation of skeletal muscle myosin-2 HMM in vitro motility by 
Drosophila myosin-18.  
Varying ratios of rabbit SkHMM to M-PDZ (●) or M-∆PDZ (○) were mixed together, with the 
total myosin concentration held constant at 0.2 mg/mL. Motility was assayed at 30ºC in buffer 
containing final concentrations of 50 mM KCl, 20 mM MOPS (pH 7.4), 5 mM MgCl2, 0.1 
mM EGTA, 1 mM ATP, 25 µg/mL glucose oxidase, 45 µg/mL catalase, 2.5 mg/mL glucose 
and 50 mM DTT. Centroid tracking of at least 15 filaments was performed and analyzed with 
the CellTrak program. Noise within the motility setup was determined to be 0.066 ± 0.035 
µm/s (N = 26) by imaging immobile actin filaments bound to a surface coated with 0.2 mg/mL 
SkHMM in the absence of ATP.  
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Figure 2.24:  Drosophila myosin-18 motor domain is unable to translocate actin in an in 
vitro motility assay.  
A, Centroid tracking from 7 representative actin filaments within an actin gliding assay using 
SkHMM as a control. Quantification of paths (N = 76) yields a velocity for SkHMM at 4.67 ± 
1.05 µm/s. B, Centroid tracks of S1-PDZ at 0.2 mg/mL in an actin gliding assay yield 0.012 ± 
0.039 µm/s (N = 15). C, Centroid tracks of S1-∆PDZ at 0.2 mg/mL in an actin gliding assay 
yield 0.070 ± 0.018 µm/s (N = 16). All analysis was done using CellTrak program run over 10 
frames (SkHMM, 2 s at 5 frames/s; Drosophila myosin-18 proteins, 10 s at 1 frame/s). 
Motility was assayed at 25ºC in buffer containing final concentrations of 50 mM KCl, 20 mM 
MOPS pH 7.4, 5 mM MgCl2, 0.1 mM EGTA, 1 mM ATP, 25 µg/mL glucose oxidase, 45 
µg/mL catalase, 2.5 mg/mL glucose and 20 mM DTT. 
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The interaction of Drosophila myosin-18 motor constructs with actin was further 
explored using optical trapping in a three-bead assay in collaboration with Dr. Yasuharu Takagi 
from our lab.  In this assay, an actin filament is tethered between two beads held by separate 
optical traps under an induced oscillation of 200 Hz and the interaction of actin with motor bound 
to a larger surface bead was measured.  Interactions between the myosin-18 motor and actin were 
detected by a decrease in the Brownian noise of the beads.  Each interaction between Drosophila 
myosin-18 and actin was characterized for displacement. Both the M–PDZ and –∆PDZ proteins 
interacted with actin within the assay (Figure 2.25 A and B). Detachment rates were determined 
from fitting a single-exponential fit to the respective histograms of lifetimes of acto-Drosophila 
myosin-18 interactions (Figure 2.25 C and D). The lifetimes for both constructs were brief, with 
detachments rates of 94.2 ± 1.0 s-1 for M-PDZ and 57.0 ± 0.6 s-1 for M-∆PDZ.  Furthermore, 
displacement histograms for both constructs during the acto-Drosophila myosin-18 interactions 
(Figure 2.25 E and F) were centered at ~0 nm, suggesting that the protein does not induce a 
power stroke against the filament even in the presence of 10 µM ATP. For a mechanically active 
myosin, the displacement histogram will show a ‘shift’ in the peak of the Gaussian distribution by 
the size of its power stroke as shown in previous studies (Baboolal et al., 2009; Sakamoto et al., 
2003).   
Optical trapping data of both myosin-18 motor constructs provide further evidence that 
this myosin binds to actin, but does not function as a typical actively cycling molecular motor.  
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Figure 2.25: Optical trapping analysis of single molecule interactions.  
A and B, Three-bead assays with oscillations show brief interactions between M-PDZ (A) or 
M-∆PDZ (B) and rhodamine-phalloidin stabilized F-actin. Arrows point to attachment events.  
C and D, Lifetime data of myosin-18 motor interactions longer than 10 ms collected in the 
optical trap were fitted to a single exponential curve. M-PDZ (C) yielded a detachment rate of 
94.2 ± 1.0 s-1 and M-∆PDZ (D) a detachment rate of 57.0 ± 0.6 s-1. E and F, Fitting the 
displacement data collected from the optical trap during each acto-myosin-18 interaction to a 
Gaussian distribution yielded histograms centered at -0.98 ± 1.6 nm for M-PDZ (E) and at -
0.03 ± 1.35 nm for M-∆PDZ (F). Data were collected at 22 °C in a buffer containing 25 mM 
KCl, 25 mM imidazole (pH 7.4), 4 mM MgCl2, 1 mM EGTA, 2 mM, creatine phosphate, 50 
mM DTT, 10 µM ATP, 0.1 mg/mL creatine phosphokinase, 3 mg/mL glucose, 0.1 mg/mL 
glucose oxidase and 0.02 mg/mL catalase. 
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2.5 Discussion 
The myosin superfamily is composed of 35 classes of myosin motors, classified based on 
amino acid sequence similarities, and another 149 myosin-like proteins that could not be assigned 
to a specific class (Odronitz and Kollmar, 2007).  Despite the high similarity in amino acid 
sequence of the motor domains, there are considerable quantitative differences in rate constants of 
the individual steps in the enzymatic cycles, in the rate of in vitro motility and in the strength of 
actin binding amongst the various myosins (De La Cruz and Ostap, 2004; Sellers, 1999).  For 
example, the actin-activated MgATPase rate and the rate of translocation of actin filaments for 
nonmuscle myosin-2B is more than 100-fold less than that of fast skeletal muscle myosin 
(Kovacs et al., 2003).  In addition, some myosins have high duty ratios and can move 
processively along actin as single molecules whereas others cannot (De La Cruz and Ostap, 2004; 
Forgacs et al., 2006). These differences in enzymatic properties along with extreme variations in 
the domain structure of the tail regions allow myosins to perform very diverse tasks within cells.  
Drosophila myosin-18 represents the most extreme example of this motor diversity since 
it does not bind ATP, but still retains the ability to bind to actin.  In this regard,  it behaves 
qualitatively similar to Limulus myosin-3 (recently reclassified as class 21 (Odronitz and 
Kollmar, 2007)), which also does not bind ATP (Kempler et al., 2007).   This suggests that some 
myosins may function as dynamic actin tethers and, in this regard, should be added to the 
extensive list of actin binding proteins with diverse functions such as controlling actin 
polymerization, localizing actin to various cellular compartments or bundling actin filaments into 
various higher order structures (Pollard and Korn, 1973). A similar theme of motor diversity has 
been proposed for the microtubule binding protein, Vik1, which appears to have evolved from a 
kinesin-14 motor to feature a tertiary structure resembling a motor-like fold but has lost the loop 
and switch regions that are necessary for ATP binding (Allingham et al., 2007).  
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In Drosophila, Myosin-18 was found to be ubiquitously localized throughout all 
embryonic tissues through several lines of evidence. On a cellular level, it appears to be 
associated with actin-based cellular structures, including membrane ruffles and microspikes, as 
well as having localization to dynamic vesicle structures evident in a subset of analyzed cells. The 
sequence similarity between the six isoforms provided a useful tool for generating an antibody, 
but proved conflicting in an effort to conduct a qPCR analysis of the isoforms.  
The expressed full-length myosin-18 was heavily degraded and therefore was not pursued 
as a course of further analysis, while the HMM truncation lacked activity and did not bind co-
expressed light chains. Since it is possible that the lack of activity was due to a tail domain-
dependent regulation, we chose to concentrate our studies on a simpler system, the minimal motor 
domain, which is missing the tail region and the light chain binding region. These minimal motor 
domain constructs, truncated at L1319 in M-PDZ and L1082 in M-∆PDZ, encode motors that are 
truncated at the residue corresponding to R761 of Dictyostelium myosin-2. Truncations of myosins 
beyond I754 of that motor have been shown to retain catalytic activity (Kuhlman and Bagshaw, 
1998; Woodward et al., 1991). We would therefore expect our truncated constructs to reflect the 
full kinetic function of myosin-18 while eliminating the need for bound light chains that, 
themselves, may require modifications to elicit function of the motor.   
We provided several lines of evidence to support the lack of nucleotide binding by 
myosin-18.  These include lack of perturbation of the fluorescence intensity and anisotropy of 
mant-ATP and deac-amino-ATP, lack of interaction with 32P-α-ATP, and lack of effect of ATP 
on the binding of myosin-18 to actin measured either by direct sedimentation assays or from the 
lifetimes of attached events in the optical trap. 
We confirmed that this lack of nucleotide binding cannot be attributed to spurious amino 
acid substitutions within the cloned sequences since the sequence of the clones matches that in 
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the database.  Further supporting evidence that the lack of ATP binding is an inherent property of 
this motor and not a result of protein misfolding was provided by CD spectrum and tryptophan 
fluorescence analyses of temperature-dependent unfolding of each molecule.  We established Tm 
values for the myosin-18 proteins in the range of 40 – 50 ºC, similar to those reported for other 
myosins (Zolkiewski et al., 1996), suggesting proper folding of our proteins.   
The inherent lack of ATP binding could be attributed to several interesting residues found 
at integral sites in the amino acid sequence of the motor (Figure 2.26 A).  The sequence of the P-
loop of myosin-18 is fairly conserved from the standard myosin sequence (GRSGAGKS 
compared to the consensus GESGAGKT).The Switch I and II regions of myosin-18 do exhibit 
several differences from conserved motor sequences (NXNSSRFGK). In Switch I, two types of 
differences can be seen. First, there are residue changes substituting consensus amino acids with 
alternative residues that have bulkier side chains. These alterations, including T709 of Drosophila 
myosin-18 replacing a serine and T712 replacing a glycine, may affect the position of Switch I, 
thereby preventing its role in coordinating potential bound nucleotide and Mg+2 or preventing the 
binding of nucleotide altogether.  Second, residues known to be important in the transition 
between states during the motor’s kinetic cycle (A708 substituted for the consensus serine) are 
altered from the conserved sequence. While these changes may not explain a total lack of 
nucleotide binding, other reports suggest that these residue differences would be expected to 
result in slower hydrolysis rates and slower Pi release (Shimada et al., 1997).  
Switch II (DIXGFE) of myosin-18 replaces a conserved glutamic acid with a glutamine 
(Q944 of Drosophila myosin-18 isoform A). In other myosins this glutamic acid forms a salt 
bridge with conserved arginine in Switch I. Disrupting the salt bridge by mutating this glutamic 
acid has been shown in smooth muscle myosin or Dictyostelium myosin-2 to dramatically 
decrease the rate of basal and actin-activated nucleotide hydrolysis by the motor, but does not 
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interfere with the binding of nucleotide into the pocket (Furch et al., 1999; Onishi et al., 1997; 
Ruppel and Spudich, 1996). However, in the case of myosin-18 motors, the glutamic acid is 
mutated to a glutamine, and such a substitution may not prevent closure of Switch II, but may 
instead destabilize the pre-powerstroke conformation and instead favor a post-rigor conformation.  
The presence of a proline in Switch II (P941 of Drosophila myosin-18 isoform A) could 
result in a restriction of the conformations that the flexible switch could adopt during the kinetic 
cycle of the motor. This proline residue would also effect the position of the nitrogen in the 
following glycine, which is integral for ATP binding and transitioning the switch to a pre-
powerstroke conformation.  
In addition to these single-residue substitutions in the myosin-18 motor, there are also 
two regions of extended amino acid insertions that we propose may also play a role in making 
this motor highly divergent from the superfamily (Figure 2.26 B-D). A 6 amino acid extension 
after Switch II, between corresponding residues N464 and S465 in Dd myo2, is likely buried within 
the interior of the motor domain. By comparison, other myosin amino acid insertions (compared 
to rabbit skeletal muscle myosin) are usually present in surface loops (Sellers et al., 1996) while 
the lengths of the various helices and β-sheets with “interior” of the myosin domain is generally 
well conserved. The added bulk from these inserted buried residues could potentially change the 
dynamics of the cleft closure of the motor, perhaps producing a well-defined structure for the 
motor with low affinity for nucleotide and weakened affinity for actin (Furch et al., 1998; Lorenz 
and Holmes, 2010; Ruppel and Spudich, 1996).   A second insertion of interest in the Drosophila 
myosin-18 sequence involves a 21-residue surface loop extension that precedes the SH2 helix of 
the motor, inserted between corresponding residues Q662 and L663 in Dd Myo2. A similar 
insertion, of 29-residues, is present in Mus musculus myosin-18A. This long, flexible extension 
may potentially change how rearrangements of regions of the motor domain occur.    
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Another possibility is the activity of Drosophila myosin-18 is regulated by some post-
translational mechanism such as a phosphorylation or the binding of a regulatory protein and that 
we have isolated the myosin in an inactive state.  However, other myosins that have been shown 
to be regulated, such as lower eukaryotic myosin-1, smooth muscle myosin-2, and myosin-5a, 
bind nucleotide and have low basal MgATPase activities in their “off” states (De La Cruz and 
Ostap, 2004; Sellers, 1985; Tan et al., 2008).  There is no precedent for a myosin regulatory 
mechanism at the level of nucleotide binding. 
The affinity of Drosophila myosin-18 for actin is intermediate between that typically 
exhibited by other myosins in their nucleotide free state (strong binding) and in the ATP-bound 
state (weak binding).  The lack of stoichiometric binding observed was similar to that seen with 
Limulus myosin-3 (Kempler et al., 2007) or with myosin-9 (Nalavadi et al., 2005) in the presence 
of ADP and suggests that there may be an equilibrium between a conformation of myosin-18 that 
is competent to bind to actin and a conformation that does not bind to actin.  In the case of all 
three of these myosins, it was found that addition of actin to the unbound fraction followed by 
another sedimentation resulted again in only partial binding of the myosin.  We have not been 
able to establish a suitable kinetic model to explain both the partial binding of myosin-18 to actin 
in the first sedimentation and the partial binding seen in the subsequent resedimentation.  
Drosophila myosin-18 bound to a coverslip surface is capable of tethering fluorescently 
labeled actin filaments.  In addition, when mixed with skeletal muscle myosin on a coverslip 
surface, it can attenuate the rapid translocation of actin filaments exhibited by that myosin and, at 
higher ratios of myosin-18 to skeletal muscle myosin, can fully stop the movement of actin 
filaments.  This supports the notion that myosin-18 dynamically binds to actin filaments as its 
behavior in this experiment mimics that of other actin binding proteins such as α-actinin and 
filamin (Janson et al., 1992).  Furthermore, the transient binding of myosin-18 to actin can be 
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seen in optical trapping experiments with no significant power stroke, consistent with myosin-18 
functioning as a tethering protein rather than a motor protein. M-PDZ and M-∆PDZ also 
exhibited slightly different detachment rates, determined from optical trapping experiments. 
Perhaps the N-terminal extension of this myosin provides an alternate actin binding mechanism to 
that of the conventional actin binding via the motor domain. Using the detachment rates from the 
optical trapping experiments and the affinity constants determined from cosedimentation assays, 
we can estimate the apparent actin binding on-rate for this myosin to be in the range of ~2 – 10 x 
107 M-1 s-1, similar to rates observed for other myosins (Cremo et al., 1990; De La Cruz et al., 
1999). 
The affinity of myosin-18 for actin is in the 1 µM range like other actin binding proteins, 
including α-catenin (Rimm et al., 1995), talin (Hemmings et al., 1996), and α-actinin (Winder et 
al., 1995). This affinity is much lower than most members of the myosin superfamily when no 
nucleotide is present, with the exception of Limulus myosin-3 whose affinity has been calculated 
to 0.1 µM (Kempler et al., 2007; Sellers, 1999).  It is well known that bound ATP (or ADP.Pi) 
dramatically reduces the actin affinity for most myosins with no nucleotide bound (Sellers, 1999).   
The affinity of myosins for actin may be modulated by the degree of closure of the cleft 
between two large subdomains that constitute the actin interface in the head.  Crystal structures of 
numerous myosins in the presence of different nucleotides show that this cleft can be in an open 
or closed conformation.  Recent molecular modeling of myosin crystal structures into the density 
obtained from electron microscopic images of myosin motor domains bound to actin suggests that 
in the higher affinity-no nucleotide bound state the cleft is closed (Lorenz and Holmes, 2010).  
The lower affinity of myosin-18 for actin suggests that the head conformation of myosin-18 is 
intermediate between that of the apo-state and the nucleotide bound state for typical myosins. 
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Figure 2.26: Unique amino acid sequence features of Drosophila myosin-18.  
A, Sequence alignments of amino acid residues from the P-loop, Switch I (upper alignment) 
and Switch II (middle alignment) regions of Drosophila myosin-18 (Dm Myo18) in 
comparison with consensus sequences from these regions and sequences from motor domains 
of Dictyostelium myosin-2 (Dd myo2) and Mus musculus myosin-18A (Mm myo18Aα).  
Lower alignment demonstrates the presence of a 21-residue insertion (Dm Myo18; 29-residue 
insertion for Mm Myo18A) between the region bounded by amino acids Q662 and L663 in Dd 
Myo2.   Alignments also reveal amino acid insertions in multiple locations, including a 6-
residue insertion between Dd myo2 residues N464 and S465. Residues in bold are discussed in 
the text.  B and C, Using ribbon diagrams of the crystal structure of the motor domain of Dd 
myo2 (PDB ID: 1MMD; ADP, blue), the two Dm myosin-18 amino acid extensions in (A) are 
illustrated by highlighting the flanking Dd myo2 amino acids. The 6-residue insertion between 
Dd myo2 N464 and S465 (red) is located at the end of Switch II, while the 21-residue insertion 
between Q662 and L663 (yellow) is located before the SH2 helix of the motor.   D, Space-filling 
model of the crystal structure of the same region as in (C).  The Q662-L663 insertion can be seen 
on the motor’s surface, suggesting it to be a large surface loop that may potentially change 
how rearrangements of the motor domain occur during the kinetic cycle. The N464-S465 
insertion, however, cannot be seen clearly in the space-filling model, suggesting that the 6-
residue insertion would be buried within the motor structure and could potentially change the 
dynamics of cleft closure and perhaps produce a well-defined motor structure with low 
nucleotide affinity and weakened affinity for actin. 
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 Only one study has been published on the biochemical properties of the mammalian 
myosin-18A protein (Isogawa et al., 2005).  In that study, heavy meromyosin-like (two-headed) 
constructs of myosin-18A with and without the amino terminal extension were expressed in HeLa 
cells and used in actin cosedimentation assays without purification.  Interestingly, the isoform 
containing the region between the KE-rich and the PDZ domains bound to actin in an ATP-
insensitive manner, while constructs missing this region did not bind to actin under either 
condition.  These data suggest that only the region between the KE-rich domain and the PDZ 
domain can interact with actin and that the mammalian myosin-18 motor domain, unlike that of 
Drosophila, does not interact with actin at all.  No attempts were made to directly measure the 
ATPase activity or the nucleotide binding of these isoforms (Isogawa et al., 2005).  
 A recent study by Dippold and coworkers (Dippold et al., 2009), suggested that 
mammalian myosin-18A interacts with the Golgi-associated protein GOLPH3 and participates in 
the maintenance of trans-Golgi structure.  This study used siRNA knock-down of the endogenous 
myosin-18A and found that trans-Golgi structure was disrupted.  Normal structure could be 
rescued by a wild-type myosin-18A construct, but not by an ATPase mutant construct of myosin-
18A corresponding to mutations in myosin-2 that abolish MgATPase activity in that myosin.  
This study suggests that the mammalian myosin-18A may have MgATPase activity and the 
authors of the study speculate that the motor activity of this myosin is necessary for formation of 
proper Golgi structure.  However, the conflicts between the above study (Dippold et al., 2009) 
and the Isogawa study (Isogawa et al., 2005) suggest the need for biochemical experiments to be 
conducted on purified mammalian myosin-18A before comparisons are made with the 
Drosophila myosin-18 protein. 
The data reported here suggest that Drosophila myosin-18 does not have MgATPase 
activity, nor does it have the ability to bind ATP, but its motor domain, both with and without the 
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N-terminal extension, does have the ability to bind and tether actin.  The full length protein is 
encoded to have a long segmented coiled-coil in the tail region that may allow it to oligomerize 
into thick filaments similar to those formed by myosin-2.  If so, these multiply aligned heads 
would dramatically increase the effective actin affinity of the complex and, if the filaments were 
bipolar such as those formed by nonmuscle myosin-2, could tether actin filaments of opposite 
polarity.  Drosophila myosin-18 may also act as a protein scaffold to tether other proteins to 
actin.  Some isoforms contain an N-terminal PDZ domain, which is a well known protein-protein 
interaction domain.  From our studies, the PDZ domain does not appear to confer any kinetic 
changes within the motor.  Future studies will seek to identify binding partners for the full length 
molecule through the PDZ domain as well as through the tail.
  
 
CHAPTER THREE: 
FIMBRIN-ACTIN BUNDLES AS A TOOL FOR ANALYZING MYOSIN MECHANICS 
 
3.1  Introduction 
 
3.1.1   Actin Crosslinking Proteins 
Within a cell, the superstructure of the actin network tends to occupy two main forms: 
meshworks and bundles. Meshworks are formed by the interconnection of actin filaments by long 
crosslinking proteins that result in an interwoven superstructure of the network, whereas actin 
bundles are the result of actin filaments being tightly packed together by small actin crosslinkers 
(Matsudaira, 1994a).  
Actin crosslinking proteins differ from actin binding proteins in that they have two actin 
binding sites rather than one. Some crosslinkers, like α-actinin and filamin A, encode only a 
single actin binding domain (ABD) within their structure and dimerize (anti-parallel dimerization 
for α-actinin; parallel dimerization through the C-terminus for filamin) to form the actin 
crosslinking structure (Matsudaira, 1994a; Otto, 1994) (Figure 3.1). Other actin crosslinking 
proteins, including fimbrin, contain two actin binding sites within a single protein (de Arruda et 
al., 1990).  
Actin bundles are common physiological features of cells. They are the structural feature 
found within filopodia extending from the leading edge of a cell, and are the core structures 
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forming the stereocilia on inner ear hair cells and on the microvilli of the intestinal brush border 
(Matsudaira, 1994a).  
 
 
 
3.1.2   Fimbrin is an Actin Bundling Protein 
Fimbrin was originally identified in chicken intestinal brush border microvilli, where it is 
responsible for the tight, parallel packing of hexagonal arrangement of the actin filaments within 
that structure (Bretscher and Weber, 1980; Matsudaira et al., 1983; Volkmann et al., 2001). 
Following its initial identification, fimbrin was also found to be a primary component of the 
stereocilia actin bundle structure (Hofer et al., 1997).  In cell cultures, fimbrin has been 
associated to filopodial cell extensions, microspike actin bundle structures within the 
 
Figure 3.1: Domain structure of 27 kDa CH-domain actin crosslinkers.  
Fimbrin is classified in a family with α-actinin and filamin A due to the similarities in their 27 
kDa CH domains for actin binding. Within the family, fimbrin is the smallest actin 
crosslinker, with two actin binding domains (ABD) encoded in a single protein, in contrast to 
α-actinin and filamin A that need to dimerize for actin crosslinking and results in a larger 
distance between linked actin filaments.  
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lamellipodia, and on actin-based membrane ruffles of cells (Bretscher, 1981; Bretscher and 
Weber, 1980; Glenney et al., 1981).   
The human homologue for chicken fimbrin is called plastin. There are three paralogs of 
plastin in the human genome which differ in their tissue expression (Arpin et al., 1994; de Arruda 
et al., 1990). L-plastin is encoded on human chromosome 13 and is expressed in leukocyte 
derived cells.  T-plastin is encoded on the human X chromosome with the protein found in a wide 
distribution of tissues. The most recently identified I-plastin is encoded on human chromosome 3 
and is found specifically expressed within the absorptive epithelium of the intestines and kidneys 
(Arpin et al., 1994; Lin et al., 1993; Lin et al., 1994).    
Fimbrin was also identified in yeast, encoded by the gene SAC6 (Adams et al., 1989; 
Adams et al., 1991). Through mutant screening analysis, SAC6 was determined to be an essential 
component of the mechanism for cytokinesis in Schizosaccharomyces pombe (Wu et al., 2001), 
resulting in abnormal actin cables, cellular asymmetry, and defective endocytosis (Lin et al., 
1993; Lin et al., 1994).  
  
 
3.1.3   Fimbrin Structure 
Fimbrin is a 68 kDa protein with a general structure consisting of an N-terminal 
headpiece that contains two EF-hand structures, a middle linker segment, and a C-terminus 
containing two actin binding domains (ABD) (de Arruda et al., 1990).  
The EF-hand domains within the N-terminal headpieces are considered to be sites of 
calcium binding and potential calcium regulation (Glenney et al., 1981). While all forms of 
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fimbrin appear to have this N-terminal headpiece, only some actually show calcium sensitivity 
(de Arruda et al., 1990; Namba et al., 1992). Specifically, the human isoforms of L- and T-plastin 
and the chicken fimbrin are known to be unable to induce actin bundling in the presence of Ca+2, 
while the fimbrin isoforms of lower eukaryotes including Schizosaccharomyces pombe and 
Arabidopsis thaliana are unaffected by Ca+2 (Kovar et al., 2000; Nakano et al., 2005).  
The two ABDs of fimbrin are similar to the 27 kDa ABDs of α-actinin and filamin, and 
therefore these three proteins have been classified into a single group of actin crosslinkers (Figure 
3.1)  (Matsudaira, 1994a). Unlike α-actinin and filamin whose ABDs are separated by a 
connector, fimbrin’s ABDs are located in tandem (de Arruda et al., 1990; Klein et al., 2004). The 
absence of a connector between the two actin binding surfaces makes fimbrin the smallest of the 
known actin crosslinkers and resulting in tightly packed parallel actin bundles, spaced 120Å apart 
center to center.  
 
 
3.1.4   The Fimbrin-Actin Complex 
Within fimbrin, each ABD consists of two calponin homology (CH) domains. The 
naming convention for the actin binding region are for the two ABDs to be named ABD1, which 
contains CH1 and CH2, and ABD2, which contains CH3 and CH4 (Klein et al., 2004; 
Matsudaira, 1994b)(Figure 3.2); or alternatively ABD1 containing CH1 and CH1’, and ABD2 
containing CH2 and CH2’ (Hanein et al., 1998). Their orientation is asymmetric, suggesting a 
unique actin binding preference between ABD1 and ABD2.  
Crystallography data has suggested that the interaction site between fimbrin and actin is 
multi-faceted. Each ABD of fimbrin interacts primarily with subdomain 2 of the actin monomer, 
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and with part of the same monomer subdomain 1, in addition to bridging a connection to the next 
actin monomer’s subdomain 1 (Figure 3.2) (Hanein et al., 1998; Matsudaira, 1994b). This 
footprint for fimbrin on the actin filament is the same as for α-actinin, suggesting that the two 
actin crosslinkers would be competing for the same spot on the actin filament within the cell 
(Holtzman et al., 1994; Honts et al., 1994; McGough et al., 1994).  
Furthermore, the fimbrin/α-actinin footprint was suspected to compete with the binding 
site for myosins on the actin filament (Matsudaira, 1994b; Rayment et al., 1993a). This 
possibility has been largely negated by the ability of actin bundled by fimbrin to be decorated by 
                
Figure 3.2: Fimbrin contains two actin binding domains in tandem with flexible linkers 
between component CH domains.  
Fimbrin’s tandem actin binding domains, ABD1 and ABD2, have been crystallized (PDB ID 
number 1PXY, left) and are asymmetric to each other. The calponin homology (CH) domains 
making up these ABDs are separated by short, flexible linkers, giving rise to tightly packed 
actin filaments. When bound to actin, crystallography of ABD 2 (purple) in complex with 
actin (grey) (PDB ID 3BYH, right) shows that a single actin binding domain in fimbrin 
interacts with two actin monomers within the filament.  
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myosin S1 (Glenney et al., 1981), by the ability to use fimbrin-bundled-actin in motility assays 
(Chabrillat et al., 2005), and by the ability of purified actin bundles from stereocilia to be used in 
optical trapping motility assays (Shepherd et al., 1990).  
In microvilli and stereocilia, fimbrin bundles are tightly packed arrays of parallel actin 
filaments separated by 120 Å (mid-filament distance) where fimbrin appears to form regularly-
spaced interactions with the actin filaments  (Batters et al., 2004; Volkmann et al., 2001) (Figure 
3.3).  
 
 
 
In vitro reconstitution of these bundles as a two-dimensional lattice suggested two 
possible conformations of the actin bundles: one that features fimbrin crosslinks perpendicular to 
the actin filaments, and one that is slanted at ~27° (Volkmann et al., 2001). Although these two-
dimensional arrangements suggest a potential for flexibility within the actin bundle, the 
 
Figure 3.3: Fimbrin-actin bundles form tightly packed hexagonal arrays.  
According to cross sections of microvillar actin bundles, fimbrin (purple) bundling of actin 
(grey) appears to involve a hexagonal arrangement of actin filaments surrounding a single 
actin filament. Fimbrin forms points of contact between each of these parallel actin filaments, 
spacing them apart by 120 Å, in a manner illustrated here.  
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artificiality of the two-dimensional lattices was suspected of resulting in a non-physiological state 
of the fimbrin-actin associations.  
Crystallography structures of the two ABDs supported the flexibility argument for three-
dimensional actin bundles, with each CH domain within a single ABD connected by a very short, 
yet flexible loop unable to be seen in crystal structures. Furthermore, the two ABDs, while in 
tandem, are also connected by a very short, yet flexible loop. These structural features allow the 
fimbrin actin binding region to connect two actin filaments in close proximity while allowing 
both filaments to retain inherent flexibility (Klein et al., 2004). Further evidence of the mechanics 
of this bundle flexibility was provided through force-exertion against actin bundled with plastin, 
which showed a decoupled bending mechanism where the plastin links are highly flexible 
connectors that bend in response to shear force against the bundle (Claessens et al., 2006).  
 
 
3.1.5   Fimbrin as a Tool for Myosin Mechanics  
The goal of this project was to determine whether fimbrin-bundled actin could be a useful 
tool for studying myosin mechanics.   There were conflicting opinions about the potential for 
myosin to be able to interact with fimbrin-actin bundles.  Doubts arose from published data 
suggesting a competitive binding site on actin for both fimbrin and myosin (Matsudaira, 1994b), 
and from preliminary unpublished data collected by Paul Matsudaira (Massachusetts Institute of 
Technology) and James R. Sellers (NIH) suggested that fimbrin-actin bundles may not be able to 
be translocated by myosin-2 in an in vitro motility assay.  Other published data contradicted these 
doubts, showing that different classes of myosins were able to bind (Glenney et al., 1981) and 
move (Chabrillat et al., 2005; Shepherd et al., 1990) on fimbrin-actin bundles. This conflict was 
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the impetus for the initial aim of this project, to determine whether fimbrin-actin bundles could be 
translocated by myosin-2 or myosin-5a in vitro.  
Furthermore, some myosins have been shown to exhibit enhanced motility, or even a 
calculable preference for actin bundles (Nagy et al., 2008; Ricca and Rock, 2010).  Along this 
line, the use of actin bundles was recognized as a potential method to enhance or maximize 
myosin mechanics as a supplement to currently used techniques, and was the subject of further 
investigation within this project.  
 
 
3.2 Experimental Procedures 
 
Expression of Fimbrin – A DNA clone for expression of untagged full length fimbrin in 
expression vector pABX4 was provided courtesy of Paul Matsudaira (Whitehead Institute, 
Massachusetts Institute of Technology) with the fimbrin construct cloned in between the EcoRI 
and BamHI sites.  Fimbrin was expressed in BL21(DE3) cells (Invitrogen) grown at 37 °C in 
2XYT media containing 100 µg/mL ampicillin with induction of expression using 1 mM IPTG 
after 2 hours, followed by an additional 3 hours growth shaking at 225 rpm at 37°C. Fimbrin was 
purified according to the methods used by Volkmann and colleagues (Volkmann et al., 2001), 
with the exception that cells were lysed with sonication, pulsing over 5 min on ice and that 
fimbrin fractions were not further concentrated following FPLC Q-Sepharose column.  
Concentrations of purified fimbrin were on the order of 50 µM protein for each purification. A 
fraction of the purified protein was stored by quick-freezing as droplets in liquid nitrogen, and 
another fraction was frozen at -20 °C in 50% glycerol (Glenney et al., 1981).    
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Cosedimentation analysis – Confirmation of the ability of the purified fimbrin construct to bind 
actin was done through cosedimentation analysis. Purified fimbrin was incubated with F-actin in 
increasing molar ratios for 1 hr at 25 °C in a buffer containing  0.1 M KCl, 20 mM MOPS (pH 
7.0), 5 mM MgCl2, 0.05 mM EGTA, 1 mM NaN3, and 1 mM DTT, followed by centrifugation at 
100,000 χ g for 15 min at 4°C in a Beckman TLA-100 rotor. The supernatant was removed and 
the pellet was resuspended in 1x SDS sample buffer to an equivalent volume.  Supernatants and 
pellets were fractionated on a 4-20 % Tris-Glycine SDS PAGE gel.  Gels were stained with 
Coomassie Blue.  
 
Generation of fimbrin-actin bundles – Labelled fimbrin bundles were polymerized by incubating 
2 µM G-actin with 4 µM Fimbrin  in the presence of 2 µM rhodamine-phalloidin overnight at 4°C 
in a buffer containing 0.1 mM KCl, 4 mM MOPS (pH 7.1), 2 mM MgCl2, 0.1 mM EGTA, 3 mM 
NaN3, and 1 mM DTT.  For experiments requiring biotinylated bundles, the 2 µM total G-actin 
was modified to include a total 10% biotinylated-G-actin in the polymerization reaction.  
 
In vitro motility assays – Motility assays were conducted using either tissue-purified rabbit 
skeletal muscle myosin-2 HMM (SkHMM) or myosin-5a-6IQ-HMM (Myo5a) in the presence of 
1.5 mM Xenopus calmodulin. Myosins were bound non-specifically to nitrocellulose-coated 
coverslips at 0.05 mg/mL and the chamber was blocked with 1 mg/mL BSA for 1 min before 
bundles were flowed in at a dilution of 1:10 in the polymerization buffer. Bundles were allowed 
to bind for 3 minutes prior to addition of activation buffer containing 40 mM KCl, 20 mM MOPS 
(pH 7.4), 2 mM MgCl2, 0.1 mM EGTA, 50 mM DTT, 25 µg/mL glucose oxidase, 45 µg/mL 
catalase, 2.5 mg/mL glucose, and 1 mM ATP at 30°C. All flow-through steps were done using 
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ashless Whatman filter paper (number 42) due to the sensitivity of fimbrin to Ca+2. Visualization 
of filaments and quantification of motility were performed in accordance with parameters 
published by Homsher and colleagues (Homsher et al., 1992).  
 
Optical Trapping Assays – Single-bead optical trapping assays were performed in a ~40 µL 
reaction chamber using biotinylated fimbrin-actin bundles that were bound specifically to a glass 
coverslip coated with NeutrAvidin (Thermo Fisher Scientific, Rockfold, IL, USA). The chamber 
was then blocked with several changes of 1 mg/mL BSA.  FLAG-tagged myosin-5a-6IQ-HMM 
were bound to 1 µm polystyrene beads (Polysciences, Warrington, PA, USA) diluted to 0.1% 
beads in AB- buffer containing 25 mM KCl, 25 mM imidazole (pH 7.4), 4 mM MgCl2, 1 mM 
EGTA , and 10 mM DTT at 22 °C  at two different densities. High density myosin beads were 
formed by incubating 1.4 nM myosin with diluted beads in AB buffer containing 1 mg/mL BSA 
and 1 µM calmodulin, and low density myosin beads were formed by using ~5 pM myosin. 
Myosin-coated beads were further diluted in AB buffer supplemented with 2 mM creatine 
phosphate, 0.1 mg/mL creatine phosphokinase, 3 mg/mL glucose, 0.1 mg/mL glucose oxidase, 
0.02 mg/mL catalase, and 10 µM ATP. Trapped beads were translocated through the chamber and 
placed on top of fimbrin-actin bundles. Beads that attached to the bundles were released from the 
trap and the subsequent movement of the beads was traced for calculations of velocity and run 
length. 
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3.3   Results 
3.3.1    Expression and Actin Binding of Fimbrin.  
Fimbrin was successfully purified as a single protein product at ~68 kDa using a series of 
gel filtration and ion exchange columns as described. The purified protein was able to bind F-
actin in cosedimentation experiments. To test the actin binding characteristics of the purified 
fimbrin, and to determine optimal ratios of fimbrin to actin for production of bundles, a series of 
cosedimentation assays were performed using increasing molar ratios of fimbrin to F-actin.   
Cosedimentation analysis suggested that the purified fimbrin shows maximum binding  
between a 1:1 ratio and a 1:3 ratio of actin to fimbrin, with unbound fimbrin remaining in the 
supernatant (Figure 3.4). These results are in line with published experiments that used a 1:2 
molar ratio of actin to fimbrin for production of bundles (Volkmann et al., 2001).  
Figure 3.4: Expressed fimbrin binds F-Actin in vitro.  
Cosedimentation analysis of fimbrin binding to F-actin confirms that bacterially expressed 
fimbrin was successfully purified (~68 kDa) and can bind to F-actin. Increasing molar ratios 
of fimbrin to actin were incubated for 1 hr followed by a centrifugation at 100,000 χ g for 15 
min at 4°C. Pellets and supernatants were separated and run on a 4-20% Tris-Glycine gel. 
Fimbrin appears to bind maximally between a 1:1 and 1: 3 molar ratio actin to fimbrin.  
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3.3.2     Fimbrin bundles can be used successfully in in vitro motility assays.   
An initial test to determine whether fimbrin-actin bundles would be useful tools for 
analysis of myosins within the lab utilized the in vitro motility assay. In contrast to the velocity of 
actin filaments in response to SkHMM and Myo5a, there is little appreciable difference of the 
velocity seen on fimbrin-actin bundles with those same motors.  
In assays with SkHMM, actin filaments moved at a velocity of 1.3 ± 0.2 µm/s (N= 173), 
while fimbrin-actin bundles moved at 1.1 ± 0.3 µm/s (N= 28) (Figure 3.5). The slightly slower 
average motility of the bundles is within the calculated standard error of the filament motility. Of 
note is the shearing of fimbrin-actin bundles in motility assays. In experiments using SkHMM, 
the bundles are sheared quickly into smaller fragments of bundles, and ultimately down into their 
component filaments during the course of the assay.  Analysis of velocities from such 
experiments required an increase in the limit of particle size analyzed by the motion analysis 
program, CellTrak, to ensure that motility analyzed was for bundles and not the individual 
filaments resultant from shearing. 
Assays with Myo5a moved actin filaments at 414.7 ± 71.1 µm/s (N= 344), while fimbrin-
actin bundles moved at 365.1 ± 55.4 µm/s (N= 182) (Figure 3.5). Shearing was also seen in the 
assays using Myo5a, but to a very limited extent during the timecourse of the assay. Rather, 
bundles were pushed as a single entity over the field of Myo5a for the much of the analysis with 
only minimal shearing.  
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Figure 3.5: In vitro motility assays using filaments and bundles show no significant 
change in velocities.  
Using traditional in vitro techniques, velocities of SkHMM and Myo5a were calculated by 
centroid tracking using the CellTrak program. Single filaments were moved by SkHMM at a 
rate of 1.3 ± 0.2 µm/s (N= 173). Fimbrin bundles used in assays with SkHMM showed a 
velocity of 1.1 ± 0.3 µm/s (N= 28), but were sheared extensively and quickly during the assay. 
In assays using myo5a, filaments were translocated at a velocity of 414.7 ± 71.1 µm/s (N= 
344), while bundles moved at a velocity of 365.1 ± 55.4 µm/s (N= 182) with no significant 
shearing. 
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3.3.3.    Fimbrin Bundles provide an extended track for velocity and run length experiments.  
With the known ability to use bundles in motility assays, they were also considered a 
potential tool for determining the maximum run length of myosins. Published data on the 
processive high duty ratio motor myosin-5a suggest a maximum run length of the dimerized 
motor along an actin filament ~2.4 µm, with an average reported 1.4 ± 0.8 µm relative to reaction 
conditions.  With the 36 nm step size of the myosin-5a motor, this equates to a maximum of 66.6 
steps of the motor along an actin filament without dissociating (Figure 3.6).  
When used in optical trapping experiments along fimbrin-actin bundles, performed in 
collaboration with Dr. Yasuharu Takagi, Myo5a had dramatically extended run length potential. 
When polystyrene beads were coated with a high density of Myo5a, the average run length seen 
by the bead was 15.5 ± 6.3 µm (N=8). This would equate to the motor taking ~430 steps along the 
fimbrin-actin bundle without dissociating.  However, the high-density coating of myosin on each 
bead could result in multiple motors interacting with the actin bundle at a single time, artificially 
extending the run length with nearby motors taking over when one motor dissociates from the 
bundle. This theory of multiple motors cooperating on the high density beads was supported by 
the motility of the bead along the actin bundle, which featured repetitive runs with interrupting 
pauses prior to the dissociation of the bead.  
Therefore, the coating of the beads with myosin was brought down to a single-molecule 
level, such that the concentration of myosin used in the system is expected to result in 
exceedingly sparse binding of myosin to the beads. In this manner, any interaction between a 
Myo5a-coated bead and the actin bundle is expected to be the result of a single myosin.  These 
single-molecule-range assays resulted in very few interactions seen (N=2) during several rounds 
of the experiment, but those interactions resulted in run lengths of 20.3 ± 3.3 µm (~564 steps) that 
featured periods of motility interrupted by long pauses.  
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3.4  Discussion 
In cells, a major component of the actin superstructure is the actin bundle. Actin bundles 
form the core of cellular structures like microvilli and stereocilia, which feature tightly packed 
parallel actin filaments connected by actin crosslinking proteins such as fimbrin.  
While fimbrin has been traditionally purified from endogenous sources such as intestinal 
brush border epithelium (Batters et al., 2004; de Arruda et al., 1990; Glenney et al., 1981) or 
stereocilia (Shepherd et al., 1990), it can also be purified successfully and to high purity using 
 
Figure 3.6: Run lengths for myosin-5a moving on actin bundles are significantly larger 
than on filaments.   
In optical trapping single bead experiments, Myo5a showed 10-fold longer run lengths than 
published data for single actin filaments. Published data suggest an average run length for 
Myo5a of 1.4 ± 0.8 µm relative to reaction conditions, and a maximum reported 2.4 µm, 
which corresponds to ~66 steps of 36 nm. On fimbrin bundles, low density and high density 
coating of myosin on beads showed exceedingly long run lengths of 20.3 ± 3.3 µm (~564 
steps)  and 15.5 ± 6.3 µm (~430 steps), respectively.  Data were collected in collaboration with 
Dr. Yasuharu Takagi. 
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bacterial expression. Purification of bacterially expressed fimbrin for this analysis was successful, 
with the purified protein able to bind actin in a ratio as expected from published data (Volkmann 
et al., 2001).   
Actin bundles formed by incubating G-actin with purified fimbrin were able to be used 
for in vitro motility analysis of myosin motors. The data collected in these assays does not 
support the preliminary data from Matsudaira and Sellers suggesting that skeletal muscle myosin-
2 is unable to translocate fimbrin-actin bundles (unpublished data). The velocities recorded in the 
current experiments suggest that actin bundles are able to be translocated by actively cycling 
myosins at rates similar to those seen with single actin filaments. 
However, the motility assays using SkHMM did cause significant shearing of fimbrin-
actin bundles. Shearing is a common feature of motility assays using SkHMM, but usually 
becomes a complication in the reaction chamber either late in the timecourse of the experiment or 
if the initial field of actin filaments used in the experiment is dense. In the case of fimbrin-actin 
bundles at concentrations of SkHMM typically used in motility assays, the shearing was 
instantaneous, resulting in rapid disintegration of the initial large bundles into smaller bundles 
and ultimately into small fragments of single actin filaments. 
Bundle shearing was not as much of an issue for myosin-5a. In contrast, the bundles 
moved well over fields of myosin-5a, gliding as a single large unit with minimal shearing during 
the course of the experiment and with velocities on par with single filament velocities.  
Optical trapping experiments proved quite useful for actin bundles, which appeared to 
provide extended tracks to maximize the run length potential of myosin-5a motors. The run 
lengths exhibited in these assays was close to 10-fold larger than run lengths reported for myosin-
5a motors on single actin filaments, but with similar velocities.  
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The extended run lengths seen in this assay, however, are questionable.  In experiments 
using a high density of myosin motors on the bead, the long run lengths are likely due to the work 
of multiple motors moving along the actin bundle, perhaps with one motor taking over following 
the dissociation of another.  While the low density experiments may negate this result, there is 
still the possibility that the extensive run lengths seen in our “single molecule” regime could be 
the result of a small number of motors working together to move the bead along the filament. Our 
number of records from the single molecule regime (N= 2) does not allow for significant 
conclusions to be made.  
Another component in our experimental design that could provide an artificially long run 
length is the bead size.  At 1 µm, the polystyrene beads used in these experiments would be 
expected to have a slower diffusion rate away from the actin bundle than a smaller bead, or a 
motor on its own. Other studies have shown that seemingly non-processive motors can become 
highly processive in an environment with decreased Brownian diffusion (Iwaki et al., 2008). 
Using a smaller bead size or another labeling mechanism to look at run length of myosin along 
actin bundles would be necessary before definitively stating that the actin bundles increase the 
processivity of myosin motors.  
If, however, the fimbrin-actin bundles do enhance processivity of myosin motors, we 
propose that it may be a consequence of the quaternary structure of the fimbrin-actin bundle. 
According to structural analysis, these bundles are expected to be hexagonal arrays of parallel 
actin filaments separated by 120 Å (Hanein et al., 1998; Volkmann et al., 2001). As such, this 
structure may increase the number of potential binding sites of myosin on the actin track. Rather 
than being required to find the next binding site on a single actin filament ~36 nm in front of the 
lead head during its diffusive search, the myosin could potentially bind to its current actin 
filament track, or to one of the proximal filaments within the bundle. In this manner, a myosin 
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that may diffuse away from a single actin track after ~66 steps could, instead, pause and continue 
moving along the proximal parallel actin filament and continue its processive run.  
Combined, these data suggest that fimbrin-actin bundles could be a useful tool for 
supplemental analysis of myosin motors. The bundles can easily be formed in the lab in a manner 
similar to the procedure used to polymerize F-actin, and those bundles can be used in a variety of 
traditional myosin assays. They do not appear to result in major alterations of myosin motor 
velocity, and may enhance processivity of motors like myosin-5a although this characterization is 
not entirely conclusive from the presented data.  
 
 
 
 
 
 
 
 
 
 
 
  
 
CHAPTER FOUR: 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
The myosin superfamily comprises a wide range of actin-based molecular motors. While 
they share a basic structure with a considerable level of sequence homology, each myosin is 
mechanically and kinetically geared toward its particular role within the cell (Sellers, 1999).  
All myosins studied to this point, conventional and unconventional, were generally 
considered to be ATPases that hydrolyze ATP and use the released energy stored within that 
molecule to generate a force against actin (Sellers, 1999). However, the data presented here 
suggest that there may be a further subcategory of myosins that do not follow the ATPase 
convention. 
Class 18 of the myosin superfamily is the only class known to date to have an encoded N-
terminal PDZ domain (Furusawa et al., 2000). The functional role of the PDZ domain in these 
myosins has yet to be determined but is expected to play a role in scaffolding or protein-protein 
interactions (Doyle et al., 1996).  Mammalian myosin-18 isoforms have been implicated as being 
essential for a number of clinically-relevant physiological roles (Furusawa et al., 2000; Nakano et 
al., 2005; Nishioka et al., 2002; Yanaihara et al., 2004). Furthermore, evidence suggests that 
knocking out the myosin-18A gene from mice causes embryonic lethality (personal 
communication, Inna Belyantseva, NIDCD, NIH). While this protein was found to play numerous 
roles within mammalian cells, it was proposed to be insensitive to ATP (Dippold et al., 2009; 
Isogawa et al., 2005; Mori et al., 2005; Tan et al., 2008). From this standpoint, the biochemistry 
  
124
of myosin-18 is unusual and would be an interesting motor to analyze with a full biochemical 
analysis.  
The previously uncharacterized Drosophila melanogaster homologue for myosin-18 
(Mhcl) was the focus of the biochemical analysis presented in this work (Berg et al., 2001; 
Yamashita et al., 2000).  The data presented here (Chapter 2) suggest that myosin-18 is the most 
highly divergent myosin motor studied to date and, in essence, is a truly unconventional myosin.  
The gene for myosin-18 is expected to encode six alternatively spliced isoforms, some of 
which contain the N-terminal PDZ domain and others that have alternative start sites featuring N-
terminal truncations. On a cellular level, Drosophila myosin-18 motors containing or lacking the 
N-terminal PDZ were found to be localized to a variety of actin-based structures, including 
lamellipodial ruffles and microspikes, as well as to a subset of vesicles, presumably Golgi 
vesicles based on previously reported associations with that cellular apparatus in mammalian cells 
(Dippold et al., 2009). At the developmental level, myosin-18 was found by multiple approaches 
to be ubiquitously expressed at all embryonic stages.  
The domain structure of Drosophila myosin-18 shows similarities to conventional 
myosins, with a short neck region (2 IQ motifs and a WPWW motif for light chain binding) and 
an extended region of coiled-coil in the tail of the protein. Further analysis of the coiled-coil 
domain showed striking similarities with the class-2 myosins, with interruptions occurring in the 
heptad repeat of the coiled-coil like those seen as regulatory mechanisms in the conventional 
myosins (Burgess et al., 2007).  
Biochemical analysis of myosin-18 provided a different picture, of a myosin strikingly 
unlike the conventional myosins, and furthermore, quite different from any myosin studied to 
date. Initial analysis of the MgATPase activity of myosin-18 appeared to lack any recognizable 
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hydrolysis of ATP. These data were supplemented with analysis of the non-physiological 
hydrolysis of Pi in a radiometric K+-EDTA ATPase assay, which showed that Drosophila 
myosin-18 did not catalyze the hydrolysis of ATP above background levels.  
The lack of ATPase activity led us to question whether this protein could bind ATP. 
Through several different approaches, including a novel approach in the field to isolate protein 
bound to nucleotide in a filter-binding assay, the myosin-18 did not bind nucleotide at all. With 
confirmation that the expressed myosin-18 motor constructs were in fact folded properly, its actin 
binding ability was probed. Myosin-18 exhibited actin binding that saturated below 100% in an 
ATP-insensitive manner, and unbound myosin-18 was able to bind actin in a subsequent actin-
binding assay. These data suggest a potential conformational shift between two conformations – 
one competent to bind actin, and one unable to bind actin. We were able to kinetically model each 
facet of these binding characteristics, saturation below 100% during the timecourse of the 
experiment and ability to rebind actin during the timecourse of the experiment, individually but 
were unable to model both facets simultaneously from a single model. Despite our lack of a 
viable kinetic model for this binding pattern, similar properties have been noted for Limulus 
myosin-3 (Kempler et al., 2007) and myosin-9 (Nalavadi et al., 2005).  According to optical 
trapping experiments, the interaction of myosin-18 with actin is rapid, but the protein is able to 
attenuate the motility of an actively cycling myosin in actin gliding motility assays.  
Overall, these data suggest that myosin-18 is a highly divergent myosin and, in fact, is the 
most highly divergent representative of the superfamily studied to date. We expect these 
divergent properties to be the result of its amino acid sequence, which contains several amino 
acid residue substitutions from the consensus sequence in key regions for nucleotide binding and 
hydrolysis and multiple sequence extensions, some of which would encode long surface loops 
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and one that appears to be buried within the motor domain at a key region for induction of a 
powerstroke.  
In addition to the biochemical analysis of myosin-18, a separate project sought to develop 
a tool utilizing fimbrin-bundled actin for in vitro analyses of myosin motors (Chapter 3). Despite 
a potential conflict between the actin footprint of fimbrin and myosin (Matsudaira, 1994b), both 
myosin-2 and myosin-5a were able to translocate the actin bundles in motility assays. 
Furthermore, myosin-5a exhibited extended run lengths on bundle tracks in an optical trapping 
assay. Some myosins have been shown to prefer moving along actin bundles (Nagy et al., 2008; 
Ricca and Rock, 2010).  However, the data reported here for the extended run lengths in the 
single molecule regime cannot be considered conclusive in suggesting that individual myosin-5a 
molecules can travel distances over 500 sequential steps due to minimal data collected for such 
runs (N= 2). More data would be required to suggest such a conclusion.  
Both projects presented here have extensive potential for continuing the investigation of 
myosin motors.  
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4.1  Drosophila melanogaster myosin-18 
There are many questions left unanswered about Drosophila myosin-18, particularly in 
light of its highly divergent biochemistry.  
Generation of a mutant fly would be an ideal method to investigate the role of myosin-18 
in vivo. The embryonic lethality of mammalian myosin-18 contributed to the decision not to 
pursue the mutant for the current work. The presence of P-elements near the beginning of the 
Mhcl gene may be useful tools for an attempt to generate a mutant. However, there are 
complicating factors to this method. The P-elements inserted within the Drosophila myosin-18 
gene are enhancer traps meant for analysis of tissue localization of the gene products. Their 
transposable elements have been removed for this purpose, making them currently unable to jump 
out of the gene. These elements could be put back in, but the likelihood of such an event is slim 
and would require extensive screening to find a genuine mutant. Additionally, the location of the 
P-elements near the beginning of the Mhcl gene also puts them exceedingly close to Akt1, which 
is known to be embryonic lethal. Therefore, any attempt at generating a mutant fly would be a 
large undertaking with a high potential for generating futile results. 
The six alternatively spliced isoforms potentially encoded by the Mhcl gene are also of 
interest for further examination.  All six share significant sequence identity, particularly in the C-
terminal coiled-coil domain where all six isoforms are encoded by the same exons. This seeming 
redundancy begs to question what the role is for each of the isoforms. In particular, the presence 
of an N-terminal PDZ domain in three of the isoforms (A, B, and G), which only differ in their 
last exon, is of interest. If all three isoforms are expressed in Drosophila at the same time, the 
amino acid sequence encoded by the last exon must result in differential localization or binding 
partners for the protein. Alternatively, these three isoforms may differ in their expression at 
different times during development. Of further interest is the encoding of a naturally-occuring 
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∆PDZ isoform (F), that would seemingly differ in the proteins it associates with due to the lack of 
an N-terminal PDZ domain. In our biochemical analysis, we did not detect any obvious 
differences between the PDZ and ∆PDZ motors. But their existence suggests there should be 
some difference between them, perhaps on a binding-partner level.  
The additional isoforms that are expected to be encoded by the myosin-18 gene appear to 
be headless, consisting only of the IQ motifs and/or coiled-coil domain. While there is precedent 
for endogenous headless myosins (Sousa et al., 2006), and the headless transcripts of Drosophila 
myosin-18 could be isolated from mRNA pools, the potential encoding of headless myosin-18 
proteins was not investigated in the current project and would be an intriguing addition to this 
group of proteins in cells. Overall, mammalian myosin-18 has been found to play many cellular 
and developmental roles, so the six alternatively spliced isoforms may play into the wide variety 
of activities all being done by myosin-18 at the same time in different locations. Unfortunately, 
current qPCR analysis procedures cannot provide an answer to these questions.  
The association of the mammalian myosin-18 with proteins involved in lamellipodial 
organization and Golgi trafficking leave open the question of what the binding partners are for the 
Drosophila isoform. Initial attempts to identify binding partners to the PDZ domain and to the 
endogenous myosin-18 from fly lysates presented in Chapter 2 showed several interacting bands, 
too many to result in reliable binding information above non-specific binding. These experiments 
should be replicated, perhaps increasing the stringency of washes to remove non-specifically 
bound proteins, or by using an alternative antibody against myosin-18 that gives cleaner results 
from immunoprecipitations.  
Identification of binding partners extends further into determining which light chains 
bind to Drosophila myosin-18 IQ motifs. The Drosophila myosin-18 sequence shows two 
encoded IQ motifs and has a WPWW motif identical to the one found in the second IQ motif of 
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scallop muscle myosin-2, which is thought to be important to the binding of regulatory light chain 
in that myosin. However, coexpression of myosin-18 HMM constructs with virus for calmodulin 
and LC17 failed to show co-purification of those light chains suggesting that they did not bind. At 
the time of HMM expression, a virus encoding RLC was not available. Now that an RLC virus 
has been cloned and produced, the Sf9/baculovirus expression of HMM should be repeated with 
co-infection of the RLC virus to determine if RLC is able to bind this myosin.  
 
 
 
4.2   Mammalian myosin-18 
Expanding the current research into mammalian protein would be a promising endeavor, 
as the majority of the research published on class-18 of the myosin superfamily has looked at 
either human or mouse protein. Currently, that body of work consists of only a handful of 
biochemical analyses that suggest that myosin-18 is an atypical motor.  
Some of the data in the field supports the conclusions drawn from the Drosophila 
myosin-18 analysis, including its ATP-insensitive actin binding properties (Isogawa et al., 2005). 
Other data conflicts with the Drosophila data, including reports that generating an “ATPase” 
mutant of myosin-18 results in dramatic changes to cell morphology (Dippold et al., 2009; Tan et 
al., 2008). From our studies, such a mutant (made to the P-loop region of myosin-18) should not, 
as suggested in those reports, result in an alteration of ATPase activity of the motor since we 
believe that this motor is likely already incompetent to bind ATP.  
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Furthermore, there is conflict between the Drosophila data and ATPase data collected by  
a former member of the lab (Dr. Yi Yang) who had begun working on mammalian myosin-18Aα 
and 18Aβ. His data suggested that myosin-18 may have a low level of ATPase activity in an 
NADH-coupled ATP regenerating assay. Initial attempts were made to purify more mammalian 
myosin-18A isoforms from frozen Sf9 cell pellets left by this investigator.  The purified protein 
did not hydrolyze ATP (Figure 4.1), but this could be due to the age of the cell pellets, which had 
been stored at -80°C since 2003. Attempts to use the original viruses produced for the expression 
of these proteins to inoculate Sf9 cells were unsuccessful. Returning to the original DNA bacmid 
constructs used for generating the viruses, sequencing analysis showed several inconsistencies. 
The myosin-18Aα construct exhibited 4 point mutations resulting in alterations to the amino acid 
sequence within the motor domain, and 18Aβ was missing an extensive segment of sequence 
within the beginning of the motor domain. As a result of these mutations, new clones of S1 and 
full length myosin-18 were generated using plasmids provided by Melanie Barzik. They were 
transferred into pFastBac1 vector between SalI and NotI for C-terminal FLAG tagging of the 
constructs for purification.  
Each virus is currently in the amplification stage and will be used for expression of each 
construct. From these protein products, we can use a similar analysis to that used to characterize 
Drosophila myosin-18, but with the added potential of knowing binding partners from other work 
in the field. It is our intent to determine whether the mammalian isoforms of myosin-18 have 
ATPase activity, or whether they, like the Drosophila protein, are unable to bind ATP. 
Additionally, an in vitro characterization of the actin binding properties of the mammalian 
isoforms would supplement the published data of actin binding in cells.  
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Of note for the actin binding characterization done by Isogawa and colleagues (Isogawa 
et al., 2005), is that their method analyzed the actin binding properties of myosin-18 in cell 
lysates. To prepare their lysates for analysis, they first performed a high speed centrifugation spin 
(436,000 χ g) to remove the endogenous actin and cell debris. They then supplemented the 
supernatant from the first spin, presumably containing myosin-18, with exogenous F-actin in the 
presence of excess ATP or in the absence of ATP, done by depleting the cellular ATP with the 
addition of hexokinase and glucose.  They then performed a second high speed spin (436,000 χ g) 
to pull down the exogenous F-actin and any myosin-18 bound to it. From this, they characterize 
the ATP-insensitivity of actin binding for myosin-18. However, in light of our data from 
 
Figure 4.1: Steady State actin activated-ATPase assay of myosin-18A HMMα purified 
from frozen Sf9 cell pellet.  
Mammalian myosin-18A HMMα was purified by FLAG affinity purification from a frozen 
Sf9 cell pellet, and the purified myosin was assayed for actin-activated MgATPase activity in 
an NADH-coupled assay.  Representative traces of data from 1.2 µM myosin-18A HMMα in 
the absence of actin (○) show no detectable hydrolysis of ATP.  In the presence of 40 µM F-
actin and 2 mM ATP, myosin-18A HMMα (●) shows no detectable difference in rate of 
change of A340 from the ATP hydrolysis rate of actin alone (■) at the same concentration.  
Experiments were conducted at 25ºC in a buffer containing 50 mM KCl , 10 mM MOPS (pH 
7.2), 2 mM MgCl2, 0.15 mM EGTA, 2 mM ATP, and 40 units/mL lactate dehydrogenase, 200 
units/mL pyruvate kinase, 1 mM phosphoenolpyruvate, and 200 µM NADH.     
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Drosophila myosin-18, it may be possible (if the Drosophila and mammalian isoforms act in a 
similar biochemical mechanism) that their initial spin removed a portion of the endogenous 
myosin-18 that was bound to actin at the time of the spin. This would mean that their pulldowns 
were the result of binding the free myosin-18 in what would equate to our resedimentation 
analysis (Figure 2.22). Examining the double pulldown experiments with mammalian myosin-18 
S1 isoforms in vitro is particularly interesting for this project.  
Other characteristics of the mammalian myosin-18 isoforms that have not yet been 
probed are structural in nature. The PDZ domain, as of yet, has not shown any significant 
alteration to biochemistry of the Drosophila protein. In the mammalian protein, only one binding 
partner, LRAP35a, has been identified through the PDZ domain (Tan et al., 2008). According to 
superfamily analysis, the N-terminal PDZ is unique to class-18 and as such, probably plays some 
role in the functioning of this myosin within the cell. Additionally, the organization of the tertiary 
structure of the myosin-18 motor domain with an N-terminally encoded PDZ domain is 
intriguing. Ideally, crystallography of the motor domain of myosin-18 would provide the 
information needed for such an analysis. The levels of protein generated by purification of 
Drosophila myosin-18 minimal motor domains (~3-5 µM) do not generate a high enough yield 
for crystallography despite the truncation of the protein. Perhaps the mammalian myosin-18Aα 
S1 protein construct will provide higher yields for a potential attempt at a crystal structure for this 
unique motor.  
The coiled-coil is also of particular interest for the structural characteristics of myosin-18. 
SDS-PAGE analysis revealed that the Drosophila myosin-18 full length proteins were heavily 
degraded upon purification, despite making every effort to minimize this degradation via the use 
of an extensive cocktail of protease inhibitors.  It is possible that these cleavages occurred in 
surface loops in the nonhelical regions of the myosin-18 heavy chain and that the molecule stays 
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intact under non-denaturing conditions. To explore this, electron microscopy or analytical 
ultracentrifugation could be employed. According to results generated by Dr. Yang, the full 
length mammalian myosin-18 proteins do not show appreciable degradation during purification. 
Through a collaboration with John Trinick (University of Leeds), those original full length 
mammalian myosin-18 constructs were examined under negative staining rotary shadow electron 
microscopy and a portion of them formed mini-filaments in vitro. While these preliminary data 
would point to a potential oligomerization of myosin-18, extending its relationship to myosin-2, 
the work was not pursued. Presumably, there is an equilibrium between the monomeric form of 
myosin and filaments, but the nature of this equilibrium and how it is affected by ionic strength 
was not explored. Furthermore, the proportion of filamentous myosin to monomeric myosin was 
not quantified.  Repeating these experiments using the new protein, with the correctly sequenced 
myosin-18 DNA constructs, will be of utmost importance.  
 
 
4.3  Fimbrin as a Tool for Myosin Mechanics 
The project attempting to develop fimbrin-actin bundles for a tool to be used in analyzing 
myosin mechanics shows promise for providing an extended track for such analyses. If the 
fimbrin bundling is considered an adequate tool for use in the lab, it could be introduced to other 
myosin motors for analysis of their ability to move along bundles.  
While there are many potential applications for such a tool, a significant amount of 
testing is still required to make the tool reliable and to confirm its value in such experiments.  
In analyzing the maximum run length of myosin-5a using optical trapping, the single 
molecule regime used must be replicated many more times before a stable conclusion can be 
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made about whether such a single dimerized cargo-carrying motor could transverse the actin 
bundle for extended distances. If, in fact, the extended run lengths (~500 consecutive steps) seen 
in the single molecule regime are reliable data, then the bundles may, as proposed, allow the 
motor to choose from multiple parallel actin filaments to continue its processive movement. 
However, the data are few in number thus far.  
An alteration to this assay, which could help probe whether or not single molecules are 
able to take extended runs, would be to use smaller polystyrene beads for myosin coating in the 
assay. A smaller bead size, on par with a vesicle size around 200 nm, would diffuse away from 
the bundle faster than the large beads used in the current analysis. The use of smaller beads could 
more accurately represent the processivity of single processive motors on bundles. Studies have 
since explored the movement of single, fluorescently labeled myosin-5a molecules (not attached 
to beads) on actin bundles made from fascin (Nagy et al., 2008). The run lengths obtained from 
those experiments are similar to reports of run lengths on single actin filaments. This raises the 
question of whether fimbrin bundles may be more amenable to processive movements of myosin-
5a or whether the large bead size facilitated the long processive runs by slowing the rate of 
diffusion during periods of transient detachment of the motor from actin.  In this regard, it is 
interesting that Yanagida and coworkers found that a single-headed myosin-6 construct bound to 
beads was capable of moving “processively” (Iwaki et al., 2008).  
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4.4   Conclusion 
The last decade has witnessed a rapid expansion in the number of proteins discovered and 
recognized as being members of the myosin superfamily. The understanding of what a myosin 
motor is has also evolved, originally from a classification of conventional myosins found in 
muscle, and expanding to include a plethora of unconventional myosins that due a variety of tasks 
within the cell. Further discovery of previously unknown myosins has come at the hand of 
genomic screening, which has allowed identification of undiscovered myosins based on the 
putative motor domain sequence shared by myosin motors. Among these genomically identified 
myosins is myosin-18 from Drosophila melanogaster.  
Through biochemical analysis, we have discovered that this myosin is particularly 
unique. While it has some structural features that would outwardly make it appear to belong to 
the conventional myosins, including a long segmented coiled-coil domain, its biochemical 
activity makes it difficult to place even within the broad spectrum of unconventional myosins. To 
date, this is the first myosin recognized as being unable to bind ATP, refuting one of the 
hallmarks of myosin motor characteristics. Despite its abnormal biochemistry, it appears to be 
essential in humans and mice, causing disease and embryonic lethality, respectively, when 
mutated or lost.  
The current characterization of Drosophila myosin-18 appears to broaden the scope of 
the myosin superfamily even beyond what is currently considered unconventional. This myosin 
suggests that some members of the myosin superfamily may not act as active motors, but rather 
as dynamic actin tethers that perform a variety of functions within the cell despite their lack of 
typical myosin activity. Together, the data collected on myosin-18 suggest that it is the first 
recognized myosin to be truly unconventional.  
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